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Abstract  
 
Background: 
The results of surgery for tears of the rotator cuff are variable, with failure occurring 
in up to 94% of cases. Demineralised bone matrix (DBM) consists of a collagen 
scaffold containing multiple growth factors and has been used successfully to improve 
tendon-bone healing. By combining DBM with stem cells its effects may be enhanced 
given that many of the growth factors it contains are able to direct stem cell 
differentiation down tenogenic, chondrogenic, and osteogenic lineages. These cell 
lines produce elements essential to the formation of a naturally graded enthesis.  
 
Aim: 
To investigate the effect of DBM on regeneration of the tendon-bone interface, and 
whether its function can be enhanced by mesenchymal stem cells (MSCs).  
 
Hypothesis:  
DBM will improve tendon-bone healing in an enthesis defect model, and its effect 
may be further enhanced by the incorporation of MSCs. 
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Methods:  
The following experiments were undertaken in order to investigate the hypothesis: 
 
1. Tensile testing of allogenic and xenogenic cortical/cancellous DBM. 
2. Evaluating the effect of allogenic and xenogenic DBM, incorporated with 
MSCs, on regeneration of the enthesis in a large animal model of severe 
tendon retraction. 
3. Development of a chronic rotator cuff tear model.  
4. Investigation of tendon-bone healing using DBM in a chronic rotator cuff tear 
model.  
5. Investigation of tendon-bone healing using DBM and MSCs in a chronic 
rotator cuff tear model. 
 
Results: 
Allogenic cortical DBM possessed the greatest tensile strength and was used in vivo 
to examine tendon-bone healing complicated by retraction. In this, DBM regenerated 
a direct enthesis characterised by fibrocartilage. A similar effect was noted in a 
chronic rotator cuff tear model with no additional effect conferred by the stem cells.  
 
Conclusion:  
This thesis has shown that DBM can regenerate a fibrocartilaginous enthesis in 
models of tendon retraction and chronic rotator cuff degeneration.  
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Chapter One: Introduction
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1.1 Aims and Hypotheses 
    
This thesis aims to investigate the effect of demineralised bone matrix (DBM) on 
regeneration of the tendon-bone interface, and whether its function can be augmented 
by mesenchymal stem cells (MSCs). To achieve this, the following overarching 
hypothesis will be tested: 
 
DBM will improve tendon-bone healing in an enthesis defect model, and its effect may 
be further enhanced by the incorporation of MSCs.  
 
The introductory chapter provides an overview of tendon biology and rotator cuff 
tears. Specific attention is given to tissue engineering strategies that are currently 
employed to enhance tendon-bone healing and the rationale for using DBM in this 
setting.  
 
Chapter Two examines the mechanical properties of ovine and porcine demineralised 
cortical and cancellous bone matrix. Given the low costs associated with xenogenic 
scaffolds its use in tendon-bone healing would be advantageous, but it is essential to 
first establish whether it possesses the appropriate mechanical properties. The second 
part of this chapter aims to determine whether there is a difference in tensile strength 
between cortical and cancellous DBM, since the latter may be a superior carrier of 
MSCs due to its porosity. Thus, it was hypothesised that the tensile strength of 
cancellous DBM would be significantly lower than that of cortical DBM, and that 
there would be no difference between ovine and porcine scaffolds.  
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Chapter Three applies the information gained about DBM in Chapter Two to 
investigate its effect on tendon-bone healing in a non-degenerative ovine model of 
tendon retraction, to simulate an irreparable rotator cuff tear. This involved creating a 
1 centimeter (cm) ovine patellar tendon defect and then repairing it with either 
xenogenic cortical DBM (porcine) + minimally manipulated MSCs (mmMSCs) or 
allogenic cortical DBM (ovine) + mmMSCs. Autogenic MSCs were derived from the 
buffy layer obtained from bone marrow aspirates, which were harvested from the iliac 
crest of each animal at the time of surgery. Functional outcome was measured using 
force plate analysis at six, nine, and 12 weeks post-operatively. Histology was used to 
assess morphological recovery of the enthesis at 12 weeks. The hypothesis tested was 
that tendon-bone healing augmented with autologous mmMSC-enhanced xenogenic 
and allogenic DBM, would result in restored function and morphology of the enthesis 
by 12 weeks. 
 
Chapter Four outlines the development of a clinically relevant chronic rotator cuff 
tear model in order to evaluate the presence of osteopenia at the enthesis and the time 
taken for degenerative changes to become apparent. The latter was examined by 
determining the extent of muscle atrophy, changes in muscle architecture, and fatty 
infiltration of the musculotendinous unit. It was hypothesised that detachment of 
supraspinatus from the humerus would result in osteopenia and tendon degeneration 
akin to what is seen in clinical practice.  
 
Chapter Five utilises the animal model established in Chapter Four to examine rotator 
cuff tendon-bone healing. The supraspinatus tendon was first detached and then 
reattached to its bony insertion at the time point identified in Chapter Four. Healing 
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was augmented with either cortical DBM or GraftJacket [Wright Medical 
Technology, Inc., Arlington, TN (Tennessee)]. It was hypothesised that compared to a 
commercially available scaffold (GraftJacket), DBM would regenerate a functionally 
and morphologically superior enthesis in a rat model of chronic rotator cuff 
degeneration. 
 
Chapter Six investigates whether the effect of DBM can be enhanced by the 
incorporation of culture-expanded MSCs at the repair site of a chronic rotator cuff 
tear. Using a similar operative protocol to Chapter Five, the supraspinatus tendon was 
detached and then later reattached to the humerus using either DBM + MSCs, 
GraftJacket + MSCs, or MSCs alone. The hypothesis was that compared to 
GraftJacket + MSCs and MSCs alone, the addition of cortical DBM + MSCs to the 
healing enthesis would regenerate a functionally and morphologically superior 
enthesis in a rat model of chronic rotator cuff degeneration.  
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1.2 The Clinical Problem 
 
Shoulder pain is a significant socioeconomic burden and accounts for 2.4% of all 
General Practitioner (GP) consultations in the United Kingdom (UK) and 4.5 million 
visits to physicians annually in the United States (Carr et al., 2015a). This equates to 
500,000 adults in England and Wales and costs the National Health Service (NHS) 
£310 million per year (Littlewood et al., 2012).  
 
Rotator cuff disease encompasses a wide spectrum of pathological conditions 
including tendinitis, partial/full-thickness tears, and calcific tendinitis. The natural 
history and progression of rotator cuff tendinitis to a subsequent tear remains poorly 
understood (Iannotti, 1994). Rotator cuff tears affect 30-50% of patients over the age 
of 50 years and are a common cause of function-limiting pain and weakness of the 
shoulder (Zhao et al., 2014, Isaac et al., 2012). Approximately 75% of all rotator cuff 
tears only involve supraspinatus (Dunn et al., 2014). Many patients choose to have 
surgery due to disabling or progressive symptoms and this has been reflected in a 
500% increase in the rate of repair since 2001, in the UK (Hakimi et al., 2013). In the 
United States an estimated 75,000 rotator cuff surgeries are performed annually and 
this number is likely to rise given an ageing population with greater functional 
demands (Vitale et al., 2007). By effectively augmenting healing of the rotator cuff 
the number of retears and tendons that failure to heal should decline, and in turn fewer 
revision surgeries would be required. Reducing the time taken for the rotator cuff to 
heal and increasing the strength of the initial repair will allow patients to rehabilitate 
more effectively and result in the restoration of normal tendon strength and function 
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at an earlier stage. Patients will consequently be able to return to work sooner and 
thereby minimise the amount of money lost by their employers through sick days. 
 
Understanding the patho-anatomy of rotator cuff tears has improved over the last 
decade and treatment strategies have evolved considerably. Poor biological healing is 
still problematic with failure of tendon-bone fixation occurring in up to 26% of small 
to medium tears and up to 94% in large and massive tears (Galatz et al., 2004, Bishop 
et al., 2006, Iannotti et al., 2006, Klepps et al., 2004, Sclamberg et al., 2004). The 
cause of the high retear rate is multifactorial and may be attributed to the older age of 
the patient, quality of the tissue, chronicity and size of the tear, muscle atrophy, fatty 
infiltration, bone mineral density, and repair technique (single vs double row repair) 
(Deniz et al., 2014, Chung et al., 2013, Chung et al., 2011, Tashjian et al., 2010). In 
selected patients, mechanical and biological enhancement of the tendon-bone 
interface may be integral to a successful outcome following surgery (Aurora et al., 
2012). 
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1.3 Tendon 
 
Microstructure  
 
Tendons connect muscle to bone and allow the transmission of forces generated by 
muscular contraction in order to produce movement at a joint. Healthy tendons are 
white in appearance and have a fibro-elastic texture. Their form is varied and can 
adopt the shape of either rounded cords, strap-like bands, or flattened ribbons. Water 
accounts for 70% of total tendon mass. The remaining 30% is dry mass and is 
primarily made up of collagen type I (65-80%) (Sharma and Maffulli, 2005). Between 
the densely pack collagen fibers are rod- or spindle-shaped fibroblast-like cells 
(tenoblasts and tenocytes) aligned parallel to the longitudinal axis of tensile load. 
These are embedded within a well-organised extracellular matrix (ECM) that contains 
glycoproteins and proteoglycans such as decorin and aggrecan (James et al., 2008).  
 
Tenoblasts are spindle-shaped immature tendon cells that contain numerous 
cytoplasmic organelles to maintain their high metabolic activity. As they mature and 
transform into tenocytes their shape becomes elongated. Tenocytes synthesise 
collagen and all components of the ECM. Collagen constitutes the basic functional 
unit of a tendon. It is organised in hierarchical levels of increasing complexity 
commencing with a triple helix polypeptide chain that unites into fibrils with cross-
links between adjacent helices. At the myotendinous interface these fibrils are 
inserted into deep recesses formed by myocytes and absorb the tension created from 
muscular contraction thereby limiting the stresses exerted on the tendon (Kvist et al., 
1991, Michna, 1983, Trotter and Baca, 1987, Tidball and Daniel, 1986). In the 
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remaining tendon, collagen fibrils are bundled together to form large fibers that are 
visible under light microscopy as a crimped pattern. This characteristic facilitates 
elongation of the tendon and prevents damage from sudden mechanical loading. 
Fibers are subsequently arranged into bundles (fascicles) by the endotenon, which in 
turn are held together by an epitenon to form the tendon (Amiel et al., 1984, Dykyj 
and Jules, 1991, Kastelic et al., 1978) (Figure 1.1). Surrounding the epitenon is a 
loose connective tissue layer (paratenon) consisting of type I and type III collagen 
fibrils, elastic fibrils, and synovial cells (Kvist et al., 1985).   
 
 
 
 
 
Figure 1.1: Hierarchical structure of tendon. Reproduced with permission from 
Sharma and Maffulli, 2005.   
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Biomechanics  
 
Tendons possess a number of unique properties in order to carry out their normal 
function of load transfer: high mechanical strength, flexibility, and elasticity 
(Kirkendall and Garrett, 1997, O'Brien, 1992, Oxlund, 1986). The mechanical 
behaviour of collagen determines the physical properties of tendon and can be 
demonstrated using a stress-strain curve (Figure 1.2).  
 
 
 
Figure 1.2: Stress-strain curve demonstrating the basic physical properties of tendon. 
 
 
 33 
The initial part of the curve (toe region) represents flattening of the crimped pattern 
that characterises collagen fibrils at rest. This occurs when the tendon is strained up to 
2% (Hess et al., 1989, Butler et al., 1978, Viidik, 1973). Beyond this, the tendon 
deforms in a linear fashion as the collagen triple helices slide and the fibers become 
more parallel (Young’s modulus/stiffness) (Mosler et al., 1985). Below 4% strain the 
tendon retains its elastic properties and returns to its original length when unloaded 
(Sharma and Maffulli, 2005). Beyond 8-10% strain macroscopic failure occurs 
(O'Brien, 1992, Butler et al., 1978, Kastelic and Baer, 1980).       
 
The Enthesis 
 
Tendon and bone demonstrate different mechanical properties. Tendon has a tensile 
modulus of approximately 200 Megapascals (MPa) in the direction of muscular 
contraction but fails under compression (Thomopoulos et al., 2010). In contrast, 
cortical bone has a modulus of 20 Gigapascals (GPa) in both tension and compression 
making it relatively brittle and rigid compared to tendon (Thomopoulos et al., 2010). 
The attachment of a flexible material such as tendon to a stiff material such as bone is 
challenging. This has been overcome by the native enthesis, which is the anatomical 
region located between these two distinct structures.  
 
The enthesis has two forms: direct and indirect (Woo and Buckwalter, 1988). Indirect 
entheses attach to the metaphysis and diaphysis of bone by merging with periosteum 
via the superficial layers of tendon, supported by deeper penetrating Sharpey’s fibers 
anchoring it to the underlying bone. In contrast, a direct enthesis such as the rotator 
cuff inserts onto bone by a naturally graded fibrocartilaginous structure comprising 
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mineralised and demineralised tissue-types (Figure 1.3). The demineralised 
component resists compression within the distal tendon, and the mineralised 
component resists shearing across the bone surface (Benjamin et al., 1986).  
 
 
 
Figure 1.3: Morphology of the supraspinatus tendon-bone insertion site illustrating 
tendon (T), fibrocartilage (FC), mineralised fibrocartilage (MFC), and normal bone 
(NB).  
 
The first zone is tendon proper, and consists of well-aligned type I collagen fibers and 
small quantities of decorin (Waggett et al., 1998, Woo SL, 2000). Zone two is the 
transitional region between tendon and bone. This is primarily composed of 
fibrocartilage, which is characterised by types II and III collagen, and small amounts 
of the proteoglycans aggrecan and decorin (Waggett et al., 1998, Thomopoulos et al., 
2003, Kumagai et al., 1994, Fukuta et al., 1998, Sagarriga Visconti et al., 1996). The 
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third zone is mineralised fibrocartilage and corresponds to the gradual change to bony 
tissue. In this area, types II and X collagen predominate (Ralphs et al., 1998, 
Thomopoulos et al., 2003, Kumagai et al., 1994, Fukuta et al., 1998, Sagarriga 
Visconti et al., 1996). Bone is the final part of the enthesis and is made of type I 
collagen with a high mineral content.   
 
Although the enthesis has been recognised to consist of several distinct tissue-types, 
there is evidence to suggest that there is a natural gradation along its length that is 
responsible for the effective distribution of forces. This encompasses a variation in 
collagen structure, ECM composition, mineral content, and viscoelastic properties 
(Thomopoulos et al., 2010). 
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1.4 The Rotator Cuff 
 
Structure and Function   
 
The muscles of the rotator cuff (subscapularis, supraspinatus, infraspinatus, and teres 
minor) play an important role in glenohumeral motion and stability (Escamilla et al., 
2009). All four tendons fuse around the tuberosities of the humerus to form an 
insertion site that is made up of ‘footprints,’ corresponding to each muscle (Figure 4) 
(Curtis et al., 2006). Subscapularis is the largest musculotendinous unit of the rotator 
cuff and inserts onto the lesser tuberosity. It predominantly functions to internally 
rotate the shoulder and produces a maximum force of 1725 Newtons (N) at 90 ° of 
abduction (Escamilla et al., 2009, Hughes and An, 1996). Infraspinatus and teres 
minor constitute the posterior cuff (by way of their insertion on the greater tuberosity) 
and mediate external rotation, whilst exerting a postero-inferior force on the humeral 
head to resist antero-superior translation (Escamilla et al., 2009, Sharkey and Marder, 
1995). Both muscles are strongest in 0 ° of abduction, with teres minor generating 159 
N and infraspinatus generating 909 N (Hughes and An, 1996).  
 
Supraspinatus inserts onto the greater tuberosity above infraspinatus, which occupies 
a larger cross-sectional area (Curtis et al., 2006). In a study examining the tendon of 
supraspinatus, the anterior portion resembled a tendinous band whereas the posterior 
portion was thin and membranous. These anatomical variations contribute to the 
greater strength associated with the anterior part (Itoi et al., 1995). Supraspinatus is 
often regarded as an initiator of shoulder abduction, but it also provides weak 
 37 
rotational movements. At 90 ° of abduction in the scapular plane it generates a peak 
force of 117 N (Figure 1.4) (Curtis et al., 2006, Hughes and An, 1996).  
 
 
 
Figure 1.4: Anterior (A) and posterior (B) views of the right humeral head showing 
attachments of subscapularis (blue), supraspinatus (green), infraspinatus (red), and 
teres minor (orange). The yellow area denotes the articular surface.  
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Considerable inter-digitation exists between tendon fibers making it difficult to 
identify specific insertion points (Curtis et al., 2006). This tendinous portion is 
confluent with the capsule of the shoulder joint, the coracohumeral ligament, and the 
glenohumeral ligaments. The rotator cuff is therefore divided into five histological 
layers with the orientation of the tendon fascicles varying according to depth. This 
allows it to resist tensile forces throughout all planes of glenohumeral motion (Figure 
1.5) (Clark and Harryman, 1992).     
 
 
 
Figure 1.5: The five layers of the rotator cuff. Layers 1 and 4 contain fibers from the 
coraco-humeral ligament. Layers 2 and 3 demonstrate a predominance of fibers that 
course medial to lateral. Layer 5 is the glenohumeral joint capsule.  
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From the glenohumeral joint the superior aspect of the rotator cuff resembles a 
capsular thickening (rotator cable) surrounding, and protecting, a thinner portion of 
tissue (the crescent region) inserting onto the greater tuberosity (Burkhart et al., 1993) 
(Figure 1.6). The rotator crescent comprises the distal portions of the supraspinatus 
and infraspinatus tendon insertions, located within the ‘critical (watershed) zone’ of 
avascularity. This makes it vulnerable to tendinopathy and eventual tearing 
(Karthikeyan et al., 2015, Burkhart et al., 1993).   
 
 
 
Figure 1.6: Posterior aspect of the rotator cable and crescent in a right shoulder. 
Rotator cable (C), mediolateral diameter of rotator crescent (Cr), supraspinatus (S), 
infraspinatus (I), and teres minor (TM).  
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Types of Rotator Cuff Tear  
 
1.1.1.1. Acute vs Chronic Tears  
 
Less than 10% of rotator cuff tears occur as a result of acute trauma. The majority are 
degenerative in nature (Loew et al., 2015, Bassett and Cofield, 1983). In patients less 
than 40 years only a forceful injury, such as a shoulder dislocation, is capable of 
tearing the rotator cuff tendon (Loew et al., 2015). Alternatively, in the elderly 
population minor traumatic events may exacerbate long-standing degenerative 
changes to result in a tear (acute-on-chronic tear) (Loew et al., 2015). Distinguishing 
between these two entities is crucial since the results of surgery are superior in 
traumatic tears (Braune et al., 2003). Indicators of acute tears include muscle oedema 
and ‘kinking’ of the proximal tendon, in contrast to chronic injuries that are 
characterised by advanced atrophy, loss of cellularity, loss of vascularity, loss of 
fibrocartilage at the enthesis, fatty infiltration, calcification, and degeneration of the 
muscle (Loew et al., 2015, Nho et al., 2008). Fatty infiltration can be graded on 
magnetic resonance imaging (MRI) according to the classification proposed by 
Goutallier et al (1994): Grade 0 – normal muscle, Grade 1 – some fatty streaks, Grade 
2 – more muscle than fat, Grade 3 – equal amounts of fat and muscle, and Grade 4 – 
more fat than muscle.   
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1.1.1.2. Full Thickness vs Partial Thickness Tears 
 
Several rotator cuff tear classification systems have been proposed in the literature 
(Patte, 1990, DeOrio and Cofield, 1984, Harryman et al., 1991, Wolfgang, 1974). 
Many of these were derived from the simple concept that tears maybe either partial or 
full-thickness. Partial thickness tears typically begin approximately 13 to 15 
millimeters (mm) posterior to the biceps tendon, near the junction of the supraspinatus 
and infraspinatus tendons, and exhibit a low rate of progression (Maman et al., 2009, 
Kim et al., 2010). Full-thickness tears allow communication between the 
glenohumeral joint and subacromial-subdeltoid bursa and are considered ‘massive’ 
when they are greater than 5 cm in the largest diameter and involve at least two 
tendons (Chang and Chung, 2014, Pill et al., 2012).   
 
The difficulty with having so many categories of tear is that agreement between 
clinicians may vary thus defeating the main objective of any classification system, 
which is to guide treatment. Kuhn et al (Kuhn et al., 2007) examined several 
classifications systems for partial and full-thickness rotator cuff tears to assess inter-
observer variation and inter-observer agreement. With the exception of distinguishing 
partial-thickness from full-thickness tears and identifying the side (articular vs bursal 
vs intratendinous) of involvement with partial-thickness tears, other methods of 
categorising tears had little inter-observer agreement. For full-thickness tears, the 
degree of retraction in the frontal plane was found to be the most reliable: Stage 1: 
close to the bony insertion, stage II: at the level of the humeral head, or stage III: at 
the level of the glenoid (Figure 1.7) (Patte, 1990).   
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Figure 1.7: Grading rotator cuff tears according to the level of retraction in the frontal 
plane. Stage 1: close to the bony insertion, stage II: at the level of the humeral head, 
or stage III: at the level of the glenoid.  
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Rotator Cuff Healing  
 
Healing of the rotator cuff takes place in three stages (inflammation, proliferation, and 
remodeling): 
  
1. Inflammation 
 
Immediately following injury, bleeding within the tendon produces a haematoma. 
This activates several chemotactic factors that recruit inflammatory cells from 
surrounding tissue to remove tissue debris by phagocytosis. Fibroblasts enter the area 
and synthesise various components of the ECM, and angiogenic proteins promote the 
formation of a vascular network (Lindsay and Birch, 1964).  
 
2. Proliferation 
 
Recruitment of fibroblasts continues and their rapid proliferation is responsible for the 
deposition of type III collagen to form callus. Once this collagen-rich ECM has been 
laid down it is remodeled, causing scar contraction. The resultant tissue has a higher 
ratio of type III collagen to type I collagen, a property that renders it weaker and more 
prone to re-rupture (Galatz et al., 2007, Gao et al., 1996, Bedi et al., 2012, Isaac et al., 
2012, Rodeo et al., 1993). One factor that may contribute to the formation of this scar 
tissue is the mechanical strain during the initial phases of healing. At birth, the rotator 
cuff tendon is attached to the perichondrium of the cartilaginous humeral head by an 
attachment that bears no histological resemblance to the adult insertion site. This 
changes first at seven days post-natally where a fibrocartilaginous bridge is seen and 
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then at 56 days postnatal where the typical four zones of the enthesis are visible. 
Since the mechanical environment changes substantially following birth, it is 
plausible that this loading of the cuff is the primary agonist for change (Galatz et al., 
2007). Furthermore, studies have indicated that compressive forces lead to the 
production of proteins associated with fibrocartilage (e.g. aggrecan) and tensile forces 
lead to the production of proteins associated with tendon (e.g. type I collagen) 
(Evanko and Vogel, 1990, Vogel et al., 1994). Other factors contributing to a poor 
healing response include an inadequate population of undifferentiated stem cells at the 
healing tendon-bone interface, the presence of macrophages at the site of tissue 
injury, and insufficient bony ingrowth into the tendon (Bedi et al., 2012, Kovacevic 
and Rodeo, 2008).   
 
3. Remodeling  
 
Remodeling begins six to eight weeks after injury and is characterised by a decrease 
in cellularity, reduction in matrix synthesis, decrease in type III collagen, and an 
increase in type I collagen. Type I collagen fibers align parallel to the mechanical axis 
of the tendon and interact with one another to result in an improvement in tensile 
strength, albeit less than the native uninjured tendon (James et al., 2008).    
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Factors Affecting Rotator Cuff Healing  
 
Healing of the rotator cuff is associated with an improvement in function (Carr et al., 
2015a, Mihata et al., 2011). It is affected by both patient and surgical factors, which if 
optimised, may result in better outcomes (Mall et al., 2014).  
 
1.1.1.3. Surgical Factors  
 
Rotator cuff repairs can be undertaken using either arthroscopic or open surgery. For 
many years there has been conflicting evidence as to which is the most effective 
method. Arthroscopic surgery causes less damage to surrounding soft tissues such as 
the deltoid, and has the theoretical advantage of causing less postoperative pain while 
permitting earlier mobilisation. This comes at the expense of longer surgical time and 
the use of expensive equipment. A recent randomised controlled trial evaluated the 
effectiveness of these two techniques and determined that in patients over the age of 
50 years with a degenerative tear, there was no difference in functional outcome or 
cost. Healed repairs gave the best outcome followed by a repair that subsequently re-
tore (Carr et al., 2015a).      
 
Tendon-bone fixation is often achieved using suture anchors (Figure 1.8). Failure of 
this mechanism has been noted to occur at the suture-tendon interface, suture anchor-
bone interface, or within the suture material itself (Kim et al., 2006). During rotator 
cuff repair, suture anchors can be place in either a single or double-row. Double-row 
repairs have the perceived advantage of increasing compression of the tendon against 
its bony footprint, but are associated with increased costs and surgical time. Mimata et 
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al (Mimata et al., 2015) reviewed 206 shoulders in 201 patients with full-thickness 
rotator cuff tears that underwent arthroscopic rotator cuff repair. Retear rates were 
10.8%, 26.1%, and 4.7% for single-row, double-row, and compression double-row 
techniques respectively. In a randomised controlled trial Franceschi et al (Franceschi 
et al., 2016) demonstrated a significantly lower full-thickness retear rate for patients 
who underwent a double-row repair compared to those that had a single-row repair 
(8% vs 24% respectively). Other surgical factors that affect healing of the rotator cuff 
include location of the knot used to repair the tendon, the use of knotless repairs, the 
material of suture anchor, and postoperative rehabilitation (early vs delayed motion) 
(Mall et al., 2014).  
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Figure 1.8: Supraspinatus tendon-bone fixation using a suture anchor. 
 
1.1.1.4. Patient Factors  
 
Despite optimising surgical techniques some rotator cuff repairs still fail to heal (Mall 
et al., 2014). Several studies have demonstrated an age difference in healing rates 
after surgery (Boileau et al., 2005, Charousset et al., 2010, Cho and Rhee, 2009). 
Yamaguchi et al (Yamaguchi et al., 2006) undertook an observational study of 588 
consecutive patients with shoulder pain and found that the average age was 49 years 
for patients with no rotator cuff tear, 59 years for those with a unilateral tear, and 68 
years for those with a bilateral tear. In a large cohort study of 272 patients who 
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underwent arthroscopic rotator cuff repair the failure rate was significantly higher in 
older patients although this was not a consistent finding on multivariate analysis, 
which identified bone mineral density, fatty infiltration of the infraspinatus, and the 
amount of tear retraction at the time of surgery as the only independent predictors of 
healing (Chung et al., 2011).     
 
Tear characteristics influence rotator cuff healing with larger tears and those 
involving multiple tendons exhibiting the highest failure rates (Mihata et al., 2011, 
Charousset et al., 2010, Nho et al., 2009, Tashjian et al., 2010). Tissue quality also 
plays an important role with fatty infiltration and degenerative changes contributing 
the most to poor healing (Nho et al., 2009, Pedowitz et al., 2012, Chung et al., 2011).  
 
Osteopenia in the greater tuberosity is a common finding in patients with rotator cuff 
tears due to the loss of physical stimuli at the enthesis (Cadet et al., 2008, Postl et al., 
2013, Waldorff et al., 2011). This reduces the pull-out strength of suture anchors and 
therefore the quality of tendon fixation (Braunstein et al., 2015). Accordingly, bone 
mineral density has been identified as an independent risk factor for rotator cuff 
healing (Chung et al., 2011).  
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1.5 Diagnosing Rotator Cuff Tears 
 
1.5.1 Clinical Presentation  
 
Rotator cuff tears present in three clinical settings: acute traumatic, acute-on-chronic, 
and chronic atraumatic (Green, 2003). Pain radiating down the arm (due to 
involvement of the subdeltoid and subacromial bursae), stiffness, and weakness of the 
arm are the most commonly reported symptoms and suggest tendon degeneration 
when present before an injury (Wolff et al., 2006, Iannotti, 1994). Pain typically 
occurs during overhead activities (in a ‘painful arc’ of movement) or at night, and is 
more severe in partial-thickness tears (Fukuda, 2000). Chronic tears present with 
insidious symptoms and are often associated with preserved range of motion due to 
compensatory deltoid muscle strength (Green, 2003).   
 
Some rotator cuff tears may be asymptomatic but approximately 50% of these 
become painful within three years (Yamaguchi et al., 2001). While this may indicate 
tear extension in some cases, in others, pain can develop without tear extension and 
tear extension can develop without pain (Yamaguchi et al., 2001, Dunn et al., 2014). 
The importance of pain in decision-making has yet to be determined, particularly 
since psychosocial factors have been demonstrated to play a more important role in 
patient-reported pain and function than tear severity (Wylie et al., 2016).  
 
A detailed physical examination is crucial to accurately evaluate the rotator cuff. Both 
shoulders and scapulae must be exposed. Swelling and bruising may be present in 
acute tears, whereas muscle atrophy is a more common feature of chronic injuries. 
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Active and passive range of movement should be examined. A ‘painful arc’ of 
movement indicating impingement may be present during passive motion, and should 
be further evaluated with provocative maneuvers such as the Hawkins-Kennedy test. 
In this, a positive impingement sign is denoted by pain in the subacromial space when 
the arm is passively internally rotated in 90° of forward elevation and 90° of elbow 
flexion (Hawkins and Kennedy, 1980). Strength is often preserved with small tears 
but weakness is often present with larger tears. Approximately 95% of rotator cuff 
tears involve supraspinatus and consequently lead to weakness in abduction and 
elevation of the arm (Dunn et al., 2014). This can be assessed using the ‘empty can 
test’ (Jobe test) where shoulder abduction is resisted in internal rotation (Hughes et 
al., 2008).  
 
Findings consistent with a chronic massive rotator cuff tear include antero-superior 
subluxation of the humeral head, infraspinatus muscle atrophy, external rotation 
weakness (due to infraspinatus involvement), and rupture of the proximal part of the 
tendon of the long head of biceps (Green, 2003). Specific attention should be given to 
tears of the subscapularis, as these may be under-diagnosed. Subscapularis 
involvement occurs in less than 10% of cases and can be associated with weakness of 
internal rotation and excessive passive external rotation (Gerber and Krushell, 1991, 
Dunn et al., 2014).    
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1.5.2 Radiographic Evaluation 
 
1.5.2.1 Plain Radiographs 
 
Several imaging modalities can be used to assist in the diagnosis of rotator cuff tears. 
Plain radiographs are often taken when a patient presents to a health-care provider 
(General Practitioner, surgeon, or other health professional) with shoulder pain and 
should involve two views: antero-posterior and axillary. Bony anatomy can be 
evaluated for arthritis (rotator cuff arthropathy) and acromiohumeral distance. The 
latter is defined as the distance between the acromion and the humeral head and is 
consistent with chronic rotator cuff pathology when less than 7 mm (Green, 2003). 
Specialised projections, such as when the X-Ray beam is directed 10° caudally, can 
examine acromial morphology (flat, curved, or hooked) and identify acromial spurs 
(Iannotti, 1994).  
 
1.5.2.2 Ultrasonography 
 
Ultrasonography is a noninvasive, cost-effective tool that can be utilised as an initial 
screening study to determine the size and level of retraction of a tear (Crass et al., 
1984, Mack et al., 1988). Sensitivity and specificity of ultrasound has been reported to 
be as high as 94% and 93% respectively but its accuracy is highly dependent upon the 
operator and can be enhanced by obtaining dynamic images through the range of 
shoulder motion (Green, 2003, Brenneke and Morgan, 1992, Wiener and Seitz, 1993). 
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1.5.2.3 Magnetic Resonance Imaging 
 
MRI provides a comprehensive assessment of the rotator cuff and has the advantage 
of being able to measure the size of a tear, the magnitude of tendon retraction, the 
extent of fatty infiltration, and the degree of muscle atrophy (Iannotti, 1994, Green, 
2003, Iannotti et al., 1991). MRI is similar to ultrasonography in its ability to estimate 
the size of a rotator cuff tear but it is a more useful preoperative investigation because 
it can define other associated pathology such as arthritis and rupture of the long head 
of the biceps tendon (Bryant et al., 2002, Iannotti et al., 2005, Teefey et al., 2004).  
 
1.5.2.4 Arthrography  
 
Arthrography is an imaging technique in which a radio-opaque contrast in injected 
into the shoulder joint. It has been reported to have an accuracy of greater than 95% in 
the diagnosis of full-thickness rotator cuff tears but it is limited in its ability to 
estimate the size of a tear and to identify a partial-thickness tear (Mink et al., 1985).    
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1.6 Treatment of Rotator Cuff Tears  
 
In the United States more than 300,000 rotator cuff repairs are performed annually 
(Colvin et al., 2012). Quantifying the risk and rate of tear progression is fundamental 
to formulating appropriate indications for surgery. In a long-term prospective study of 
224 patients with an asymptomatic rotator cuff tear (118 initial full-thickness tears, 56 
initial partial-thickness tears, and 50 controls) in one shoulder and pain due to rotator 
cuff disease in the contralateral shoulder, tear enlargement was observed in 49% of 
cases within 2.8 years. This was related to the magnitude of the initial tear, with a 
greater proportion of full-thickness tears increasing in size when compared to partial-
thickness tears (61% vs 41%). Tear enlargement was significantly associated with 
ongoing degeneration and the onset of new pain (Keener et al., 2015).     
 
Without repair, the rotator cuff has limited capacity to heal; yet conservative 
treatment often yields a satisfactory outcome (Kukkonen et al., 2015, Lambers 
Heerspink et al., 2015, Yamaguchi et al., 2001). The main drawbacks of a non-
operative approach are tear progression, ongoing pain, and deterioration in function 
over time. These problems are still a concern following surgery, particularly retears. 
These most frequently occur between six and 26 weeks postoperatively and have been 
noted to occur in up to 94% of cases (Galatz et al., 2004, Iannotti et al., 2013).  
 
Optimal treatment of symptomatic, non-traumatic (degenerative) rotator cuff tears is 
unknown. In a randomised controlled-trial of 160 patients over the age of 55 years 
with symptomatic, non-traumatic rotator cuff tears there were no significant 
differences in function between surgery and conservative treatment at two years 
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follow-up. Surgery was associated with a significantly smaller tear size and increased 
costs. Long-term monitoring of tear progression and its effect on function was not 
undertaken (Kukkonen et al., 2015). In a similar trial comparing the results of surgery 
and non-operative treatment for degenerative rotator cuff tears in patients over 60 
years, no significant difference was observed in functional outcome at short-term 
follow-up (12 months). Surgery did yield a significant improvement in pain, but 
retears were still reported in 73% of cases (Lambers Heerspink et al., 2015). In order 
to determine whether this difference in conservative and surgical treatment was 
maintained in the medium-term, Moosmayer et al (Moosmayer et al., 2014) compared 
the outcome of patients with small and medium-sized tears treated with either primary 
tendon repair or, physiotherapy and optional secondary repair. Degenerative and acute 
cases were included for study and participants were followed-up for five years. 
Twelve patients (24%) initially randomised to have physiotherapy underwent surgery. 
At five years, 14 tears (38%) treated with physiotherapy alone increased in size, and 
this was associated with an inferior outcome. The retear rate in the surgical cohort 
was 25%. Overall, a better outcome was associated with repaired tears.  
 
Treatment of massive rotator cuff tears poses a considerable challenge to current 
management strategies. The prevalence of massive tears has been reported to be as 
high as 40% of all tears and the rate of retears following surgery is recognised to be 
higher than for smaller tears (Bedi et al., 2010, Galatz et al., 2004). Shoulders with 
massive tears involving the postero-superior cuff demonstrate weakness in active 
external rotation and increase in passive internal rotation, whereas tears involving the 
antero-superior cuff lead to weakness in active internal rotation and increased passive 
external rotation (Giphart et al., 2013). Large retracted tears have been shown to 
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cause traction on the suprascapular nerve thereby propagating atrophy and fatty 
infiltration of the supraspinatus and infraspinatus through disuse (Costouros et al., 
2007, Mallon et al., 2006, Shi et al., 2014).  
 
To restore normal glenohumeral kinematics several surgical strategies have been 
introduced: debridement with biceps tenotomy (detachment of the tendon)/tenodesis 
(detachment of the tendon and subsequent re-fixation to surrounding bone/soft tissue), 
complete repair, partial repair, biological augmentations using scaffolds, superior 
capsular reconstruction, muscle-tendon transfer, and reverse anatomy total shoulder 
arthroplasty (Greenspoon et al., 2015).  Failure to heal and retears are still common 
and therefore further work is required to develop new strategies and to improve 
existing ones (Chung et al., 2013, Zumstein et al., 2008).  
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1.7 Tissue Engineering Strategies for Rotator Cuff Tears 
 
Scaffolds  
 
Scaffolds have emerged as a potential solution to the problems (high retear rate and 
failure to heal) associated with surgical repair of the rotator cuff. They currently exist 
in three main forms: Xenografts (tissue taken from a donor of one species and 
transplanted into a recipient belonging to another species), allografts, and synthetic 
matrices.    
  
1.1.1.5. Xenografts  
 
Adverse immune reactions are the main concern with using xenografts in the clinical 
setting. In order to avoid these, decellularisation is carried out using gamma 
irradiation or physical, chemical, or enzymatic techniques. Physical methods entail 
freezing or mechanical agitation to lyse native cells whereas chemical-based 
strategies use hypotonic solutions or detergents to lyse the cells in the harvested 
tissue, which is then washed to remove them. Trypsin, an enzyme that hydrolyses 
proteins, is found in the digestive system of vertebrates. When used as a single agent 
it is capable of degrading cellular material within a matrix, but its effect can been 
enhanced when used in combination with gamma irradiation (Cheung et al., 2010, 
Fini et al., 2012).   
 
Porcine small intestinal submucosa contains type I collagen and growth factors such 
as fibroblast growth factor (FGF)-2, transforming growth factor (TGF)-β and vascular 
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endothelial growth factor (VEGF) (Badylak et al., 1998, McPherson et al., 2000). 
Clinical studies evaluating the efficacy of porcine xenografts to augment rotator cuff 
repairs have shown variable results. In one of the few randomised controlled trials 
investigating rotator cuff healing with a xenograft, Iannotti et al (Iannotti et al., 2006) 
treated 15 shoulders with porcine small intestinal mucosa (Restore Orthobiologic 
Implant; DePuy, Warsaw, Indiana) and compared them to 15 non-augmented open 
repairs. No significant improvement in healing or functional outcome was found.  
 
Phipatanakul and Petersen (Phipatanakul and Petersen, 2009) used porcine small 
intestinal mucosa to augment the repair of massive rotator cuff tears. Despite an 
improvement in functional outcome scores only 44% of repairs were partially or 
completely intact postoperatively. Furthermore, three complications occurred 
including one infection and two skin reactions. Poor results were additionally reported 
by Walton et al (Walton et al., 2007) who found that patients whose rotator cuffs were 
repaired using the Restore Orthobiologic Implant (DePuy, Warsaw, Indiana), a 
collagen-based material derived from the small intestinal mucosa of pigs, had 
decreased muscle strength, greater impingement in external rotation, slower rate of 
pain resolution, and reduced participation in sport. Two years postoperatively MRI 
demonstrated comparable retear rates between the study group and non-augmented 
controls. Due to the high number of severe inflammatory reactions that required 
further surgery, use of this material was discouraged.  
   
The current body of evidence suggests that xenografts do not appear to enhance 
rotator cuff repair in humans, with retear rates similar to non-augmented controls 
(Iannotti et al., 2006, Walton et al., 2007). Major concerns have been raised over their 
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immunogenic potential and severe inflammatory reactions (Malcarney et al., 2005, 
Zheng et al., 2005). This could be due to traces of deoxyribonucleic acid (DNA) and 
TGF-β remaining in the graft material despite thorough decellularisation. Another less 
commonly found cell-associated marker responsible for hyper-acute rejection of 
porcine xenografts is Galactose-alpha-1,3-galactose (α-Gal). The α-Gal epitope is 
synthesised on glycolipids and glycoproteins present in non-primate mammals by the 
glycosylation enzyme alpha 1,3-galactosyltransferase. This epitope is not present in 
humans, who instead have the anti-Gal antibody, which constitutes approximately 1% 
of circulating immunoglobulins and specifically targets α-Gal (Zheng et al., 2005, 
McDevitt et al., 2003, Mathapati et al., 2011).    
 
1.1.1.6. Allografts 
 
Allogenic matrices are produced by the decellularisation of cadaveric material from 
humans and are capable of bridging soft tissue defects whilst reducing the risk of graft 
rejection. Bond et al (Bond et al., 2008) reviewed the outcome of 16 patients with 
massive, contracted, immobile rotator cuff tears that were treated with arthroscopic 
placement of a GraftJacket allograft (acellular human dermal matrix) (Wright Medical 
Technology, Arlington, TN). This yielded a failure rate of 19%, which is considerably 
lower than the 30-94% quoted in the literature (Isaac et al., 2012). No complications 
were noted and follow-up analysis of the graft at 12 months illustrated its viability. 
Furthermore, in one of the patients who had a documented failure, a biopsy revealed 
partial neo-tendon formation at the site of graft insertion. Histological analysis of the 
remaining specimens was not undertaken and therefore the extent of any tendon 
remodeling remains unknown. Barber et al (Barber et al., 2012) further assessed the 
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effectiveness of the GraftJacket in a randomised, prospective, multicenter clinical 
study of 42 patients undergoing arthroscopic repair of large (> 3cm) rotator cuff tears. 
At 24 months follow-up, using the American Shoulder and Elbow Surgeons (ASES) 
and Constant scores, superior functional outcomes were noted in the augmented group 
compared to non-augmented controls. Significantly more intact repairs were also 
found in the GraftJacket group using enhanced MRI and no adverse reactions related 
to the graft were observed.  
   
Although the results of acellular dermal matrices are promising there have been no 
large human studies conducted evaluating their effectiveness. Bony ingrowth into a 
healing tendon is essential for regeneration of a functional enthesis, but little sign of 
bone integration is seen with current allografts (Bedi et al., 2012). Despite no serious 
complications being reported there have been concerns over the presence of residual 
DNA that may cause an inflammatory response and increase tendon degeneration 
(Gilbert et al., 2009, Zheng et al., 2005).  
 
1.1.1.7. Synthetic Grafts 
  
Degradable polyesters such as poly (lactic-co-glycolic) acid (PLGA), poly-L-lactic 
acid (PLLA) and polydioxanone (PDO) have emerged as potential biomaterials 
(Hakimi et al., 2013). Upon their initial conception rapidly absorbable sheets of 
polyglycolyic acid (PGA) were used to regenerate the enthesis however they 
displayed poor mechanical properties and created a tendon insertion comprised 
primarily of type III collagen (Yokoya et al., 2008).  
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Few human studies examining the effect of synthetic scaffolds on regeneration of the 
enthesis have been conducted. In a non-randomised retrospective three-year follow-up 
study, Ciampi et al (Ciampi et al., 2014) compared the results of mini-open repair of 
postero-superior massive rotator cuff tears between non-augmented controls, 
augmentation with an absorbable collagen patch, and augmentation with a synthetic 
non-absorbable polypropylene patch. The polypropylene patch performed the best, 
exhibiting a significantly lower 12-month retear rate and superior functional outcome 
(using the University of California, Los Angeles shoulder rating scale), abduction and 
elevation at 36-months. No adverse reactions were related to patch application. 
Proctor (Proctor, 2014) evaluated the functional results of 18 consecutive patients 
with large to massive rotator cuff tears treated with a woven mesh of absorbable 
PLLA (X-Repair; Synthasome Inc., San Diego, CA, USA). A combination of 
ultrasound and MRI showed that 83% of patients had intact repairs 12 months 
following surgery. At 42 months one additional failure occurred, which reduced long-
term survival to 78%. There was a progressive improvement in functional outcome in 
the cuff repair-‘survivor’ group, assessed by the ASES scoring system, at all time 
points.  
 
Although many studies investigating synthetic scaffolds have yielded encouraging 
results there are several concerns over the degradation products of the polymers used 
to produce them. High levels of lactic and glycolic acid have been shown to impair 
osteoblast proliferation and inhibit matrix mineralisation whereas in non-toxic 
concentrations they were found to decrease cellular proliferation and increase 
differentiation of osteoblasts (Meyer et al., 2012b). These toxic effects have been 
shown to vary between polymers and thus further research is required to ensure that 
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the liberation of these degradation-products remains within safe levels for the duration 
that the implant is in situ (Taylor et al., 1994).     
 
Mesenchymal Stem Cells  
 
MSCs are multipotent stromal cells derived from mesenchymal tissue that have the 
capacity to self-renew and differentiate into cells capable of producing bone, fat, 
muscle, and tendon (Castro-Malaspina et al., 1980). Stem cells can be sourced from 
bone marrow, adipose tissue, muscle, synovia, periosteum, tendon, dermis, and 
umbilical cord but their numbers decline with age (Nixon et al., 2012). Techniques to 
optimise the proportion of stem cells isolated from bone marrow include using a 
Ficoll-induced density gradient and flow cytometry (Kastrinaki et al., 2008).  
 
1.1.9.1 Mesenchymal Stem Cell Characterisation  
  
MSCs are frequently isolated from the mononuclear layer of bone marrow and can be 
expanded in vitro following separation by a density gradient (Hernigou et al., 2005). 
Cells produced in this manner are spindle-shaped and adhere to plastic flasks (features 
commonly observed in MSCs) but further characterisation is often necessary because 
of the lack of a single cell surface marker present ubiquitously on MSCs 
(Chamberlain et al., 2007). The Mesenchymal and Tissue Stem Cell Committee 
within the International Society for Cellular Therapy proposed criteria to define 
MSCs within a cell population: (1) plastic adherence in vitro; (2) positive expression 
of CD105, CD90, and CD73 in greater than 95% of cells in the culture and negative 
expression of CD34, CD45, CD14 or CD11b, CD79a or CD19, and HLA-DR; (3) the 
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capacity to tri-differentiate into chondrocytes, adipocytes, and osteoblasts (Dominici 
et al., 2006). 
 
Human MSCs express on their surface CD105 (SH2), CD73 (SH3/4), CD44, CD90 
(Thy-1), CD71, and Stro-1, while lacking the expression of CD45, CD34, CD14, or 
CD11 hematopoietic markers (Haynesworth et al., 1992, Galmiche et al., 1993, 
Pittenger et al., 1999, Conget and Minguell, 1999, Sordi et al., 2005, Le Blanc et al., 
2003a). By negatively and positively selecting these markers antibodies can identify 
MSCs within a mixed cell population (Baddoo et al., 2003, Jones et al., 2002, 
Gindraux et al., 2007). Another method that can be used is to evaluate the capacity of 
cells to tri-differentiate into bone, fat, and cartilage (Chamberlain et al., 2007).  
 
Osteoblastic differentiation is accomplished by incubating a confluent layer of MSCs 
with ascorbic acid, β-glycerophosphate, and dexamethasone for two-to-three weeks. 
MSCs express alkaline phosphatase and produce calcium deposits that can be stained 
with Alizarin Red (Pittenger et al., 1999). Culturing MSCs with dexamethasone, 
insulin, isobutyl methyl xanthine, and indomethacin can induce adipogenic 
differentiation by causing the accumulation of lipid-rich vacuoles within cells. These 
can be positively stained by Oil Red O (Pittenger et al., 1999). To induce 
chondrogenic differentiation, MSCs are centrifuged in order to form a cell pellet. 
Culturing this with TGF-β will cause the production of type II collagen (a typical 
marker of articular cartilage) that can be positively stained with toluidine blue 
(Pittenger et al., 1999, Kopen et al., 1999).   
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1.1.9.2 Therapeutic Mechanisms of Mesenchymal Stem Cells  
 
Several functions of MSCs highlight their ability to enhance tendon-bone healing: 
migration to sites of tissue damage, differentiation potential, growth factor 
production, and immunosuppression (Wei et al., 2013). Together, these limit 
degeneration and ongoing degradation associated with tendon fiber rupture (Caplan, 
2007, Caplan and Dennis, 2006, Wagner et al., 2009). 
 
1. Migration to sites of tissue damage  
 
MSCs migrate to damaged/inflamed tissue from the circulation by adhering to and 
rolling on endothelial cells using adhesion molecules such as integrins and selectins 
(Chamberlain et al., 2007). This process is similar to leukocyte recruitment and is 
mediated by chemokines, adhesion molecules, and matrix metalloproteinases (MMPs) 
(Wynn et al., 2004, Belema-Bedada et al., 2008). Specifically, the chemokine (C-X-C 
motif) ligand 12- chemokine (C-X-C motif) receptors 4, 5, and 10 (CXCR4, CXCR5, 
and CXCR 10 respectively) have been demonstrated to enhance the engraftment and 
effect of MSCs (Von Luttichau et al., 2005, Cheng et al., 2008). However, these 
receptors are expressed to varying degrees on MSCs thus highlighting their 
heterogeneity (Chamberlain et al., 2007).  
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2. Production of growth factors  
 
After MSCs enter damaged tissue they interact with local cytokines and produce 
growth factors critical to tissue regeneration (Crisostomo et al., 2008, Caplan and 
Dennis, 2006, Jing et al., 2011). These include VEGF, insulin-like growth factor 1 
(IGF-1), and basic fibroblast growth factors (bFGFs) (Caplan and Dennis, 2006, Xu et 
al., 2007, Liu et al., 2011). 
  
3. Immunosuppression   
 
MSCs suppress the activity of B cells, T cells, macrophages, and natural killer cells 
(Uccelli et al., 2008, Han et al., 2012). By modulating the function of these 
inflammatory cells, MSCs are able to exert an immunosuppressive effect 
(Bartholomew et al., 2002). Reports suggest that this is achieved through direct cell-
cell contact and/or the presence of chemokines (Di Nicola et al., 2002, Krampera et 
al., 2003, Le Blanc et al., 2003b). In tendon healing, the anti-inflammatory effect of 
MSCs has been shown to reduce tendon fiber degeneration (Nixon et al., 2008, 
Schnabel et al., 2009).  
 
1.1.9.3 Mesenchymal Stem Cell use in Rotator Cuff Healing  
 
MSCs are an appealing tissue-engineering strategy because they can differentiate into 
several cell types and possess a non-immunogenic phenotype making them suitable 
for allogenic transplantation without immunosuppression (Javazon et al., 2004). In 
rotator cuff tears the levels of MSCs at the enthesis decrease as a function of a 
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number of clinical factors such as tear size, time between the onset of a tear and 
treatment, and stage of fatty infiltration (Hernigou et al., 2015). The effects of MSCs 
on tendon-bone healing have been investigated in a number of animal studies with 
varying outcomes, ranging from an improvement in fibrocartilage and reduction in 
fatty infiltration, to no change in histology or mechanical properties of the resultant 
tissue (Gulotta et al., 2009, Gulotta et al., 2010, Gulotta et al., 2011a, Oh et al., 
2014a).  
 
Few human studies have investigated the role of MSCs in rotator cuff healing and 
there are currently no evidence-based guidelines outlining when they should be used 
(Hernigou et al., 2014, Ellera Gomes et al., 2012). Ellera Gomes et al (Ellera Gomes 
et al., 2012) reported the results of 14 patients who underwent mini-open repair of a 
rotator cuff tear using autologous bone marrow mononuclear cells. Tear 
characteristics included injury to three tendons with fatty infiltration grade II 
(Goutallier classification) or higher (five patients), injury to two tendons with fatty 
infiltration grade II or higher (eight patients), and injury to one tendon (one patient). 
The stem cell population was derived from bone marrow aspirates concentrated using 
a Ficoll density gradient. Subsequent flow cytometry analysis of this suspension 
revealed that it contained 3.81 × 108 mononuclear cells. After 12 months follow-up 
all tendons were intact and there was an improvement in functional outcome. 
Evidence from this series is limited due to the lack of a control group and the small 
heterogeneous sample.   
 
In a case-controlled study, Hernigou et al (Hernigou et al., 2014) reviewed 45 patients 
that received concentrated bone marrow-derived MSCs as an adjunct to single-row 
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rotator cuff repair and compared them to a matched control group who did not receive 
MSCs. The concentration of MSCs (the number of connective-tissue progenitor cells 
per 1.0 cc of aspirate) and the prevalence of MSCs (the number of MSCs per million 
nucleated cells) were estimated by counting the number of colony forming unit 
fibroblasts. The average number of MSCs per milliliter (ml) of concentrated cells 
returned to the 45 patients was 4,300 + 1,00 per mL of bone marrow concentrate. The 
average total number of MSCs returned to the patient was 51,000 ± 25,000 cells in 12 
mL of injected bone marrow concentrate. Only tears less than 3 cm were included for 
study. At six months, all repairs with MSCs had healed, in comparison to 30/45 
repairs (67%) without MSCs. At 10 years, intact repairs were noted in 39/45 (87%) 
patients in the MSC group in contrast to 20/45 (44%) of the controls.  
  
1.1.9.4 Mesenchymal Stem Cell Delivery into Tissues 
 
When MSCs are applied to the enthesis it is imperative that they are localised and 
maintained in that area. Two strategies that have received considerable attention in the 
literature are the use of fibrin glue and scaffolds (Beitzel et al., 2014, Kalia et al., 
2006, Lee et al., 2005). Fibrin glue, a combination of fibrinogen and thrombin, is a 
matrix whose principal component fibrin, has an integral role in blood clotting and 
wound healing (Kalia et al., 2006). It is potentially a suitable carrying media for 
cellular implantation as it has proven biocompatibility, biodegradability, and binding 
capacity to cells (Lee et al., 2005). A further advantage of fibrin glue is that it can be 
injected into a deep layer of tissue and remains confined to that area due to its high 
viscosity. To examine the use of MSCs in fibrin glue, Lee et al (Lee et al., 2005) used 
it to treat 1.5 mm rat femoral defects to determine whether it could induce new bone 
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formation in chemotherapy-treated rats. One hundred thousand cells were suspended 
in 1.0 mL of the thrombin component of the fibrin glue (Tisseel; Baxter BioScience, 
Newbury, UK) before mixing the thrombin and fibrin components. After the glue had 
set, culture medium was added and the cells were cultured. An alamarBlue (Biosource 
International/Invitrogen, Camarillo, CA) assay was performed to evaluate cell 
viability and cell proliferation was measured by [3H]thymidine uptake. A cell 
proliferation assay was performed on cells after 24, 48, 72, and 96 hours in culture. 
The results of this indicated that cells remained viable up to 96 hours and there was 
no difference in the rate of proliferation at any time point, thus demonstrating the 
efficacy of fibrin glue as a potential carrier of MSCs.   
 
As described above, scaffolds exist in different forms and maybe used as a 
mechanical graft to improve load distribution across the enthesis or as a biological 
strategy to enhance tissue regeneration. To successfully integrate into the scaffold 
cells must attach to the surface, proliferate, produce a matrix, and migrate into the 
deep structure (Beitzel et al., 2014). Beitzel et al (Beitzel et al., 2014) compared the 
response of human MSCs to several commercially available scaffolds and a control 
(rotator cuff tendon allograft). Scaffolds used in the study included human highly 
cross-linked collagen membrane (Arthroflex; LifeNet Health, Virginia Beach, VA), 
porcine non cross-linked collagen membrane (Mucograft; Geistlich Pharma, Lucerne, 
Switzerland), a human platelet-rich fibrin matrix (PRF-M), and a fibrin matrix based 
on platelet-rich plasma (ViscoGel; Arthrex, Naples, FL). Each material was seeded 
with MSCs and examined for cellular adhesion (24 hours), proliferation (thymidine 
assay at 96 hours), and viability (live/dead stain at 168 hours). Cellular adhesion and 
proliferation varied between the different materials with the non cross-linked porcine 
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collagen scaffold (Mucograft) demonstrating superior results, due to its highly porous 
structure permitting greater initial cell loading during seeding.  
 
1.1.9.5 Enhancing Stem Cell Therapy  
 
In vivo studies examining the effect of MSCs on enthesis regeneration have reported 
the absence of a fibrocartilaginous interface, citing the potential lack of signaling as a 
reason for the transplanted cells not differentiating and creating a naturally graded 
structure (Gulotta et al., 2009). Methods used to enhance stem cell activity include 
supplementary growth factors, mechanical stimulation, and scaffolds. Scaffolds are 
commonly used to carry stem cells (Rutledge et al., 2014, Shen et al., 2015). Their 
composition has been suggested to affect cell seeding and migration (Beitzel et al., 
2014) but may also direct differentiation (Shen et al., 2015, Rutledge et al., 2014). 
These properties can be enhanced by mechanical stimulation but further studies are 
required to determine whether this strategy is effective for all materials (Juncosa-
Melvin et al., 2007, Butler et al., 2008).    
 
Membrane type 1 matrix metalloproteinase (MT1-MMP) is thought to regulate the 
formation of mineralised cartilage and thus bony ingrowth into the enthesis. Using an 
adenovirus to upregulate MSCs with its expression, Gulotta et al (Gulotta et al., 2010) 
repaired the supraspinatus tendon in rats using either MSCs in a fibrin glue carrier or 
the adenoviral membrane MT1-MMP (Ad-MT1-MMP)–transduced MSCs. At four 
weeks, the Ad-MT1-MMP group exhibited more fibrocartilage and superior 
biomechanical results than the MSC group. Using the same rat model of an acute 
supraspinatus tear, Gulotta et al (Gulotta et al., 2011a) repaired the tendon using 
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either MSCs in fibrin glue or adenoviral-mediated scleraxis-transduced MSCs. At 
four weeks, the adenoviral-mediated scleraxis-transduced MSCs produced more 
fibrocartilage and had better biomechanical results.  
 
Other Non Cell-Based Strategies  
 
During the initial phases of rotator cuff healing the activation of fibroblasts results in 
the expression of several growth factors including bone morphogenetic proteins 
(BMPs), bFGF, platelet-derived growth factor (PDGF), and TGF-β (Bedi et al., 
2012). Wurgler-Hauri et al (Wurgler-Hauri et al., 2007) demonstrated that over an 
eight-week period the concentrations of these growth factors fluctuate before 
returning to normal, suggesting that administration of a single growth factor is 
unlikely to promote the formation of a normal enthesis. This has not been addressed 
by current augmentation strategies and may be partly responsible for their failure.  
   
1.1.1.8. Bone Morphogenic Proteins 
 
BMPs are part of the TGF-β superfamily and are recognised to stimulate bone 
formation (Isaac et al., 2012). This is an important stage in the formation of a 
naturally graded enthesis and has eluded many of the augmentation strategies used to 
date. BMP-12 and BMP-13 regulate fibrocartilage and neotendon formation whilst 
BMP-13 and BMP-14 increase the tensile strength of a regenerated tendon (Longo et 
al., 2011, Aspenberg and Forslund, 1999). In an ovine model of rotator cuff repair, 
BMP-12 resulted in superior biomechanical properties and greater collagen continuity 
at the healing interface (Seeherman et al., 2008). In contrast, a rat study of rotator cuff 
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repair did not find a difference in new cartilage formation or collagen fiber 
organisation between groups treated with BMP-13 and non-augmented controls. 
There were also no differences in the biomechanical properties of the repairs between 
groups (Gulotta et al., 2011b). More recently, BMP-2 and BMP-7 have been 
demonstrated to induce collagen production when added to tenocyte-like cells (Pauly 
et al., 2012).  
  
1.1.1.9. Basic Fibroblast Growth Factor  
 
Concentrations of bFGF peak between five and nine days after tendon rupture 
(Wurgler-Hauri et al., 2007, Kobayashi et al., 2006, Takahashi et al., 2002). By 
improving collagen proliferation and secretion, bFGF has been shown to stimulate 
tendon-bone healing in vivo but further studies are required to evaluate its effect on 
rotator cuff healing (Ide et al., 2009a, Ide et al., 2009b, Ju et al., 2008). 
  
1.1.1.10. Platelet-Derived Growth Factor  
 
PDGF is expressed in the acute phase of rotator healing and reaches its highest levels 
between seven and 14 days after injury (Gulotta et al., 2009, Kobayashi et al., 2006, 
Wurgler-Hauri et al., 2007, Gulotta and Rodeo, 2009). It has been demonstrated to be 
an essential cytokine responsible for tendon healing because of its ability to promote 
chemotaxis, cell proliferation, ECM production, and angiogenesis (Hoppe et al., 2013, 
Kovacevic et al., 2015). In a rat model of an acute supraspinatus tear, administration 
of PDGF enhanced cellular proliferation and angiogenesis during the early phase of 
healing, but this did not result in either a more structurally organised or stronger 
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attachment site at the latter stages of healing (Kovacevic et al., 2015). In a further 
study examining PDGF in a rat model of an acute supraspinatus tear, greater collagen 
fiber orientation and superior biomechanical properties were noted in the 
experimental group when compared to controls (Tokunaga et al., 2015).  
 
1.1.1.11. Transforming Growth Factor-β  
 
TGF-β is present during rotator cuff healing in three isoforms: TGF-β1, TGF-β2, and 
TGF-β3 (Kobayashi et al., 2006, Wurgler-Hauri et al., 2007). Variable expression of 
these different proteins has been postulated to be responsible for wound healing 
similar to what occurs during fetal development (increased TGF-β3), as opposed to 
adult wounds that are characterised by scar tissue (increased TGF-β1) (Campbell et 
al., 2004, Klein et al., 2002). In a rat model of rotator cuff repair, application of an 
osteoconductive calcium-phosphate matrix was associated with new bone formation, 
increased fibrocartilage, and improved collagen organisation at the healing tendon-
bone interface. The addition of TGF-β3 significantly improved strength of the repair 
at four weeks postoperatively and resulted in a more favorable collagen I/III ratio 
(Kovacevic et al., 2011). Using a similar model, Manning et al (Manning et al., 2011) 
administered exogenous TGF-β3 to the healing enthesis and demonstrated that it was 
associated with increased vascularity and cell proliferation at 56 days compared to 
controls. 
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1.1.1.12. Platelet Rich Plasma  
 
Platelet-rich plasma (PRP) is manufactured by centrifuging blood plasma to produce a 
dense matrix of platelets containing multiple growth factors (TGF-b, bFGF, PDGF, 
VEGF, connective tissue growth factor, and epidermal growth factor) (Randelli et al., 
2008, Everts et al., 2006). For this reason it has received considerable attention in 
orthopaedics for treating a range of musculoskeletal problems (Dallari et al., 2016, 
Kilincoglu et al., 2015). However, recent evidence from randomised controlled trials 
and systematic reviews suggest that PRP does not reduce the retear rate or improve 
functional outcome following rotator cuff repair (Saltzman et al., 2015, Barber, 2016, 
Carr et al., 2015b, Wang et al., 2015).  
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1.8 Demineralised Bone Matrix   
 
DBM first emerged as a biomaterial following pioneering work by Urist who 
highlighted its potential to be osteoinductive through endochondral ossification (Urist, 
1965). It has subsequently been incorporated into an allograft that has been used as a 
successful surgical adjunct in non-union surgery, spinal fusion, and the filling of bone 
defects (Chakkalakal et al., 1999, Block and Russell, 1998, Killian et al., 1998). 
Commercial production of DBM has been achieved by demineralising bone with 0.6 
Normal (N) hydrochloric acid (HCL) and then washing it in 0.15 molar (M) sodium 
chloride (NaCl). Prior to implantation it is often sterilised by gamma irradiation. 
Manufacturing in this manner exposes a type I collagen matrix, which is rich in 
growth factors such as BMPs (BMP-2, BMP-4, and BMP-7), TGF-β1, TGF-β2, and 
TGF-β3 (Sawkins et al., 2013, Veillette and McKee, 2007, Urist, 1965, Urist et al., 
1983, Reddi, 1998). Evidence suggests that BMP-2 and TGF-β may act on bone 
marrow-derived stem cells and form new bone in the developing enthesis. This new 
bony ingrowth may then develop into fibrocartilage and mineralised fibrocartilage as 
the interface matures creating a structure that resembles the uninjured enthesis 
(Sundar et al., 2009b).  
 
Rotator cuff healing involves a complex interplay of biological and mechanical 
factors. Whilst an optimal biological milieu is required to produce a naturally graded 
enthesis, it is the mechanical environment that stimulates this to happen. Several 
stratified constructs incorporating different cell groups are available but tend to be 
unstable and prone to detrimental stress concentrations (Spalazzi et al., 2008, Spalazzi 
et al., 2006, Dormer et al., 2010). By producing bone through a fibrocartilage 
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intermediate, DBM may be the ideal scaffold as both of these tissues are seen at the 
native enthesis. Very few studies though have examined its effect on the tendon-bone 
interface (Sundar et al., 2009b, Kilicoglu et al., 2012, Sundar et al., 2009a, Hsu and 
Wang, 2014).  
 
In an ovine model of the extensor mechanism at the knee, Sundar et al (Sundar et al., 
2009b) used DBM to augment patellar tendon re-attachment to a metal implant 
positioned on the tibial tuberosity. This model was used to investigate the attachment 
of a tendon to a metallic segmental prosthesis typically used to treat bone tumours of 
the proximal tibia. At six weeks the DBM group exhibited an increase in functional 
weight bearing (% full weight-bearing) compared to controls and by 12 weeks, there 
was regeneration of a more direct-type of enthesis made up of regions of 
fibrocartilage and mineralised fibrocartilage. New bone formation also accompanied 
these soft tissue changes. A slow release of growth factors by DBM was thought to 
stimulate the formation of this naturally graded structure. Sundar et al (Sundar et al., 
2009a) additionally examined functional recovery of the ovine patella tendon-bone 
interface following tendon reattachment with DBM. Repair failure was noted in 33% 
of non-augmented controls. In contrast, none of the repairs failed in the DBM group 
and the resultant enthesis comprised new bone and fibrocartilage (demineralised and 
mineralised). Earlier mobilisation and superior function was also noted at all time 
points. Unlike other animal models of tendon regeneration around the shoulder, the 
ovine knee is entirely dependent upon an intact extensor mechanism.  
 
Kilicoglu et al (Kilicoglu et al., 2012) assessed the effect of DBM on fixation of the 
extensor digitorum longus tendon within a proximal tibial bone tunnel in a rabbit 
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model. At three weeks a greater proportion of Sharpey’s fibers, fibrocartilage, and 
new bone was found in the DBM group when compared to non-augmented controls. 
This was not maintained throughout the study period and at six weeks there was no 
significant difference. To further evaluate the influence of DBM on tendon-bone 
healing within a bony tunnel, Hsu and Wang (Hsu and Wang, 2014) used a rabbit 
model of anterior cruciate ligament (ACL) reconstruction. Similar to previous reports, 
DBM was associated with new bone formation, greater mineralised fibrocartilage, and 
less fibrous tissue. 
  
Demineralised bone has been used successfully to augment tendon-bone healing 
(Sundar et al., 2009a, Kilicoglu et al., 2012). One of its properties is to induce new 
bone formation. In doing so, it may improve the strength of the enthesis and reverse 
osteopenia at the bony insertion as this has been demonstrated to occur following a 
rotator cuff tear (Meyer et al., 2004a). By combining DBM with stem cells its effects 
may be enhanced given that many of the growth factors it contains are able to direct 
MSC differentiation down tenogenic, chondrogenic, and osteogenic lineages (Dorman 
et al., 2012, Na et al., 2007, Gomiero et al., 2016). These cell lines produce elements 
essential to the formation of a naturally graded enthesis.        
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1.9 Chapter Overview  
 
 
Are the mechanical properties of ovine and 
porcine demineralised cortical and 
cancellous bone matrix different? 
Can xenogenic/allogenic demineralised 
cortical bone matrix enhanced with 
mmMSCs augment tendon-bone healing in a 
non-degenerative ovine model of tendon 
retraction?  
 
Development of a degenerative small animal 
model of rotator cuff tendon-bone healing. 
In a degenerative rotator cuff tear model, can 
DBM enhance tendon-bone healing to a 
greater extent than a commercially available 
scaffold (GraftJacket)?  
 
In a degenerative rotator cuff tear model, can 
MSCs enhance the effect of DBM on 
tendon-bone healing? 
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Chapter Two: Allogenic and Xenogenic 
Demineralised Bone Matrix as a Scaffold for  
Tendon-Bone Healing
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2.1 Introduction  
 
When used to treat rotator cuff tears, scaffolds reinforce the strength of the repair and 
improve biological healing (Beitzel et al., 2014). Tissue regeneration can be further 
enhanced by seeding cells into a biomaterial, but for this to happen there needs to be 
an interaction between the microstructure of the graft and the different types of cell 
surface receptors (Ide et al., 2009b, Tokunaga et al., 2015, Hidalgo-Bastida and 
Cartmell, 2010). Integrins in particular play an important role, as they are essential for 
MSC survival, proliferation, and differentiation (Derwin et al., 2010, Schwartz and 
DeSimone, 2008). Porous biomaterials facilitate this process as they optimise initial 
cell loading, and allow neovascularization and haematoma ingrowth, with its 
endogenous progenitor cells and growth factors (Whang et al., 1999). However, 
porosity may compromise the biomechanical properties of the repair construct leading 
to failure if it cannot resist the forces transmitted through the supraspinatus tendon 
during maximum contraction (196N) (Itoi et al., 1995).  
  
Cancellous bone is a cellular material comprising struts and plates that form a 
trabecular, porous structure (Gibson, 1985). A network of struts produces open cells 
whilst one of plates produces closed cells. The stress-strain curve of cancellous bone 
responds to compressive load in three ways: (1) As it bends or undergoes axial 
compression, behaviour is initially linear elastic; (2) At high enough loads the cell 
walls collapse at a constant rate until they meet and touch, creating a plateau phase 
characterised by a greater resistance to load due to crushing of the cancellous 
structure; (3) After this, the resistance to load rises and results in an increasingly steep 
portion to the curve (Figure 2.1). 
 79 
 
 
Figure 2.1: Stress-strain curve for cancellous bone under compressive load.   
 
The structural arrangement of cancellous bone depends upon the direction of the load 
applied to it. When this is uniaxial, such as in vertebrae, the trabeculae develop a 
columnar structure with cylindrical symmetry. These columns are orientated 
vertically, giving a relatively high stiffness and strength in the direction of load 
(Gibson, 1985). This is reflected in cancellous bone exhibiting a significantly higher 
strength, ultimate strain, and work to failure when it is loaded in tension as opposed to 
compression (Rohl et al., 1991). This is an important consideration for tendon-bone 
healing where tensile loads are predominantly encountered.  
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Compared to their allogenic derivatives, xenografts are cost-effective and have almost 
unlimited availability (Sachs, 1994). For the purposes of xenotransplantation the most 
suitable donor is a non-human primate such as the chimpanzee, but the rarity of this 
species prevents them from being considered (Sachs, 1994). Accordingly, porcine 
materials have received considerable attention in the literature but due to high failure 
rates and adverse tissue reactions in clinical studies evaluating their use in tendon-
bone healing, they are not widely used (Walton et al., 2007, Phipatanakul and 
Petersen, 2009). Refining the ways in which xenografts are produced could reduce the 
costs associated with expensive scaffolds and increase their uptake by healthcare 
providers.    
 
This study aims to determine whether there is a difference in mechanical properties 
between porcine and ovine cortical and cancellous DBM in order to establish the 
scaffold to be used in Chapter Three (in vivo study examining tendon-bone healing in 
a large animal model of tendon retraction). Lumbar vertebrae were used as its 
cancellous nature gives rise to a porous structure resulting in longitudinal stiffness 
and strength, thereby making it a suitable graft material to improve tendon-bone 
healing (Smit et al., 1997, Gibson, 1985). The porous nature would also allow stem 
cells to penetrate the inner structure of the graft and improve graft remodeling at the 
healing enthesis. It was hypothesised that the tensile strength of cancellous DBM 
would be significantly lower than that of cortical DBM, and that there would be no 
difference between ovine and porcine scaffolds.  
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2.2 Materials and Methods 
 
2.2.1 Study Overview  
 
The tensile strength of porcine and ovine cancellous/cortical DBM (n = 3) was 
examined to determine which scaffold possessed appropriate mechanical properties to 
be used in a large animal model of tendon retraction (Chapter Three).   
 
2.2.2 Preparation of DBM  
 
DBM was manufactured according to a protocol modified from that used by Urist 
(Urist, 1965). Porcine bones were obtained from a local abattoir (Cheale Meats, 
Brentwood, UK) and ovine bones were obtained from a local veterinary institution 
(Royal Veterinary College, Hatfield, UK). Tibiae (cortical DBM) and lumbar 
vertebrae (cancellous DBM) of three skeletally mature female ewes and sows were 
harvested immediately post euthanasia; all soft tissues and periosteum were removed 
and the bones were cut into longitudinal strips using a band saw (Exact, Hamburg, 
Germany). Proximal and distal ends of each tibia were excised and the shafts were cut 
into three longitudinal strips measuring 3-4 mm in thickness, 17 mm (+/- 2 mm) wide, 
and 200 mm long. The body of each lumbar vertebra was cut into two strips (Figure 
2.2).   
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Figure 2.2: Superior aspect of an ovine lumbar vertebra. 
 
Each strip was demineralised in 0.6N HCL at room temperature. The solution was 
changed every 12 hours and demineralisation was confirmed with radiographs [300 
seconds, 30 kilovolts (kV), Faxitron Corporation, Illinois, United States of America 
(USA)] before washing with phosphate-buffered saline (PBS) until the pH was 7.4 +/- 
0.1 (Figures 2.3 and 2.4).  
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Figure 2.3: Radiographs of porcine and ovine cortical (tibia) bone pre- and post-
demineralisation. 
 
 
 
Figure 2.4: Radiographs of porcine and ovine cancellous (lumbar vertebra) bone pre- 
and post-demineralisation. 
Porcine cortical 
bone pre-
demineralisation  
 
Porcine cortical 
bone post-
demineralisation  
 
Ovine cortical 
bone pre-
demineralisation  
 
Ovine cortical 
bone post-
demineralisation  
 
Porcine 
cancellous bone 
pre-
demineralisation  
 
Porcine 
cancellous bone 
post-
demineralisation  
 
Ovine 
cancellous bone 
pre-
demineralisation  
 
Ovine 
cancellous bone 
post-
demineralisation  
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2.2.3 Ultimate Tensile Strength Testing  
 
Three samples were tested in each group. Each strip was cut into a ‘dog bone’ shape 
as the wider ends of the sample ensured that stress concentrations were concentrated 
in the midsection, leading to rupture at the ultimate tensile strength (UTS). In 
contrast, if failure occurred at the fixed end of the specimen then it could be attributed 
to improper loading or a pre-existing defect in the material (Driscoll, 1998). 
 
Specimens [3-4 mm in thickness, 17 mm (+/- 2 mm) wide, and 30 mm long] were 
mounted on a custom made testing machine (Zwick/Roell Group, Ulm, Germany) and 
secured using a piece of grit paper to prevent slippage (Figure 2.5). Samples were 
tested until failure at a displacement rate of 10 mm per minute without 
preconditioning. A stress-strain curve was produced and the UTS was recorded for 
each strip.  
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Figure 2.5: Ovine cortical DBM in a custom made tensile testing machine.  
 
2.2.4 Statistical Analysis 
 
Data was analysed using the Mann-Whitney test in IBM SPSS version 22 (Statistical 
Package for Social Sciences, SPSS Inc., Chicago, Illinois, USA) and statistical 
significance was considered at p < 0.05.  
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2.3 Results 
 
All samples failed in their mid-substance. Ovine cortical DBM exhibited the greatest 
UTS with a median force of 142.0 N [95% confidence interval (CI) 125.9 to 161.3]. 
Porcine cancellous DBM was the weakest scaffold, with a median UTS of 2.5 N (95% 
CI -6.9 to 17.5). Porcine cortical and ovine cancellous DBM demonstrated a median 
UTS of 64.4 N (95% CI 23.7 to 124.6) and 16.1 N (95% CI 15.7 to 16.7) respectively 
(Table 2.1 and Figure 2.6). Each test produced a stress-strain curve characterised by 
an initial toeing segment, a linear region, and a narrow phase of plastic deformation 
(Figure 2.7). Stiffness was greatest in cortical DBM.  
 
 Ultimate 
tensile strength 
– 1st repetition 
(N) 
Ultimate 
tensile strength 
– 2nd repetition 
(N) 
Ultimate 
tensile strength 
– 3rd repetition 
(N) 
Median (N) 
Porcine cortical 
DBM 
64.4 60.6 97.5 64.4 
Porcine 
cancellous 
DBM 
11 2.5 2.5 2.5 
Ovine cortical 
DBM 
136.9 142.9 151.1 142.9 
Ovine 
cancellous 
DBM 
16 16.4 16.1 16.1 
 
Table 2.1: Ultimate tensile strength of porcine and ovine cortical/cancellous DBM. 
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Figure 2.6: Box and whisker plot showing the maximum tensile strength of different 
DBM groups.  
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Figure 2.7: Stress-strain curve of representative samples of DBM in each group.  
 
In both ovine and porcine groups, cancellous DBM had the lowest UTS. This reached 
statistical significance between porcine specimens (p = 0.046), and between porcine 
cancellous and ovine cortical DBM. Ovine cancellous DBM was significantly 
stronger than its porcine derivative (p = 0.046). No difference was demonstrated 
between cortical and cancellous samples in the ovine group (p = 0.05) (Table 2.2).   
 89 
 Porcine 
cortical DBM 
Porcine 
cancellous 
DBM 
Ovine cortical 
DBM 
Ovine 
cancellous 
DBM 
Porcine cortical 
DBM 
- 0.046 0.05 0.05 
Porcine 
cancellous 
DBM 
0.046 - 0.046 0.046 
Ovine cortical 
DBM 
0.05 0.046 - 0.05 
Ovine 
cancellous 
DBM 
0.05 0.046 0.05 - 
 
Table 2.2: Statistical significance (p-values) between porcine/ovine cortical and 
cancellous DBM.  
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2.4 Discussion  
 
Bone is composed of hydroxyapatite mineral crystals arranged within an organic 
collagen matrix (Chen and McKittrick, 2011). Tensile testing data from this chapter 
demonstrates that both cortical and cancellous DBM behave like tendon, in that their 
stress-strain curves are made up of an initial toeing segment followed by a linear 
region. Similar findings were noted by Bowman et al (Bowman et al., 1996) who 
suggested that the early non-linear behaviour of DBM was due to the straightening of 
crimped collagen fibers, and the subsequent linear behaviour was due to stretching of 
the straightened collagen fibers. Under tension, DBM therefore behaves like the 
native collagen present in soft tissues such as tendon, highlighting its suitability as a 
potential graft material.  
 
Bone is a complex, hierarchical structure made up of type I collagen and carbonated 
hydroxyapatite. It exists in two forms: cortical (or compact) bone and cancellous (or 
trabecular) bone. The major difference between the two is in their relative density, 
defined as the apparent density of bone divided by that of its solid material (bone with 
a relative density less than 0.7 is classified as cancellous) (Chen and McKittrick, 
2011, Gibson, 1985). Cancellous bone can be considered as a cellular solid made up 
of a network of struts and plates. Its density depends upon the external stresses it 
experiences (Chen and McKittrick, 2011). In a low stress environment, a strut-like 
structure develops, whereas a plate-like structure forms when stresses are high. To 
understand the behaviour of cancellous bone after demineralisation it should be 
considered as a composite of protein and mineral. Removing either of these 
constituents reduces the elastic modulus and compressive strength, but preserves the 
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porous trabecular structure. Reducing the mineral content in particular (as occurs in 
demineralisation) alters the mechanical response of cancellous bone such that it 
exhibits plastic deformation (Chen and McKittrick, 2011). The results from this study 
suggest that the tensile properties of cancellous bone are weaker than that of cortical 
bone. Whilst this only reached statistical significance in the porcine group, the 
absolute values were not ignored and still considered when the graft material for the 
in vivo study (Chapter Three) was chosen. The decision was based on both the force 
transmitted through the human supraspinatus during maximum contraction and the 
UTS of supraspinatus, which have been estimated to be 196 N and 601 N respectively 
(Itoi et al., 1995, France et al., 1989).  
 
Interspecies differences are an important factor when choosing an appropriate 
xenograft. Aerssens et al (Aerssens et al., 1998) examined the difference in bone 
composition, density, and quality between different species including sheep and pigs. 
Compared to other animals, the cortical bone of sheep and pigs were found to have 
less collagen and more non-collagenous protein. In sheep, the cortical bone had a 
greater proportion of high-density bone particles than pigs. Similar findings were 
noted in trabecular bone (lumbar vertebrae) composition. Bone mineral content, bone 
mineral density, and fracture stresses were higher in sheep samples. These findings 
support the results of this experiment where the ovine scaffold displayed superior 
mechanical properties than its porcine derivative.  
 
Limitations of this study include the inability to establish the age of the animals used 
to provide the specimens because they were obtained from an abattoir, and the 
absence of gamma irradiation in the manufacturing protocol of demineralised bone. 
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This is a crucial stage when processing DBM in the clinical setting, but gamma 
irradiation has been shown not to have a significant effect on the mechanical 
properties of demineralised bone and so it was not used in the present study (Summitt 
and Reisinger, 2003). Additionally, the inclusion of quantitative data on stiffness and 
Young’s modulus would have provided a more comprehensive assessment of the 
biomechanical properties of the specimens.  
  
Key findings from this chapter include: (1) Cancellous DBM possessing weaker 
tensile properties than cortical DBM; (2) Ovine DBM having greater tensile 
properties than porcine DBM; (3) Ovine cortical DBM having the highest UTS. Since 
the force transmitted through supraspinatus 196 N during maximum contraction, 
ovine cortical DBM is the only graft material strong enough to be used in vivo to 
examine tendon-bone healing (Itoi et al., 1995).  
 
2.5  Conclusion  
 
The results from this chapter illustrate that DBM has similar tensile properties to other 
collagen-based structures such as tendons. The ovine cortical scaffold was the only 
specimen that could potentially resist the forces transmitted through the native 
supraspinatus, and will therefore be used in Chapter Three to augment healing in an 
ovine model of tendon retraction. 
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Chapter Three: Augmentation of Tendon-Bone 
Healing using Allogenic and Xenogenic 
Demineralised Cortical Bone Matrix Enhanced with 
Minimally Manipulated Mesenchymal Stem Cells in a 
Non-Degenerative Ovine Model
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3.1  Introduction  
 
Chronic tears of the rotator cuff are associated with muscle atrophy, fatty infiltration, 
muscle fiber shortening, and retraction of the musculotendinous unit (Meyer et al., 
2012a, Meyer et al., 2006). A degenerative process has been implicated in these 
architectural changes, but recently evidence has emerged that in a retracted tendon the 
pennation angle (the angle between a fasicle’s orientation and the tendon axis) 
increases and allows fatty and fibrous tissue to infiltrate the newly created space 
between the reoriented muscle fibers (Meyer et al., 2004b). After several weeks, these 
changes become permanent and represent the main cause of persistent disability 
following a technically successful tendon repair (Matsumoto et al., 2002, Goutallier et 
al., 1995). Accordingly, the failure rate following surgery exceeds 50% (Harryman et 
al., 1991, Zumstein et al., 2008).  
 
Musculotendinous retraction is regarded as one of the most important consequences 
of a chronic rotator cuff tear as it precludes direct apposition of the tendon stump onto 
its bony footprint (Dines et al., 2007, Meyer et al., 2012a). This is compounded by 
diminished elasticity that occurs due to the shortening of muscle fibers, development 
of scar tissue, and the formation of fibrous tissue within the muscle (Meyer et al., 
2004b, Jozsa et al., 1990, Hersche and Gerber, 1998). Retraction is a dynamic process 
characterised by independent shortening of both muscle and tendon. Tendon 
shortening contributes the most to retraction and has been demonstrated to be an 
important factor affecting the outcome following surgery; with longer preoperative 
tendon stumps associated with lower failure rates (Meyer et al., 2012a, Meyer et al., 
2006).  
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When the tendon cannot be reattached to the bone (irreparable rotator cuff tear) 
further reconstructive procedures may be required (Merolla et al., 2014). These can 
involve debridement +/- partial repair (arthroscopic or open), tendon transfer, and 
non-anatomic/reverse anatomy arthroplasty. Outcomes are varied, with failure 
occurring in up to 94% of non-arthroplasty cases (Gupta et al., 2013, Castricini et al., 
2014, Sclamberg et al., 2004, Galatz et al., 2004, Iannotti et al., 2006). To address 
this, scaffolds have emerged as a possible solution (Cheung et al., 2010). These aim to 
decrease gap formation at the repair site as this reduces healing and load to failure 
(Burkhart et al., 2007, Shea et al., 2012).  
 
Enhancing the function of scaffolds can be achieved using a number of different cell-
based strategies (Cheung et al., 2010). MSCs are contained in the bone marrow at a 
concentration of approximately 10 – 100 per 1x106 bone marrow cells (Kasten et al., 
2008). Their use in the clinical setting is restricted due to the high costs associated 
with time-consuming tissue culture techniques. This can be overcome by isolating the 
connective tissue progenitor cell-containing mononuclear fraction by centrifugation 
with a Ficoll gradient (Kasten et al., 2008, Hernigou et al., 2006, Hernigou et al., 
2005). Using this technique, bone marrow obtained from the iliac crest has been 
shown to contain 2579 ± 1121 progenitor cells/cm3 (Hernigou et al., 2006). Cells 
obtained in this manner are deemed ‘minimally manipulated MSCs’ and entail lower 
costs, faster processing, and less chance of an immunogenic reaction (Black et al., 
2007, Raposio et al., 2014). In the only study examining this cell population in the 
treatment of rotator cuff tears, it was associated with a significant improvement in 
healing compared to non-augmented controls. Tears with retraction were excluded 
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from this study, thus the role of minimally mmMSCs in their treatment is yet to be 
established (Hernigou et al., 2014). 
 
Chapter Two demonstrated that cortical DBM possessed sufficient mechanical 
properties to be considered as a tendon graft. It was therefore used as the basis for this 
study in order to evaluate the effect of allogenic and xenogenic DBM enhanced with 
mmMSCs on regeneration of the tendon-bone interface in an ovine model of tendon 
retraction. Since xenografts are cheaper and more readily available than their 
allogenic derivatives, their potential for augmenting tendon-bone healing was 
assessed (Oryan et al., 2014). The hypothesis was that augmentation of a healing 
tendon-bone interface with DBM and mmMSCs would result in improved function, 
and restoration of the native enthesis, with no difference between xenogenic and 
allogenic scaffolds. 
  
 
 
 97 
3.2  Materials and Methods 
 
3.2.1 Study Design   
 
All animal work was conducted in accordance with a Project License protocol 
accepted under the UK Home Office Animals (Scientific Procedures) Act 1986. Ten 
skeletally mature non-pregnant female Friesland ewes, two-to-three years old, 
weighing between 78 and 97 kilograms (kg) were selected for this study. All 10 
animals underwent surgical excision of the distal 1 cm of the right hind limb patellar 
tendon; the defect was repaired using a strip of xenogenic (porcine)/allogenic (ovine) 
cortical DBM and mmMSCs. One surgeon carried out all procedures and all animals 
were randomly allocated (using simple randomisation) to one of the two treatment 
groups. In keeping with the regulations set out by the UK Home Office Animals 
(Scientific Procedures) Act 1986, a control group was not used in this study since 
previous work has shown that a tendon defect does not heal spontaneously, rendering 
the animals lame (Yokoya et al., 2008, Yokoya et al., 2012). Animals were freely 
mobilised in individual pens and specimens were retrieved at 12 weeks following 
euthanasia using intravenous Sodium Pentobarbital. Force plate analysis, radiographs, 
peripheral quantitative computer tomography (pQCT) scans, and histological analysis 
were performed.    
 
3.2.2 DBM Manufacture  
 
DBM derived from cortical bone was manufactured according to Urist’s protocol, 
with modifications (Urist, 1965). Six tibiae from three skeletally mature female ewes 
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(allograft) and sows (xenograft) were harvested immediately post euthanasia; all soft 
tissues and periosteum were stripped from the bone surface. Proximal and distal ends 
of each tibia were excised and the shafts were cut into three longitudinal sections 
corresponding to the three surfaces of the prismatic shape of the tibia using a diamond 
edged band saw (Exact, Hamburg, Germany). The resulting bone strips were then 
demineralised in 0.6 N HCL at room temperature. Demineralisation was confirmed by 
taking radiographs (300 seconds, 30 kV, Faxitron Corporation, Illinois, USA). This 
was followed by prolonged washing in PBS until the pH was 7.4 +/- 0.1. Strips 
measuring 3-4 mm in thickness, 20 mm (+/- 2 mm) wide, and 15 cm long were cut 
and stored at -20 ̊ C for two hours and moved to a lyophiliser (Edwards Girovac Ltd, 
Crawley, West Sussex, UK) for three days. Specimens were sealed in individual 
plastic bags, sterilised by gamma irradiation at a dose of 25 kilograys (Isotron 
Limited, Reading, UK), and stored at -20 ̊ C. Samples were rehydrated at the time of 
surgery in normal saline for 45 minutes prior to use.    
 
3.2.3 Bone Marrow Aspiration and mmMSC Isolation  
 
Following the induction of anaesthesia, 20 ml of marrow was aspirated from the 
contralateral iliac crest in small fractions to reduce the degree of contamination by 
peripheral blood. Several aspirations were made through the same skin incision with 
each being spaced approximately 1 cm apart to avoid dilution from aspiration in the 
previous channel. All aspirates were stored in vials containing heparin and then 
concentrated by centrifugation with Ficoll for 30 minutes (Hernigou et al., 2006). The 
mononuclear layer containing mmMSCs was returned to the operative room after 45 
minutes. 
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3.2.4 Surgical Procedure  
 
A tendon retraction model was developed from a pre-existing ovine model used to 
investigate tendon-bone healing (Sundar et al., 2009a). All animals were sourced from 
The Royal Veterinary College (Hatfield, Hertfordshire, UK). Anaesthesia was 
induced with intravenous Midazolam [2.5 milligrams (mg)] and Ketamine 
Hydrochloride (2 mg/kg), and then maintained using 2% Isoflurane mixed with pure 
oxygen via an endotracheal tube.  
 
A longitudinal skin incision was made over the right stifle joint from the patella to the 
tibial tuberosity (Figure 3.1A). The patellar tendon was identified and a transverse 
strip of the distal 1 cm was excised from its bony insertion (Figure 3.1B). Using a 
sagittal saw the superficial 3 mm of the tendon footprint was osteotomised, and two 
3.2 mm drill holes were made 1 cm apart on the prepared flat bone surface into which 
two 5.5 mm metallic suture anchors (Corkscrew, Arthrex, Naples, Florida, USA) for 
repair of the DBM strip were inserted using a standard surgical technique (Figure 
3.1C). The mononuclear layer was combined with the fibrinogen component of a 
fibrin sealant (Tisseel, Baxter Health Care, Berkshire, United Kingdom) and then 
mixed with the thrombin component and applied onto the osteotomy site (Kalia et al., 
2006, Kalia et al., 2009).     
 
The defect was repaired with allograft in five sheep and xenograft in the remaining 
five sheep. An interlocking Krakow suture technique was used to secure the DBM 
strip to the remaining proximal patellar tendon using #2 FiberWire suture (Figure 
3.1D). The distal end of the DBM strip overlying the tibial tuberosity was secured to 
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the surrounding tissue, with the remaining sutures from the suture anchors, to ensure 
consistent and complete contact with the bone. The dimensions of the DBM strip 
were adjusted to match the length and width of the host patellar tendon prior to repair: 
this averaged 20 mm wide and 100 mm long. The surgical wound was closed in layers 
using absorbable 3’0 Vicryl (Ethicon, Johnson & Johnson Medical Ltd., Berkshire, 
UK). No restrictions in weight bearing were imposed postoperatively and the sheep 
were allowed to move freely. Digital lateral radiographs of both hind limbs were 
taken at 12 weeks.      
 
 
 
Figure 3.1A: Mid-line skin incision. 
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Figure 3.1B: Distal patellar-tendon defect. 
 
 
 
Figure 3.1C: Osteotomised tibial tuberosity with two suture anchors in situ. 
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Figure 3.1D: Patellar tendon defect repaired with allogenic DBM.  
 
3.2.5 Force Plate Analysis   
 
Animals underwent force plate analysis pre-operatively and at six, nine, and 12 weeks 
postoperatively as this has been demonstrated to be an appropriate marker of 
functional recovery (Sundar et al., 2009a). Twelve readings of each hind limb were 
taken by walking the animals over a force plate (Kistler Biomechanics Limited, 
Alton, UK) in a gait analysis laboratory. The mean peak vertical component of the 
ground reaction force (GRFz) of each hind limb was obtained and normalised for 
weight (Fmax/weight). Functional weight bearing (FWB) was expressed as the mean 
GRFz of the right hind limb as a percentage of the left (control) limb. Improvements 
in FWB were compared statistically between groups at each time point. 
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3.2.6 pQCT   
 
pQCT scanning was performed to examine for ossification within the patellar tendon, 
the DBM, and surrounding tissues. Using an XCT 2000 Bone Scanner (Stratec 
Medizintechnik Gmbh, Germany) with Software version 6.20, 5 mm CT slices were 
taken through the tibial tuberosity, patellar tendon/DBM, and patella. 
 
3.2.7 Histology 
 
The patella-patellar tendon/DBM graft-tibial tuberosity complex was harvested at 12 
weeks. Visual assessment of the tissue during the dissection, and pQCT were 
undertaken to determine if ossification had occurred within/around graft. Samples 
were fixed in 10% formal saline and underwent ascending graded alcohol 
dehydration, defatting in chloroform, and embedding in LR White Hard Grade Resin 
(London Resin Company Limited, Reading, UK). Sections were cut, ground, and 
polished to 70–100 µm before staining with Toluidine Blue and Paragon.  
Three distinct zones were defined and evaluated by two observers blinded to the 
origin of the graft (Figure 3.2). These comprised: zone 1, DBM-patellar tendon 
interface; zone 2, DBM in the region of the tendon defect; zone 3, DBM neo-enthesis, 
(the area of the new tendon enthesis over the tibial tuberosity). Sections were assessed 
semi-qualitatively for new bone formation, inflammatory cells, cellularity, 
vascularisation, and collagen fiber crimp.  
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Figure 3.2: Three morphological zones examined histologically. Zone 1: DBM-
patellar tendon interface; Zone 2: DBM in the region of the tendon defect; Zone 3: 
DBM neo-enthesis, examining the area of the new tendon enthesis over the tibial 
tuberosity. 
 
Semi-quantitative analysis was undertaken for interactions between DBM and the 
patellar tendon (zone 1), remodeling of the DBM in the tendon defect (zone 2), and 
the formation of a neo-enthesis (zone 3). In Zone 1, four separate equally spaced 
regions were analysed in order to comprehensively examine the entire length of the 
DBM-patellar tendon interface. The maximum score for this area was therefore 20, in 
contrast to Zones 2 and 3 that could yield a maximum score of 5. Tables 3.1 and 3.2 
describe the scoring criteria used for these assessments.  
 
 
 
 
 
 
DBM 
Patellar tendon 
Patella 
Zone 2 
Tibial tuberosity 
Zone 1 Zone 3 
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Score Criteria 
1 DBM still present with no evidence of 
tendon integration 
2 DBM: very little evidence of remodelling 
and integration 
Collagen: poorly aligned, poorly 
organised, not parallel 
3 DBM: partial remodeling 
Collagen: partially aligned in a parallel 
manner, partially organised 
4 DBM: almost completely remodeled 
Collagen: mostly aligned in parallel  
5 Completely remodeled DBM 
Normal tendon: 
− Parallel aligned collagen fibers 
− Elongated fibroblast nuclei 
 
 
Table 3.1: Criteria for semi-quantitative analysis of DBM remodelling (Zones 1 and 
2). 
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Score Criteria 
1 No fibrocartilage 
No mineralised fibrocartilage 
2 Fibrocartilage present 
No mineralised fibrocartilage 
3 Fibrocartilage present 
Mineralised fibrocartilage present 
Disorganised arrangement  
4 Fibrocartilage present 
Mineralised fibrocartilage present  
Organised graduation between distinct 
regions but no tidemark 
5 Fibrocartilage present 
Mineralised fibrocartilage present  
Organised graduation between distinct 
regions with tidemark 
 
 
Table 3.2: Criteria for semi-quantitative analysis of the tendon-bone interface (Zone 
3). 
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3.2.8 Statistical Analysis   
 
Nonparametric statistical methods were used for all analyses because of the non-
normality of the data in the groups being compared. Numerical data were inputted 
into SPSS software package, version 23 (SPSS Inc, an IBM Company, Chicago, 
Illinois). Mann Whitney U tests were used to compare data between groups, whilst 
Wilcoxon Signed Rank tests were used to assess differences within each group over 
time. Results were considered significant at the p < 0.05 level. 
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3.3  Results  
 
All animals survived the duration of the study and none had post-operative infection 
or failure of the fixation, as noted on radiographs (Figure 3.3). At 12 weeks, the gait 
pattern had returned to normal in both groups.   
 
 
 
Figure 3.3: Lateral radiograph of the right stifle joint 12 weeks following surgery.  
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3.3.1 Force Plate Analysis  
  
In the allograft group, FWB reached a median of 55.1% (95% CI 36.6 to 74.9) at six 
weeks, 68.1% (95% CI 48.4 to 90.7) at nine weeks, and 81.0% (95% CI 78.1 to 86.2) 
at 12 weeks. A significant improvement was noted between six and nine weeks (p = 
0.043) but not between nine and 12 weeks (p = 0.273). In the xenograft group, FWB 
reached a median of 39.1% (95% CI 28.8 to 47.1) at six weeks, 43.7% (95% CI 33.3 
to 54.4) at nine weeks, and 47.0% (95% CI 35.1 to 67.4) at 12 weeks. A significant 
improvement was noted between six and nine weeks (p = 0.043) but not between nine 
and 12 weeks (p = 0.273). At six, nine, and 12 weeks, FWB was significantly greater 
in the allograft group compared to the xenograft group (p = 0.047, 0.028, and 0.021, 
respectively) (Figure 3.4).    
   
 
 
 
 
 
 
 
 
 
 
 
 
 110 
 
 
Figure 3.4: Box and whisker plot showing percentage functional weight bearing of 
allogenic and xenogenic DBM groups at six, nine, and 12 weeks. 
 
3.3.2 pQCT Scans  
 
Ossification within the DBM or the patellar tendon was not found in any of the 
specimens.  
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3.3.3 Gross and Histological Findings 
 
Normal post-operative scar tissue was present and there was no evidence of 
inflammatory reaction, infection, or excessive granulation tissue. The DBM had 
remodeled and was well integrated into both the patellar tendon and tibial tuberosity. 
The suture anchors remained well fixed with no evidence of pull out or migration. All 
suture materials were intact with no evidence of rupture or failure.  
 
3.3.3.1 Qualitative Histology 
   
At 12 weeks, both allogenic and xenogenic DBM had remodeled and integrated into 
the surrounding tissue with evidence of neovascularisation. In the allograft group, the 
DBM-patellar tendon interface (zone 1) and tendon defect (zone 2) appeared normal 
and both were characterised by well-organised, crimped collagen fibers with 
elongated fibroblast nuclei (Figure 3.5). At the enthesis (zone 3), this was 
accompanied by mineralised fibrocartilage made up of chondrocytes surrounded by a 
mineralised matrix (Figure 3.5). This direct type of enthesis, with a distinct transition 
between bone, mineralised fibrocartilage, demineralised fibrocartilage, and tendon 
was seen in both groups. However the xenogenic DBM possessed fewer regions of 
mineralised fibrocartilage at the tendon-bone interface (zone 3) and displayed a more 
disorganised DBM-patellar tendon interface (zone 1) with fewer crimped collagen 
fibers (Figure 3.6). No evidence of heterotopic ossification or inflammatory cells were 
observed in either group.            
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Figure 3.5: Photomicrograph showing appearance of allogenic DBM at 12 weeks. 
Specimens stained with Toluidine Blue and Paragon. (a) Zone 1: Patellar tendon-
DBM interface characterised by well-organised, crimped collagen fibers with 
elongated fibroblast nuclei. (b) Zone 2: Tendon defect with complete remodeling of 
DBM and large areas of well-organised, crimped collagen fibers with elongated 
fibroblast nuclei. (c) Zone 3: DBM neo enthesis comprising tendon (T), fibrocartilage 
(FC), mineralised fibrocartilage (MFC) and bone (B). 
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Figure 3.6: Photomicrograph showing appearance of xenogenic DBM at 12 weeks. 
Specimens stained with Toluidine Blue and Paragon. (a) Zone 1: Patellar tendon-
DBM interface characterised by disorganised, crimped collagen fibers with elongated 
fibroblast nuclei. (b) Zone 2: Tendon defect with complete remodeling of DBM and 
large areas of disorganised, crimped collagen fibers with elongated fibroblast nuclei. 
(c) Zone 3: DBM neo enthesis comprising disorganised tendon (T), fibrocartilage 
(FC), mineralised fibrocartilage (MFC) and bone (B). 
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3.3.3.2 Quantitative Histology    
 
At 12 weeks, remodeling of the DBM was assessed using the criteria outlined in 
Table 1. In the region of the DBM-patellar tendon interface (zone 1), this scored a 
median of 14 (95% CI 12.5 to 15.3) in the allograft group and 12.5 (95% CI 10.5 to 
14.2) in the xenograft group. This difference did not reach statistical significance (p = 
0.147). At the tendon defect (zone 2), this scored a median of 4 (95% CI 3.7 to 4.5) in 
the allograft group and 3 (95% CI 2.7 to 3.8) in the xenograft group. In this region, 
the remodeled allograft resembled native tendon tissue significantly more than the 
xenograft (p = 0.015).   
 
Analysis of the neo-enthesis (zone 3) was conducted using the criteria detailed in 
Table 2 with evaluation of its maturation and presence of four distinct zones (tendon, 
demineralised fibrocartilage, mineralised fibrocartilage and bone). This scored a 
median of 4 (95% CI 3.8 to 4.4) in the allograft group and 4 (95% CI 2.9 to 4.1) in the 
xenograft group. A significantly more mature neo-enthesis was formed in the allograft 
group (p = 0.039). 
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3.4  Discussion  
 
This experiment suggests that allogenic and xenogenic DBM, used with mmMSCs, 
can regenerate an enthesis with favorable histological and mechanical properties in an 
ovine model of tendon retraction. All animals survived the duration of the study and 
there were no cases of post-operative infection or failure of the fixation. An 
improvement in functional weight bearing at all time points was noted in both groups, 
but was significantly greater in those animals that were treated with the allograft. At 
12 weeks, the DBM had remodeled across the entire length of the patellar tendon and 
the defect. This area was made up of well-organised crimped collagen fibers arranged 
parallel to the direction of load. The construct was well cellularised and vascularised 
throughout. Compared to the xenograft, the allograft was significantly more mature in 
the tendon defect and had remodeled into tendon-like tissue with crimped collagen 
fibers orientated in the direction of the tendon. The tendon-bone interface had been 
restored in both groups and was defined by the four distinct regions that make up a 
direct enthesis. This was significantly more mature and organised in the allograft 
group.  
 
Endochondral ossification has been proposed as a potential mechanism responsible 
for the development of the native enthesis (Thomopoulos et al., 2010). This involves 
the release of growth factors (inflammatory phase) and the secretion of a cartilaginous 
matrix that undergoes mineralisation and remodeling to form bone (Thomopoulos et 
al., 2010). BMP-2 and BMP-7 mediate this process and additionally cause bony 
ingrowth into the enthesis, thereby strengthening it (Ma et al., 2007, Schwarting et al., 
2015). DBM induces new bone formation by a similar process and may therefore 
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represent a suitable scaffold to regenerate a functional tendon-bone interface (Urist, 
1965). Lovric et al (Lovric et al., 2012) examined the effect of a DBM paste on 
healing of a bone tunnel during ACL reconstruction in a rodent model. At six weeks, 
peak load to failure was significantly higher in the DBM group when compared to 
non-augmented controls. Increased woven bone formation at the healing interface and 
greater expression of BMP-2 and BMP-7 were thought to be responsible for this. 
Histology did not show any evidence of fibrocartilage formation and the collagen 
present at the enthesis was disorganised and immature. Sundar et al (Sundar et al., 
2009a) examined functional recovery of the ovine patella tendon-bone interface 
following tendon reattachment with a DBM scaffold. Repair failure was noted in 33% 
of non-augmented controls. None of the repairs failed in the DBM group and the 
resultant enthesis comprised new bone and fibrocartilage. Earlier mobilisation and 
superior function was noted at all time points.    
 
Kilicoglu et al (Kilicoglu et al., 2012) assessed the effect of DBM on fixation of the 
extensor digitorum longus tendon within a proximal tibial bone tunnel in a rabbit 
model. At three weeks a greater proportion of Sharpey’s fibers, fibrocartilage, and 
new bone was found in the DBM group when compared to non-augmented controls. 
To further evaluate the influence of DBM on tendon-bone healing within a bony 
tunnel, Hsu and Wang (Hsu and Wang, 2014) used a rabbit model of ACL 
reconstruction. Similar to previous reports, DBM was associated with new bone 
formation and greater mineralised fibrocartilage.  
 
The tri-differentiation capacity of MSCs makes them a potentially suitable strategy 
for the enhancement of tendon-bone healing (Hernigou et al., 2014). Their use in the 
 117 
clinical setting has been restricted because in vitro expansion is costly and time-
consuming. To negate the need for expensive laboratory techniques in this study, 
mmMSCs were isolated from autologous bone marrow aspirates and made available 
within 45 minutes. This is an appealing ‘translational’ concept but few studies have 
treated rotator cuff tears using this method, and none have examined their effect on 
chronic tears with retraction (Hernigou et al., 2014, Juncosa-Melvin et al., 2006). The 
majority of studies use tissue culture-expanded MSCs to treat tendon defects but the 
results are variable. Awad et al (Awad et al., 1999) examined the results of a full 
thickness patellar tendon defect repaired in rabbits using culture-expanded MSCs 
within a collagen gel. Compared to controls, the treatment group exhibited superior 
biomechanical properties but no differences in histological appearance. Juncosa-
Melvin et al (Juncosa-Melvin et al., 2006) evaluated the results of a collagen sponge 
implanted with culture-expanded MSCs that was used to repair a full thickness 
patellar tendon defect in rabbits. At 12 weeks, there was no difference in cellularity 
between the MSC group and non-augmented controls. No fibrocartilage was found in 
either group and the biomechanical properties of the MSC group were superior.  
 
The results from this experiment contrast the aforementioned studies in that both the 
histological and biomechanical outcomes were improved. This may be due to the 
increased amounts of BMPs present in DBM (Lovric et al., 2012) causing the locally 
applied mmMSC population to differentiate down osteoblastic, chondrocytic, and 
tenocytic lineages (Dorman et al., 2012, Liu et al., 2010, Gulati et al., 2013, Sun et al., 
2015). The resultant interface resembled a direct enthesis containing organised 
fibrocartilage, and was able to resist the strong forces applied to it throughout the 
postoperative period without failure. Early postoperative weight bearing leading to 
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mechanotransduction may have contributed to this since applying load to a 
developing enthesis causes bone at the insertion site to mature, increases 
fibrocartilage formation, and improves collagen organisation (Thomopoulos et al., 
2010). Together, these factors contribute to the formation of a direct enthesis capable 
of resisting physiological forces.  
 
In this study, an ovine patellar tendon retraction model was used to assess tendon-
bone healing with DBM augmentation to simulate the clinical condition of the repair 
of a retracted tendon. Despite this model not precisely representing chronic rotator 
cuff tears in the clinical setting due to the lack of degeneration associated with 
creating an acute tear, it does permit more objective measurements of functional 
recovery in a healing enthesis as the extensor mechanism in a sheep has no supporting 
subsidiary structures and is entirely dependent upon the attachment of the patellar 
tendon to the tibial tuberosity. Detachment of supraspinatus in a sheep, and other 
animal models, would have had a substantially lesser effect on gait function as other 
components of the rotator cuff could compensate for its loss (Halder et al., 2002). In 
this study the use of mmMSCs in the setting of tendon retraction is novel, but it is 
difficult to be certain of the precise number of cells implanted into each repair site and 
whether variation between each animal affected their proliferation and/or viability. 
Other limitations of this study are associated with the lack of a control group. 
However, not treating the tendon defect would have rendered the animals lame, and 
therefore the study unethical, since previous work has shown that spontaneous healing 
does not occur (Yokoya et al., 2008, Yokoya et al., 2012).    
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3.5  Conclusion  
 
In conclusion, this is the first study to examine the effect of DBM used with 
mmMSCs on healing of a tendon-bone defect simulating tendon retraction. All 
animals were allowed unrestricted activity following surgery, which led to no failures. 
At 12 weeks, the tendon defect had successfully remodeled into tendon-like tissue and 
was accompanied by a direct enthesis. Functional weight bearing improved at all time 
points. Superior biomechanical and histological results were noted with the allogenic 
scaffold, highlighting DBM as a potential solution for the treatment of rotator cuff 
tears complicated by retraction. 
 
In order to overcome the limitations associated with this work, the next chapter details 
the development of a small animal model of rotator cuff tendon degeneration akin to 
what is seen in the clinical setting. This clinically applicable model will subsequently 
be used to examine the effect of DBM on tendon-bone healing.   
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Chapter Four: Development of a Degenerative Rat 
Model of Rotator Cuff Tendon-Bone Healing 
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4.1  Introduction  
 
Rotator cuff degeneration is common and can result in the development of tears which 
lead to degenerative changes in the muscle, bone, and tendon (Nho et al., 2008). 
Structural changes include retraction of the tendon away from the bone surface, 
muscle atrophy, reduced/increased cellularity, reduced/increased vascularity, fatty 
infiltration, calcification, and degeneration of the muscle (Loew et al., 2015, Nho et 
al., 2008). Degeneration can be initiated by a number of factors that are either 
intrinsic or extrinsic to the cuff itself. The degenerative-microtrauma model is the 
most important intrinsic factor and encompasses age-related degeneration 
compounded by repetitive microtrauma, eventually resulting in the development of a 
tear (Nho et al., 2008).    
   
Extrinsic causes comprise both anatomical and environmental influences. The latter 
includes increasing age, shoulder overuse, smoking, and any medical condition that 
impairs the healing response such as diabetes mellitus (Nho et al., 2008). In contrast, 
abnormal acromial morphology has been highlighted as the principal anatomical 
variant inciting the degenerative process (Nho et al., 2008). This is characterised by a 
progressive change in the shape of the acromion (Type 1-flat, Type 2-curved, and 
Type 3-hooked) and ‘spurs’ forming at its antero-inferior margin. These changes 
narrow the subacromial space and abut the supraspinatus tendon as it passes below the 
coracoacromial arch, causing inflammation. This is most prominent during abduction 
and elevation of the arm and is referred to as the ‘painful arc’ or ‘impingement 
syndrome’ (Carr et al., 2015a). Delayed treatment may further propagate these 
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intrinsic and extrinsic processes and compromise repair strategies (Romeo et al., 
1999).  
 
Poor healing and recurrent tears frequently occur following repair of a degenerative 
rotator cuff and are associated with a poor functional outcome (Carr et al., 2015a). In 
order to accurately determine the effect of biological augmentation on healing, it is 
imperative to examine such strategies in a degenerative environment akin to what is 
observed in the clinical setting. Several animal models of tendon degeneration have 
been developed, but it is the rat’s shoulder that seems to have gained the most 
popularity (Gerber et al., 2004, Buchmann et al., 2011). Advantages of using the rat 
as a surrogate for rotator cuff function include the presence of an arch-like structure 
that encloses supraspinatus (similar to the coracoacromial arch) and the high loads 
passing through the tendon. Alternatively, some primate models possess greater 
similarities in their anatomy to humans but due to their expense and restricted use, 
they are an impractical alternative (Soslowsky et al., 1996). Using a rat model, 
supraspinatus detachment has been shown to lead to degenerative changes 
comparable to those seen in the clinical setting: tendon degeneration, inflammation, 
and muscle atrophy combined with a persisting defect. These were most apparent 
after an interval of three weeks, with longer time points associated with complete 
closure of the defect (Buchmann et al., 2011).  
 
In a large animal model of tendon retraction, Chapter Three of this thesis 
demonstrated that allogenic cortical DBM regenerated an enthesis with favorable 
histological and mechanical properties. This study was limited by the use of a non-
degenerative model and so the aim of this chapter was to develop a rat model of 
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rotator cuff degeneration and assess the development of osteopenia at the bony 
insertion of supraspinatus following tendon detachment. Osteopenia of the humeral 
head occurs following a rotator cuff tear in humans and compromises fixation 
techniques where tendon is reattached to bone (Cadet et al., 2008). DBM induces 
bone formation by endochondral ossification and may be able to improve tendon-bone 
healing and reduce the rate of re-tears (Urist, 1965). The hypothesis was that 
detachment of supraspinatus from the humerus would result in tendon degeneration 
and osteopenia of the greater tuberosity in a rat model.  
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4.2  Materials and Methods 
 
4.2.1 Study Design  
 
All animal work was conducted in accordance with a Project License protocol 
accepted under the UK Home Office Animals (Scientific Procedures) Act 1986. 
Eighteen randomly allocated (using simple randomisation) female Wistar rats, which 
had not previously been subject to any experimentation, underwent unilateral 
detachment of the supraspinatus tendon. One surgeon carried out all procedures. 
Using a power calculation and previously published data, an n of 6 has been shown to 
provide a power of 0.8, which provides significance at p =0.05 (Sundar et al., 2009a). 
Animals were freely mobilised with cage mates and specimens were retrieved at three 
(n = 6), six (n = 6), and nine weeks (n = 6) postoperatively for histological analysis 
and pQCT. Euthanasia was carried out using carbon dioxide insufflation.  
   
4.2.2 Surgical Technique  
  
A chronic, degenerative full thickness rotator cuff tear model was developed from one 
that has previously been used to investigate tendon degeneration (Gulotta et al., 
2009). Anaesthesia was induced and maintained using 2% Isoflurane mixed with pure 
oxygen via a facemask. The right shoulder was used for tendon detachment in all 
cases and the contralateral left shoulder served as a control. A 1.5 cm skin incision 
was made directly over the anterolateral border of the acromion. The deltoid was 
detached from the anterior, lateral, and posterior margins of the acromion and split 
caudally for 0.5 cm. The acromio-clavicular joint was divided and a traction suture 
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was placed around the clavicle to facilitate visualisation of supraspinatus (Figure 
4.1A). The supraspinatus tendon was marked at its musculotendinous junction with a 
5’0 prolene suture to assess retraction during tissue harvest. Under tension of the 
suture, the tendon was detached using sharp dissection from the greater tuberosity of 
the humeral head and allowed to retract medially (Figure 4.1B and 4.1C). The deltoid 
muscle and fascia were closed with 5’0 Vicryl suture (Ethicon, Johnson & Johnson 
Medical Ltd., Berkshire, UK). Skin closure was achieved using 5’0 Monocryl suture 
(Ethicon, Johnson & Johnson Medical Ltd., Berkshire, UK) and the animals were 
permitted unrestricted cage activity (Figure 4.1D). Postoperative pain was assessed 
daily and analgesia (intra-muscular buprenorphine 0.6 mg) was given every 12 hours 
for three days.     
 
 
Figure 4.1A: Supraspinatus tendon insertion on the greater tuberosity. 
 
Suture around 
musculotendinous 
junction of 
supraspinatus 
 
Traction suture around 
clavicle 
 
Supraspinatus tendon 
insertion on greater 
tuberosity of humeral 
head 
 126 
 
Figure 4.1B: Supraspinatus tendon detachment from greater tuberosity. 
 
Figure 4.1C: Supraspinatus tendon stump following detachment. 
Supraspinatus tendon 
attachment 
Detached 
supraspinatus tendon 
stump 
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     Figure 4.1D: Surgical wound following closure. 
 
4.2.3 Macroscopic Assessment  
 
Animals were euthanised at three (n = 6), six (n = 6), and nine weeks (n = 6). 
Supraspinatus tendon-bone defects were classified as: persistent, partial, and 
completely closed.  
 
4.2.4 pQCT 
 
After sacrifice pQCT scanning was performed to measure bone mineral density at the 
humeral head. Using an XCT 2000 Bone Scanner (Stratec Medizintechnik Gmbh, 
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Germany) with Software version 6.20, 1 mm CT slices were taken through the 
humeral head and supraspinatus musculotendinous unit. 
   
4.2.5 Histological Assessment 
 
At euthanasia, the right shoulder was dissected and a specimen comprising the 
humerus with its attached supraspinatus musculotendinous unit was removed. The 
contralateral left shoulder served as a control (n = 6). Each sample was fixed in 10% 
formal saline and underwent decalcification in Ethylenediaminetetraacetic acid 
(EDTA), which was checked by radiography. The specimens were then processed in 
ascending graded alcohol dehydration followed by defatting in chloroform, and 
embedding in paraffin wax. Multiple sections were cut in the coronal plane through 
the humerus, enthesis, supraspinatus musculotendinous unit, and any scar tissue that 
filled the gap between tendon and bone. Using a Reichert-Jung Model 1130 
microtome (Reichert-Jung, Vienna, Austria), these were used to make slides 4 
micrometers (µm) thick before H&E staining. The process of sectioning samples was 
undertaken by Mr Frederick Henshaw (Undergraduate medical student, as part of an 
MSc Thesis, UCL, London, UK) under supervision.  
 
Two blinded observers evaluated all sections using an Olympus BH-2 light 
microscope (Olympus, Glasgow, UK). Using a semi-quantitative scoring system (0 = 
none, 1 = mild, and 2 = severe), four high-powered fields were examined in each 
muscle to determine the extent of fatty infiltration, cellularity, and inflammation 
(Buchmann et al., 2011).  
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Tendon degeneration was assessed according to a modified Movin scale (Movin et al., 
1997) and included the following variables: (1) fiber structure, (2) fiber arrangement, 
(3) rounding of the nuclei, (4) regional variations in cellularity, (5) increased 
vascularity, and (6) hyalinisation. A four-point scoring system was used: 0 = normal 
appearance, 1 = slightly abnormal appearance, 2 = a moderately abnormal 
appearance, and 3 = a markedly abnormal appearance (Longo et al., 2008). Based on 
this, the total score for any given slide could range from 0 (normal tendon) to 18 (the 
greatest level of degeneration).  
 
4.2.6 Statistical Analysis  
 
Nonparametric statistical methods were used for all analyses because of the non-
normality of the data in the groups being compared. Numerical data were inputted 
into SPSS software package, version 23 (SPSS Inc, an IBM Company, Chicago, 
Illinois). Mann Whitney U tests were used to compare data between groups. Results 
were considered significant at the p < 0.05 level.  
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4.3  Results  
 
All animals survived the duration of the study and none had post-operative infection. 
Limping was noted for the first three to five postoperative days but a normal gait 
pattern returned afterwards.  
  
4.3.1 Macroscopic Findings  
 
Scar tissue was noted in all animals. Based on the position of the suture marker, the 
supraspinatus tendon had retracted approximately 5 mm in all cases. The muscle belly 
of supraspinatus was atrophic and pale in appearance (Figure 4.2). Some degree of 
tendon-bone defect closure occurred in all animals at all time points. At three weeks, 
partial defect closure was evident in all cases. At six weeks, two animals had partial 
closure of the defect and four animals had complete closure. All animals in the nine-
week group had complete closure of the tendon-bone defect (Figure 4.2). The 
contralateral control group demonstrated no gaps in the supraspinatus tendon-bone 
interface.       
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Figure 4.2: Scar tissue in supraspinatus tendon-bone gap at nine weeks following 
tendon detachment.  
 
4.3.2 pQCT Scans   
 
In controls (contralateral shoulder in which the supraspinatus had not been detached), 
the median total bone mineral density at the supraspinatus tendon-bone insertion was 
793.25 mg/ccm (95% CI 754.24 to 844.70). This significantly decreased three, six, 
and nine weeks following tendon detachment to a median of 684.70 (95% CI 639.21 
to 739.82) (p = 0.006), 642.85 (CI 610.74 to 711.33) (p = 0.004), and 665.20 mm/ccm 
(CI 594.01 to 763.62) (p = 0.025) respectively (Figure 4.3). No significant change in 
bone mineral density occurred between three, six, and nine weeks (Table 4.1).      
 
 
 
Supraspinatus 
muscle 
 
 
Scar tissue in 
tendon-bone gap 
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Figure 4.3: Box and whisker plot showing total bone mineral density at the 
supraspinatus tendon-bone insertion three, six, and nine weeks following tendon 
detachment.    
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 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.006 0.004 0.025 
3 week group      
(n = 6) 
0.006 - 0.200 0.749 
6 week group    
(n = 6) 
0.004  0.200 - 0.631 
9 week group    
(n = 6) 
0.025 0.749 0.631 - 
 
Table 4.1: Statistical significance (p-values) between total bone mineral density at the 
supraspinatus tendon-bone insertion three, six, and nine weeks following tendon 
detachment.   
 
4.3.3 Histological Findings 
 
4.3.3.1 Muscle Evaluation 
  
A loss of muscle mass was observed at all time points, and was accompanied by 
degenerative changes (characterised by increased amounts of fibrotic tissue) that were 
most prominent three weeks after detachment and less evident by nine weeks. No 
inflammatory changes were present in any of the specimens. All groups demonstrated 
a degree of fatty infiltration, which peaked at three weeks (Figure 4.4). Compared to 
controls (where there was no fatty infiltration present) fatty infiltration significantly 
increased to a median score of 0.5 (95% CI 0.40 to 0.94) (p = 0.002) at three weeks 
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but reduced to a median score of 0 at six- (95% CI -0.19 to 0.69) (p = 0.140) and nine 
weeks (95% CI -0.10 to 0.44) (p = 0.138) (Table 4.2) (Figure 4.5).  
 
 
 
Figure 4.4: Photomicrograph showing fatty infiltration within the supraspinatus 
muscle belly. (a) Control: no fatty infiltration. (b) Three-week specimen: fatty 
infiltration (FI).   
 
 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.002 0.140 0.138 
3 week group      
(n = 6) 
0.002 - 0.061 0.014 
6 week group    
(n = 6) 
0.140 0.061 - 0.847 
9 week group    
(n = 6) 
0.138 0.014 0.847 - 
 
Table 4.2: Statistical significance (p-values) between the level of fatty infiltration 
three, six, and nine weeks after tendon detachment.   
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Figure 4.5: Box and whisker plot demonstrating fatty infiltration within the 
supraspinatus muscle three, six, and nine weeks after tendon detachment. 
  
Cellularity significantly increased at all time-points compared to controls: all control 
specimens exhibited a normal appearance and therefore scored 0. Compared to 
controls, cellularity reached a median of 2 (95% CI 2 to 2) at three weeks (p = 0.001), 
1 (95% CI 0.91 to 1.69) (p = 0.002) at six weeks, and 1.5 (95% CI 1.02 to 1.81) (p = 
0.002) at nine weeks (Table 4.3) (Figure 4.6). Furthermore, cellularity was 
significantly greater in the three-week group than in the six- and nine-week groups.   
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 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.001 0.002 0.002 
3 week group      
(n = 6) 
0.001 - 0.006 0.007 
6 week group    
(n = 6) 
0.002 0.006 - 0.382 
9 week group    
(n = 6) 
0.002 0.007  0.382 - 
 
Table 4.3: Statistical significance (p-values) between the level of cellularity three, six, 
and nine weeks following tendon detachment.   
 
Figure 4.6: Box and whisker plot demonstrating the change in cellularity within the 
supraspinatus muscle three, six, and nine weeks following tendon detachment.
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4.3.3.2 Tendon Evaluation 
 
4.3.3.2.1 Modified Movin Score 
  
The modified Movin score was significantly higher (indicating degeneration) in the 
three experimental groups compared to the controls (p = 0.003: three, six, and nine 
weeks after supraspinatus tendon detachment) (Table 4.4) (Figure 4.7). Tendon 
degeneration was most noticeable three weeks after detachment. The median modified 
Movin score was 0 (95% CI -0.27 to 0.60) in the controls, 8.75 (95% CI 7.08 to 
11.26) at three weeks, 7.75 (95% CI 6.45 to 9.38) at six weeks, and 8 (95% CI 7.53 to 
9.87) at nine weeks. There were no significant inter-group differences.      
 
 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.003 0.003 0.003 
3 week group      
(n = 6) 
0.003 - 0.256 0.326 
6 week group    
(n = 6) 
0.003 0.256 - 0.513  
9 week group    
(n = 6) 
0.003 0.326 0.513 - 
 
Table 4.4: Statistical significance (p-values) between modified Movin scores three, 
six, and nine weeks following tendon detachment.  
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Figure 4.7: Box and whisker plot illustrating the modified Movin scores three, six, 
and nine weeks following tendon detachment.  
 
4.3.3.2.2 Fiber Structure 
 
In control specimens, collagen fibers were close together and arranged in parallel. 
Loss of this uniform structure (increased waviness and distance between fibers) to 
differing degrees characterised abnormal specimens (Figure 4.8). The median scores 
were 0 (95% CI 0 to 0) for the control tendons, 2 (95% CI 1.56 to 2.10) for the three-
week group, 1.75 (95% CI 1.40 to 2.26) for the six-week group, and 2.5 (95% CI 2.40 
to 2.94) for the nine-week group. Fiber structure was significantly more abnormal in 
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the nine-week group compared to the three- (p = 0.003) and six-week groups (p = 
0.007) (Table 4.5) (Figure 4.9).   
 
 
 
Figure 4.8: Photomicrograph (under polarised light) showing collagen fiber structure. 
(a) Controls. (b) Three-week group. (c) Six-week group. (d) Nine-week group.    
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 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0 0 0 
3 week group      
(n = 6) 
0.002 - 0.859 0.003 
6 week group    
(n = 6) 
0.002 0.859 - 0.007 
9 week group    
(n = 6) 
0.002 0.003 0.007 - 
 
Table 4.5: Statistical significance (p-values) between fiber structure three, six, and 
nine weeks following tendon detachment.  
 
Figure 4.9: Box and whisker plot illustrating the difference in fiber structure three, 
six, and nine weeks following tendon detachment.   
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4.3.3.2.3 Fiber Arrangement  
 
In control specimens, the fibers were arranged in parallel. Loss of this arrangement to 
differing degrees characterised abnormal specimens (Figure 4.8). The median scores 
were 0 (95% CI 0 to 0) for the control tendons, 2 (95% CI 1.52 to 2.31) for the three-
week group, 1.5 (95% CI 1.20 to 1.63) for the six-week group, and 1.5 (95% CI 1.02 
to 1.81) for the nine-week group. Fiber arrangement was significantly more abnormal 
in the three-week group compared to the controls (p = 0.002), the six-week group (p = 
0.001), and the nine-week group (p = 0.002) (Table 4.6) (Figure 5.0).  
 
 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.002 0.001 0.002 
3 week group      
(n = 6) 
0.002 - 0.019 0.051 
6 week group    
(n = 6) 
0.001 0.019 - 0.923  
9 week group    
(n = 6) 
0.002 0.051 0.923 - 
 
Table 4.6: Statistical significance (p-values) between fiber arrangement three, six, and 
nine weeks following tendon detachment.  
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Figure 5.0: Box and whisker plot illustrating the difference in fiber arrangement three, 
six, and nine weeks following tendon detachment.  
 
4.3.3.2.4 Tenocyte Nuclei 
 
Tenocyte nuclei were flattened and spindle-shaped in control specimens, but 
following tendon detachment became more rounded (Figure 5.1). The median scores 
were 0 (95% CI – 0.13 to 0.30) for the control tendons, 2.50 (95% CI 2.06 to 2.60) for 
the three-week group, 1.75 (95% CI 1.40 to 2.26) for the six-week group, and 2 (95% 
CI 1.56 to 2.10) for the nine-week group. Tenocyte nuclei were significantly more 
abnormal than controls following tendon detachment (p = 0.002 at three-, p = 0.003 at 
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six-, and p = 0.002 at nine weeks), with the three-week group demonstrating more 
abnormal rounded nuclei than the six- and nine-week groups (Table 4.7) (Figure 5.2). 
 
 
 
 
Figure 5.1: Photomicrograph illustrating flattened and spindle-shaped nuclei in 
controls (a), and rounded nuclei three weeks after tendon detachment (b). 
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 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.002 0.003 0.002 
3 week group      
(n = 6) 
0.002 - 0.041 0.014 
6 week group    
(n = 6) 
0.003 0.041 - 0.859 
9 week group    
(n = 6) 
0.002 0.014 0.859 - 
 
Table 4.7: Statistical significance (p-values) between tenocyte nuclei morphology 
three, six, and nine weeks following tendon detachment.  
 
Figure 5.2: Box and whisker plot illustrating the difference between tenocyte nuclei 
morphology three, six, and nine weeks following tendon detachment.  
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4.3.3.2.5 Cellularity 
 
Specimens were evaluated for an increase in cellularity. The median scores were 0 
(95% CI -0.13 to 0.30) for the control tendons, 1.25 (95% CI 0.84 to 2.16) for the 
three-week group, 1.75 (95% CI 1.40 to 2.26) for the six-week group, and 1.75 (95% 
CI 1.46 to 2.03) for the nine-week group. There was a significant increase in 
cellularity following tendon detachment (p = 0.003 at three, p = 0.003 at six, and p = 
0.002 at nine-weeks), however there were no significant differences between 
experimental groups (Table 4.8) (Figure 5.3). 
 
 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.003 0.003 0.002 
3 week group      
(n = 6) 
0.003 - 0.246 0.315 
6 week group    
(n = 6) 
0.003 0.246 - 0.789 
9 week group    
(n = 6) 
0.002 0.315 0.789 - 
 
Table 4.8: Statistical significance (p-values) between cellularity three, six, and nine 
weeks following tendon detachment.  
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Figure 5.3: Box and whisker plot illustrating the difference in cellularity three, six, 
and nine weeks following tendon detachment.  
 
4.3.3.2.6 Vascularity 
 
Vascular bundles run with collagen fibers and increase in number with degeneration 
(Longo et al., 2008). The median scores were 0 (95% CI 0 to 0) for the control 
tendons, 1.5 (95% CI 0.68 to 2.49) for the three-week group, 1 (95% CI 0.53 to 1.47) 
for the six-week group, and 0.5 (95% CI 0.67 to 1.10) for the nine-week group. The 
number of vascular bundles significantly increased at three- (p = 0.002), six- (p = 
0.002), and nine-weeks (p = 0.006) following supraspinatus detachment (Table 4.9) 
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(Figure 5.4). A significant reduction in vascularity was noted between three- and 
nine-weeks (p = 0.030).  
 
 Control      
(non-operated 
shoulder) group 
(n = 6) 
3 week group 
(n = 6) 
6 week group 
(n = 6) 
9 week group 
(n = 6) 
Control      
(non-operated 
shoulder) group 
(n = 6) 
- 0.002 0 0.006 
3 week group      
(n = 6) 
0.002 - 0.249 0.030 
6 week group    
(n = 6) 
0.002 0.249 - 0.120 
9 week group    
(n = 6) 
0.006 0.030 0.120 - 
 
Table 4.9: Statistical significance (p-values) in vascularity three, six, and nine weeks 
following tendon detachment.   
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Figure 5.4: Box and whisker plot illustrating the difference in vascularity three, six, 
and nine weeks following tendon detachment.  
 
4.3.3.2.7 Hyalinisation  
 
Hyalinisation was not observed in any of the specimens.  
 
 
 
 
 149 
4.4 Discussion  
  
This study presents a rat model for the investigation of chronic rotator cuff tears. 
Following detachment of supraspinatus there was a significant rise in the modified 
Movin score characterised by a loss of muscle mass, fatty infiltration, an increase in 
musculotendinous cellularity, loss of normal collagen fiber structure/arrangement, 
rounded tenocyte nuclei, and an increase in the number of vascular bundles. The 
hypothesis was that tendon detachment would induce supraspinatus musculotendinous 
degeneration and a reduction in bone mineral density at the enthesis. The results 
support this, and demonstrate that these changes occur acutely after three weeks 
duration. However, after this time period, defect closure occurs and results in 
complete closure at nine weeks. Contrary to previous reports, fatty infiltration was 
present in muscle specimens at three-weeks but was no longer evident during the 
latter stages of the study (Buchmann et al., 2011, Barton et al., 2005). These transient 
changes suggest that with time, there is gradual reconstitution of the tendon-bone 
interface with fibrous tissue that permits the transfer of load and subsequent 
remodeling of this neo-enthesis into a tendon-like structure (Barton et al., 2005, 
Gimbel et al., 2004).  
 
Chronic rotator cuff tears are characterised by retraction, muscle atrophy, 
reduced/increased cellularity, reduced/increased vascularity, fatty infiltration, 
calcification, and degeneration of the muscle (Loew et al., 2015, Nho et al., 2008). 
Several animal models have been developed to reproduce the aforementioned 
pathological changes but it is the structure and function of the rat’s shoulder that most 
reliably resembles the human rotator cuff. Specifically, the rat possesses a bony arch 
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comprising the acromion, coracoid, and clavicle through which the supraspinatus 
tendon passes during movement (Soslowsky et al., 1996). Furthermore, following 
rotator cuff detachment in a rat the musculotendinous unit undergoes retraction, 
increased stiffness, and an increase in passive tension (Gimbel et al., 2004, Hersche 
and Gerber, 1998).  
 
Buchmann et al (Buchmann et al., 2011) performed complete detachment of the 
supraspinatus tendon in Sprague-Dawley rats and analysed the results after three, six, 
and nine weeks. The three-week group demonstrated the highest rate of persistent 
defects and muscle atrophy, whereas the nine-week group exhibited the greatest 
degree of tendon degeneration and defect closure. Although fatty infiltration was 
found in some animals, this was not significantly greater than in control specimens. 
Using a similar model, Barton et al (Barton et al., 2005) examined muscle mass, 
morphology, and fiber properties. Tendon detachment resulted in a reduction in 
muscle mass, an increase in the proportion of fast twitch muscle fibers, and an 
increase in fibrous tissue. At 16-weeks post detachment, muscle mass and fiber 
properties returned to normal parameters. This acute degenerative response to tendon 
detachment followed by rapid histological recovery has also been demonstrated in 
other studies examining the rat model of a chronic rotator cuff tear (Gimbel et al., 
2004, Dourte et al., 2010).  
 
Fatty infiltration into the rotator cuff is irreversible and represents an important 
predisposing factor to repair failure and poor functional outcomes (Deniz et al., 2014). 
Current rodent models have been unable to establish a significant amount of fat 
accumulation following tendon detachment, making it difficult to specifically 
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examine hypotheses related to it (Buchmann et al., 2011, Barton et al., 2005). In this 
study, there was a significant amount of fatty accumulation into the muscle belly of 
supraspinatus compared to controls, peaking at three-weeks following tendon 
detachment and subsiding thereafter. This novel finding may be associated with 
fundamental inter-species differences between the Wistar rats used in this study and 
the Sprague-Dawley rats used in others (Buchmann et al., 2011, Barton et al., 2005). 
Lipoprotein lipase catalyses the hydrolysis of triglycerides and is highly expressed in 
skeletal tissues. It is regulated differently between Wistar and Sprague-Dawley rats 
and may account for the lack of fat accumulation in otherwise degenerative muscle 
tissue in some studies (Galan et al., 1993).  
 
Rotator cuff tears can cause osteopenia at the enthesis due to a loss of physical stimuli 
(Oh et al., 2014b, Meyer et al., 2004a). During surgery, suture anchors are inserted 
into the greater tuberosity and therefore any reduction in bone mineral density may 
cause loosening or pullout before adequate tendon-bone healing can occur (Tingart et 
al., 2003). Accordingly, this has been recognised to be an independent risk factor 
predictive of healing, with a higher bone mineral density resulting in better outcomes 
(Cadet et al., 2008, Chung et al., 2011). The majority of studies ascribe this alteration 
in bone mineral density to attritional changes secondary to tendon damage, but it is 
plausible that they may precede the tear and be causative in nature (Chen et al., 2015). 
In order to examine biological strategies that specifically address bone quality it is 
imperative that there are suitable animal models available. While the anatomical 
similarities between the rat and human rotator cuff have been extensively described, 
there have been no studies to-date evaluating the onset of osteopenia in the rat. This 
prevents examination of hypotheses directly related to bone mineral density and 
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strategies targeted towards it. In this study, supraspinatus detachment caused a 
reduction in bone mineral density at three-, six-, and nine-weeks with no significant 
change between successive time-points. This may have occurred as a result of a 
reduction in the forces borne by the greater tuberosity following tendon injury, thus 
causing an imbalance in bone turnover, favoring bone resorption over bone formation: 
a principle governed by Wolff’s law (Cadet et al., 2008).   
 
Limitations of this study include the small number of specimens tested in each group 
and that only selected areas in the humeral head were analysed for bone mineral 
density analysis. Additional time points (two and 12 weeks) would have been 
beneficial to evaluate the progression and further resolution of degenerative 
musculotendinous changes, and alterations in bone mineral density. Subtle variations 
in the degree of rotation of the affected shoulder at the time of pQCT may contribute 
to minor differences in calculated bone mineral density scores. Given that all animals 
were limping during the immediate postoperative period, the enthesis of the contra-
lateral shoulder may have been influenced by the increased tensile loading, and thus 
may not have represented the most suitable control.  
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4.5 Conclusion   
 
In conclusion, this study has determined that three weeks following detachment, the 
supraspinatus musculotendinous unit in a rat undergoes degeneration, and the greater 
tuberosity exhibits a reduction in bone mineral density. These changes are similar to 
those that occur in the clinical setting following a chronic rotator cuff tear, with the 
difference that scar tissue bridges the defect in a rat whereas in a human the tendon-
bone gap is largely maintained.  
 
The results of this chapter indicate that for investigating biological strategies targeted 
towards improving chronic rotator cuff tendon-bone healing, the detached 
supraspinatus after three weeks represents a suitable surrogate. The next chapter 
utilises this model and applies DBM to the healing enthesis three weeks after 
supraspinatus detachment.   
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Chapter Five: The Effectiveness of Demineralised 
Cortical Bone Matrix in a Degenerative Rotator Cuff 
Repair Model
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5.1  Introduction 
 
Tendon-bone healing is an important factor affecting the outcome of rotator cuff 
repair (Gulotta et al., 2009). Anatomical reattachment of the rotator cuff to its bony 
insertion is crucial, but musculotendinous degeneration compromises tissue quality 
and challenges even the most well-performed repair (Nho et al., 2008). In order to 
facilitate the transmission of forces between tendon and bone, the native enthesis 
comprises four histological zones arranged in a graded structure (tendon, 
demineralised fibrocartilage, mineralised fibrocartilage, and bone) (Thomopoulos et 
al., 2010). Following injury, this is replaced by a weak fibrovascular bridge with 
inferior biomechanical properties, which renders it prone to rupture (Liu and Baker, 
1994, Carpenter et al., 1998, Harryman et al., 1991).  
 
DBM is made up of a collagen scaffold containing several growth factors conducive 
to endochondral ossification, and has been demonstrated to regenerate an enthesis 
with favorable histological and mechanical properties (Urist, 1965, Pietrzak et al., 
2012, Sundar et al., 2009a). Chapter Three has further illustrated the capacity of DBM 
to enhance tendon-bone healing in the presence of severe acute retraction. However, 
this study was undertaken in a non-degenerative large animal model and so its results 
have limited clinical application since the majority of rotator cuff tears are 
degenerative (Yamaguchi et al., 2006). To overcome this problem, a chronic rotator 
cuff tear model was developed in Chapter Four. This study established that 
degenerative changes were most prominent three weeks after supraspinatus tendon 
detachment. Osteopenia was evident at this time point and has been identified as a 
critical factor affecting the quality of tendon-bone fixation as it reduces the pullout 
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strength of suture anchors that are used as the basis of most repairs (Cadet et al., 
2008). In this context, DBM may be able to improve the quality of fixation by 
inducing new bone formation through a cartilaginous precursor (Urist, 1965). 
 
The aim of this chapter was to assess the effect of DBM on regeneration of a 
degenerative rotator cuff tear using the model presented in Chapter Four. DBM has 
previously not been compared to a commercially available augmentation strategy, and 
so in this study GraftJacket (Wright Medical Technology, Inc., Arlington, TN) was 
used as an alternative scaffold. GraftJacket is obtained from donated human cadaveric 
dermal tissue processed to remove its cellular components whilst retaining its ECM. 
Its acellularity has the advantage of not causing a host inflammatory reaction and it 
has been safely used in rats to enhance healing of a large acute rotator cuff tear (Ide et 
al., 2009c). The hypothesis was that compared to a commercially available scaffold 
(GraftJacket), DBM will result in a higher bone mineral density and regenerate a 
morphologically superior enthesis characterised by greater fibrocartilage formation 
and improved collagen fiber organisation, in a rat model of chronic rotator cuff 
degeneration.       
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5.2  Materials and Methods 
 
5.2.1 Study Design  
 
All animal work was conducted in accordance with a Project License protocol 
accepted under the UK Home Office Animals (Scientific Procedures) Act 1986. 
Eighteen female Wistar rats underwent unilateral detachment of the supraspinatus 
tendon. Three weeks later, tendon repair was carried out in three groups of 
randomised animals: Group 1 received augmentation of the repair with cortical 
allogenic DBM (n = 6); Group 2 received augmentation with non-meshed, ultra-thick 
GraftJacket (average 1.4 mm thickness) (n = 6); and Group 3 underwent tendon-bone 
repair without augmentation (n = 6). Using a power calculation and previously 
published data, an n of 6 has been shown to provide a power of 0.8, which provides 
significance at p =0.05 (Sundar et al., 2009a). One surgeon carried out all the 
procedures. Animals were allowed free mobilisation. Specimens were retrieved six 
weeks after tendon reattachment for histological analysis and pQCT to evaluate bone 
mineral density at the tendon insertion, reversal of degenerative changes within the 
tendon, and histological remodeling of the implanted scaffold.     
 
5.2.2 DBM Manufacture 
 
DBM derived from cortical bone was manufactured according to Urist’s protocol, 
with modifications (Urist, 1965). Tibiae of skeletally mature female Wistar rats were 
harvested immediately post euthanasia; all soft tissues and periosteum were stripped 
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from the bone surface. Bones measuring approximately 30 mm length by 3 mm width 
were demineralised in 0.6 N HCL at room temperature. Demineralisation was 
confirmed by taking radiographs (300 seconds, 30 kV, Faxitron Corporation, Illinois, 
USA). This was followed by washing in PBS until the pH was 7.4 +/- 0.1. Samples 
were stored at -20 ̊ C for two hours and moved to a lyophiliser (Edwards Girovac Ltd, 
Crawley, West Sussex, UK) for three days. Specimens were sealed in individual 
plastic bags, sterilised by gamma irradiation at a dose of 25 kilograys (Isotron 
Limited, Reading, UK), and stored at -20 ̊ C. Samples were rehydrated at the time of 
surgery in normal saline for 30 minutes prior to use. 
 
5.2.3 GraftJacket 
 
For this study, non-meshed, ultra-thick GraftJacket (average 1.4 mm thickness) was 
used (Figure 5.1). Samples were rehydrated at the time of surgery in normal saline for 
30 minutes prior to use.  
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Figure 5.1: Two strips of GraftJacket measuring 1 cm by 1 cm. 
 
5.2.4 Surgical Technique  
  
Two surgeries were performed on each animal: full-thickness supraspinatus tendon 
detachment and complete tendon reattachment (Figure 5.2). Anaesthesia was induced 
and maintained using 2% Isoflurane mixed with pure oxygen via a facemask. The 
right shoulder was operated on in all cases. Tendon detachment was performed as 
outlined in Chapter Four (section 4.2.2). The second surgery to reattach the tendon 
was undertaken three weeks after the first procedure. Prior to making the skin 
incision, the scaffold (DBM or GraftJacket) was rehydrated for 30 minutes in sterile 
normal saline at the operating table.  
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A 2 cm skin incision was made in line with the supraspinatus muscle belly, ending 
anterior to the lateral end of the clavicle. This approach was perpendicular to the 
incision used for tendon detachment in order to utilise a virgin anatomical plane 
devoid of scar tissue. The muscle belly of supraspinatus was identified and followed 
distally to reveal the tendon stump with the suture marker in the musculotendinous 
junction. Scar tissue was excised and the tendon was grasped using a double-armed 
5’0 prolene (Ethicon, Johnson & Johnson Medical Ltd., Berkshire, UK) modified 
Mason-Allen suture technique (Thomopoulos et al., 2002). Despite traction on the 
tendon stump, it could not be directly brought back to the humeral head in any of the 
cases.  
  
The tendon-bone insertion was decorticated using a #11 blade until bleeding was 
seen. Using a custom-made dental drill, a 1 mm drill hole was made from the neck of 
the humerus to the bony insertion of the detached supraspinatus. The scaffold (DBM 
or GraftJacket) was cut into a strip measuring 10 mm long and 3 mm wide. Each limb 
of the suture was passed through the graft to secure its position. One suture arm was 
passed through the superior aspect of the drill hole (on the tendon footprint) and the 
remaining suture arm was passed through the inferior aspect of the drill hole (on the 
neck of the humerus). The supraspinatus tendon-scaffold complex was attached to the 
insertion site, with the graft in contact with both the tendon stump proximally and 
decorticated bone surface distally (Figure 5.2). In the control group the sutures were 
inserted directly into the drill holes, leaving a 5 mm gap in the tendon-bone interface 
in all cases.  
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Figure 5.2A: Supraspinatus tendon-bone fixation. 
 
 
Figure 5.2B: Supraspinatus tendon-bone fixation with cortical DBM.  
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Figure 5.2C: Supraspinatus tendon-bone fixation with GraftJacket.  
 
A layered wound closure was undertaken in a similar manner to the first surgery, and 
the animals were permitted unrestricted cage activity. Postoperative analgesia (intra-
muscular Buprenorphine 0.6 mg) was given every 12 hours for three days.   
 
5.2.5 Histological Assessment  
 
Histological assessment was undertaken six weeks following tendon reattachment 
using the same method described in Section 4.2.5. In addition to this though, 
maturation of the enthesis was assessed according to the scoring system developed by 
Ide et al (Ide et al., 2009c): score 1 – the insertion had continuity without fibrous 
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tissue or bone ingrowth, score 2 – the insertion had continuity with fibrous tissue 
ingrowth but no fibrocartilage cells, score 3 – the insertion had continuity with fibrous 
tissue ingrowth and fibrocartilage cells but no tidemark, and score 4 – the insertion 
had continuity with fibrous tissue ingrowth, fibrocartilage cells, and a tidemark.  
 
5.2.6 pQCT 
 
Changes in bone mineral density at the humeral head were assessed using pQCT 
scanning. One millimeter slices were obtained through the humeral head and 
supraspinatus musculotendinous unit using an XCT 2000 Bone Scanner (Stratec 
Medizintechnik Gmbh, Germany) with Software version 6.20. Controls were obtained 
from the contralateral (non-operated) shoulder in six animals subjected to the same 
rehabilitation conditions as the study groups.  
 
5.2.7 Statistical Analysis 
  
Nonparametric statistical methods were used for all analyses because of the non-
normality of the data in the groups being compared. Numerical data were inputted 
into SPSS software package, version 23 (SPSS Inc, an IBM Company, Chicago, 
Illinois). Mann Whitney U tests were used to compare data between groups. Results 
were considered significant at the p < 0.05 level. 
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5.3  Results 
 
All animals survived the duration of the study and none had post-operative infection. 
Limping was noted for the first three to five postoperative days but a normal gait 
pattern returned afterwards.  
 
5.3.1 Macroscopic Findings  
 
At the time of euthanasia there was continuity between the repaired tendon and the 
bone in all groups (Figure 5.3). No signs of infection were noted in any specimen, 
none of the repairs had failed, and all the sutures were intact. Remodeling of the graft 
material occurred to a greater extent in the DBM group, whereby the scaffold could 
not be discerned from other tissues in the regenerated tendon-bone interface. In 
contrast, GraftJacket was clearly visible at necropsy. Control group specimens 
demonstrated complete closure of the enthesis.    
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Figure 5.3A: Post-mortem supraspinatus tendon-bone fixation using cortical DBM. 
 
 
 
Figure 5.3B: Post-mortem supraspinatus tendon-bone fixation using GraftJacket. 
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Figure 5.3C: Post-mortem supraspinatus tendon-bone fixation using no augmentation 
strategy (control group).    
  
5.3.2 Quantitative Histology 
 
5.3.2.1 Enthesis Maturation Score 
  
No significant differences were observed in the enthesis maturation scores between 
experimental groups. However, the GraftJacket specimens exhibited a more 
disorganised enthesis than control and DBM groups, which were characterised by a 
well organised, graded structure (Figure 5.4) (Table 5.1) (Figure 5.5). The median 
enthesis maturation score was 2.5 (95% CI 1.88 to 3.46) in the controls, 3 (95% CI 2 
to 4) in the DBM group, and 2.5 (95% CI 2.02 to 2.81) in the GraftJacket group.  
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Figure 5.4: Photomicrograph of the enthesis at six weeks. Specimens stained with 
H&E. (a) Control: Non-augmented tendon-bone repair characterised by a graded 
enthesis comprising tendon (T), fibrocartilage (FC), mineralised fibrocartilage, and 
bone (B). (b) DBM: DBM neo enthesis comprising a well organised graded enthesis. 
(c) GraftJacket: GraftJacket neo enthesis with a disorganised structure.  
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 Controls DBM GraftJacket 
Controls - 0.413 0.672  
DBM 0.413 - 0.161 
GraftJacket 0.672 0.161 - 
 
Table 5.1: Statistical significance (p-values) between the enthesis maturation scores 
following tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket. 
 
 
Figure 5.5: Box and whisker plot illustrating the enthesis maturation scores following 
tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket. 
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5.3.2.2 Modified Movin Score  
 
No significant differences in the modified Movin scores (indicating degeneration) 
were demonstrated between experimental groups (Table 5.2) (Figure 5.6). The median 
modified Movin score was 7 (95% CI 5.04 to 10.62) in the controls, 6 (95% CI 3.37 
to 10.47) in the DBM group, and 9.25 (95% CI 6.94 to 10.89) in the GraftJacket 
group.   
 
 Controls DBM GraftJacket 
Controls - 0.470 0.422 
DBM 0.470 - 0.296  
GraftJacket 0.422 0.296 - 
  
 
Table 5.2: Statistical significance (p-values) between the modified Movin scores 
following tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket.  
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Figure 5.6: Box and whisker plot illustrating the modified Movin scores following 
tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket.  
 
5.3.2.3 Fiber Structure   
 
All groups exhibited increased waviness and distance between collagen fibers, 
compared to the organised structure identified in the control specimens in Chapter 
Four (Figure 5.7). The median score was 1.75 (95% CI 1.07 to 2.10) in the controls, 
1.75 (95% CI 0.66 to 2.83) in the DBM group, and 1.5 (95% CI 0.83 to 2.67) in the 
GraftJacket group (Table 5.3) (Figure 5.8).  
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Figure 5.7: Photomicrograph (under polarised light) showing collagen fiber structure. 
(a) Controls (non-augmented tendon-bone repair). (b) DBM group. (c) GraftJacket 
group.    
 
 Controls DBM GraftJacket 
Controls - 0.742 0.800  
DBM 0.742 - 0.933 
GraftJacket 0.800 0.933 - 
 
Table 5.3: Statistical significance (p-values) between fiber structure following tendon 
reattachment using no augmentation strategy (controls), DBM, and GraftJacket. 
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Figure 5.8: Box and whisker plot illustrating the difference in fiber structure 
following tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket.  
 
5.3.2.4 Fiber Arrangement  
 
All groups exhibited a loss of the parallel arrangement observed in the control 
specimens in Chapter Four (Figure 5.7). The median score was 1.5 (95% CI 0.88 to 
2.46) in the controls, 1.25 (95% CI 0.84 to 2.16) in the DBM group, and 2.25 (95% CI 
1.90 to 2.76) in the GraftJacket group (Table 5.4) (Figure 5.9). Fiber arrangement was 
significantly more abnormal in the GraftJacket group than in the DBM group (p = 
0.039).  
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 Controls DBM GraftJacket 
Controls - 0.675 0.071  
DBM 0.675 - 0.039 
GraftJacket 0.071 0.039 - 
 
Table 5.4: Statistical significance (p-values) between fiber arrangement following 
tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket. 
 
Figure 5.9: Box and whisker plot illustrating the difference in fiber arrangement 
following tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket. 
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5.3.2.5 Tenocyte Nuclei   
 
Rounding of nuclei (indicating persistent degeneration) was identified in all groups 
following tendon reattachment (Figure 6.0). The median score was 1.75 (95% CI 1.12 
to 2.55) in the controls, 1.50 (95% CI 1.03 to 1.97) in the DBM group, and 2 (95% CI 
1.56 to 2.10) in the GraftJacket group (Table 5.5) (Figure 6.1). There were no 
significant inter-group differences.  
 
 
Figure 6: Photomicrograph illustrating rounded nuclei. (a) Controls (non-augmented 
tendon-bone repair). (b) DBM group. (c) GraftJacket group.     
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 Controls DBM GraftJacket 
Controls - 0.403 0.727 
DBM 0.403 - 0.162 
GraftJacket 0.727 0.162 - 
 
Table 5.5: Statistical significance (p-values) between tenocyte nuclei morphology 
following tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket. 
 
Figure 6.1: Box and whisker plot illustrating the differences in tenocyte nuclei 
morphology following tendon reattachment using no augmentation strategy (controls), 
DBM, and GraftJacket. 
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5.3.2.6 Cellularity    
 
Specimens were evaluated for an increase in cellularity, indicating persistent 
degeneration. The median score was 1.50 (95% CI 0.97 to 2.20) in the controls, 1.25 
(95% CI 0.70 to 1.97) in the DBM group, and 2 (95% CI 1.69 to 2.48) in the 
GraftJacket group (Table 5.6) (Figure 6.2). Cellularity was significantly less in the 
DBM group than in the GraftJacket group (p = 0.037), but there were no other 
significant inter-group differences. 
 
 Controls DBM GraftJacket 
Controls - 0.508 0.115 
DBM 0.508 - 0.037 
GraftJacket 0.115 0.037 - 
 
Table 5.6: Statistical significance (p-values) between cellularity following tendon 
reattachment using no augmentation strategy (controls), DBM, and GraftJacket. 
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Figure 6.2: Box and whisker plot illustrating the differences in cellularity following 
tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket. 
 
5.3.2.7 Vascularity  
 
Specimens were evaluated for an increase in vascularity, indicating persistent 
degeneration (Longo et al., 2008). The median score was 1.50 (95% CI 0.54 to 2.12) 
in the controls, 0.25 (95% CI -0.35 to 2.01) in the DBM group, and 1 (95% CI 0.30 to 
1.53) in the GraftJacket group (Table 5.7) (Figure 6.3). There were no significant 
inter-group differences.    
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 Controls DBM GraftJacket 
Controls - 0.459 0.216 
DBM 0.459 - 0.623 
GraftJacket 0.216 0.623 - 
 
Table 5.7: Statistical significance (p-values) in vascularity following tendon 
reattachment using no augmentation strategy (controls), DBM, and GraftJacket. 
 
Figure 6.3: Box and whisker plot illustrating the differences in vascularity following 
tendon reattachment using no augmentation strategy (controls), DBM, and 
GraftJacket. 
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5.3.2.8 Hyalinisation 
 
Hyalinisation was not observed in any of the specimens.  
 
5.3.3 pQCT 
  
Control specimens comprised the contralateral shoulder of animals that had 
undergone unilateral tendon detachment three weeks earlier, as outlined in Chapter 
Four. In this group (n = 6), the median total bone mineral density at the supraspinatus 
tendon-bone insertion was 793.25 mg/ccm (95% CI 754.24 to 844.70) (Figure 6.4). 
This significantly decreased six weeks following tendon repair with DBM and 
GraftJacket to a median of 721.20 (95% CI 537.52 to 771.68) (p = 0.004) and 620.55 
mg/ccm (95% CI 551.01 to 733.80) (p = 0.006) respectively (Table 5.8). Following 
non-augmented repair of the supraspinatus tendon to bone without the addition of an 
augmentation strategy, median bone mineral density was 756.30 mg/ccm (95% CI 
648.01 to 818.46). This was not significantly different to controls (p = 0.078).  
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Figure 6.4: Box and whisker plot showing total bone mineral density at the 
supraspinatus tendon-bone insertion six weeks following non-augmented tendon-bone 
repair, repair with cortical DBM, and repair with GraftJacket. 
 
 Non-operated 
control 
Non-
augmented 
repair  
DBM GraftJacket 
Non-operated 
control 
- 0.078 0.004 0.006 
Non-
augmented 
repair 
0.078 - 0.025 0.055 
DBM 0.004 0.025 - 0.749 
GraftJacket 0.006  0.055 0.749 - 
 
Table 5.8: Statistical significance (p-values) between total bone mineral density at the 
supraspinatus tendon-bone insertion six weeks following non-augmented tendon-bone 
repair, repair with DBM, and repair with GraftJacket.  
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5.4  Discussion  
 
In this study, it was hypothesised that compared to a commercially available scaffold 
(GraftJacket), DBM would regenerate a morphologically superior enthesis 
characterised by greater fibrocartilage formation and improved collagen fiber 
organisation. It was further hypothesised that DBM would result in a higher bone 
mineral density at the insertion site. However, the results do not support this 
hypothesis. Using a rat model of chronic rotator cuff degeneration, the supraspinatus 
tendon was reattached to its bony insertion with DBM, GraftJacket, and no 
augmentation strategy (controls) and analysed after six weeks. All groups 
demonstrated closure of the tendon-bone gap with a fibrocartilaginous interface, but 
the degenerative process at this time point could not be reversed (as illustrated by a 
persistently high Modified Movin score). Although there was no significant difference 
in enthesis maturation scores at the conclusion of the study, the GraftJacket specimens 
exhibited a disorganised structure with significantly more abnormal collagen fiber 
arrangement and cellularity than the DBM repairs (indicating more severe 
degeneration).  
 
Bone mineral density at the enthesis was the second parameter examined because it 
has been shown to determine the quality and degree of tendon-bone healing, and the 
pullout strength of suture anchors in the clinical setting (Lovric et al., 2012, Cadet et 
al., 2008). Following tendon reattachment with DBM and GraftJacket, this did not 
recover to the baseline levels established in Chapter Four (bone mineral density at the 
non-operated tendon insertion site). In contrast, the non-augmented repairs exhibited a 
significantly higher bone mineral density than DBM and GraftJacket specimens, and 
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were not significantly different to the control specimens in Chapter Four. This 
indicates that at this time point bone density had not recovered to normal levels.  
Several in vivo studies have demonstrated the ability of DBM to enhance tendon-bone 
healing, but none in a degenerative rotator cuff tear model (Sundar et al., 2009a, 
Kilicoglu et al., 2012, Lovric et al., 2012). In the first study to examine the use of 
DBM at the healing enthesis, Sundar et al (Sundar et al., 2009a) created an acute tear 
in an ovine patellar tendon model and repaired it with the scaffold. Compared to 
controls at 12-weeks, the DBM group showed increased amounts of mineralised 
fibrocartilage and improved functional weight bearing. To determine the effect of 
DBM on tendon healing within a bone tunnel, Kilicoglu et al (Kilicoglu et al., 2012) 
developed a rabbit model and retrieved specimens three, six, and nine weeks after 
surgery. At three weeks, a higher number of Sharpey’s fibers, marginally increased 
fibrocartilage formation, and new bone formation was observed in the DBM group, 
but this difference was not significant at later time-points. In a further study 
examining the healing potential of a DBM paste in a tendon-bone tunnel, Lovric et al 
(Lovric et al., 2012) created a rat model of ACL reconstruction. No reconstitution of 
the fibrocartilage layer was observed in either the DBM or control groups. The main 
finding was a significantly greater amount of new bone formation in DBM-augmented 
animals associated with a significantly higher peak load to failure of the tendon-bone 
interface at six weeks.  
 
The current study could not reproduce the results of DBM-induced tendon-bone 
healing observed in other animal models, including those described in Chapter Three 
of this thesis. Considering that the overall contact area between tendon and bone is a 
major determinant of healing, the limited tendon-bone surface area in a rat model 
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does not present an environment that is as conducive to healing as large animal 
models and those that utilise a tendon-bone tunnel (Greis et al., 2001). Furthermore, 
the high shear forces from contraction of supraspinatus are distributed over a 
relatively small surface area and therefore may not have allowed adequate tendon 
healing to take place (Gulotta et al., 2009). The next important finding of this study 
was that the non-augmented control group demonstrated an equivalent histological 
outcome to those tendons repaired with DBM and GraftJacket, and also resulted in a 
bone mineral density at the tendon insertion comparable to the non-operated controls 
described in Chapter Four. This may be due to the two bulky scaffolds inhibiting 
motion of the shoulder joint and thus remodeling of the grafts into a native tendon-
bone interface, within the allocated time frame of six weeks.    
 
There are several limitations to this study. Previous work has shown that most control 
tendons in a rat model heal by eight weeks, making it challenging to detect 
differences between control and experimental groups because it is difficult to improve 
upon a solid mass of healed tissue (Gulotta et al., 2009). Earlier time points in the 
healing phase (two and four weeks) may have highlighted differences that later 
became non-significant between groups. Similarly, later time points (nine and 12 
weeks) may have allowed greater time for the scaffolds to remodel and exert their 
restorative effect on the tendon-bone interface. Finally, biomechanical evaluation of 
the repair construct would have strengthened the results of this study, but due to the 
limited number of specimens this could not be performed.  
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5.5  Conclusion   
 
This study has highlighted the difficulty of developing a suitable model of a chronic 
rotator cuff tear, and a scaffold to improve healing of the rotator cuff tendon-bone 
interface. Although the application of DBM to a chronic rotator cuff tear does result 
in a fibrocartilaginous enthesis, this was not significantly more mature than non-
augmented controls or a commercially available alternative scaffold (GraftJacket). 
However, without further time points for histological analysis it is not possible to 
discern between subtle differences in the healing interface, early and late in the 
remodelling process of tendon healing. It is possible that the addition of cell-based 
strategies to the healing enthesis may enhance the results observed in this study, and 
so the next chapter investigates the use of MSCs in chronic rotator cuff healing.  
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Chapter Six: Application of Demineralised Cortical 
Bone Matrix and Mesenchymal Stem Cells to a 
Degenerative Rotator Cuff Repair Model
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6.1 Introduction  
 
Approximately 75,000 rotator cuff repairs are performed each year in the United 
States (Vitale et al., 2007). Up to 94% of tendons fail to heal back to bone and result 
in a worse functional outcome than those tendons that do go onto heal (Carr et al., 
2015a, Galatz et al., 2004). The native enthesis is a graded structure that allows 
stresses to be evenly distributed between tendon and bone (Thomopoulos et al., 2010). 
Following surgery, scar tissue is deposited at the healing interface and has been 
identified as a potential cause of the high failure rate because it possesses weak 
mechanical properties and does not contain mineralised fibrocartilage (St Pierre et al., 
1995, Cooper and Misol, 1970) (Cooper and Misol, 1970, Gerber et al., 1999, Koike 
et al., 2006, St Pierre et al., 1995). In order to improve rotator cuff healing, biological 
strategies must enhance tissue regeneration and provide an optimal mechanical 
environment to resist tearing during the crucial postoperative rehabilitation period 
(Miller et al., 2011).      
 
MSCs are multipotent cells that are capable of differentiating into several cell types, 
including chondrocytes, adipocytes, and osteoblasts (Chamberlain et al., 2007). In 
vivo examination of MSCs on enthesis regeneration have reported the absence of a 
fibrocartilaginous interface, citing the lack of signaling as a reason for the 
transplanted cells not differentiating and improving healing (Gulotta et al., 2009). To 
enhance their effect studies have engineered stem cells in vitro to express specific 
proteins (Gulotta et al., 2010, Gulotta et al., 2011a). In doing so, fibrocartilage 
production and strength of the repair have been increased (Gulotta et al., 2010).   
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DBM consists of a network of collagen fibers that provide a sustained release of 
growth factors such as BMPs (Pietrzak et al., 2012). Wurgler-Hari et al (Wurgler-
Hauri et al., 2007) demonstrated that a slow release of growth factors is required for 
tendon-bone healing, and there is evidence to indicate that BMPs are important 
proponents of a naturally graded, mechanically favorable enthesis (Longo et al., 2011, 
Aspenberg and Forslund, 1999, Pauly et al., 2012). Differentiation of MSCs can be 
directed by the introduction of BMPs; a property that may be utilised to increase 
production of mineralised fibrocartilage at the healing enthesis (Dorman et al., 2012, 
Liu et al., 2010, Gulati et al., 2013, Sun et al., 2015). In an acute tear model of 
tendon-bone healing, DBM has been shown to regenerate a strong enthesis with 
mineralised fibrocartilage (Sundar et al., 2009a). Chapters Three and Five of this 
thesis have further highlighted the potential of DBM to be used as a graft material for 
tendon repair to bone, in a model of severe retraction (Chapter Three) and 
degeneration (Chapter Five). Since the ultimate strength of the tendon-bone interface 
is dependent upon bony ingrowth into healing tissue containing fibrocartilage, the 
addition of MSCs into the DBM-based repair construct may produce an enthesis 
resembling the native insertion site with a natural gradation between tendon, 
demineralised fibrocartilage, mineralised fibrocartilage, and bone.      
 
The purpose of this study was to determine if DBM enhanced with MSCs could 
improve healing when applied to a degenerative model of rotator cuff repair. As in 
Chapter Five, DBM was compared to GraftJacket (Wright Medical Technology, Inc., 
Arlington, TN), as this is a commonly used scaffold in clinical practice (Bond et al., 
2008). The hypothesis was that compared to MSCs alone, DBM enhanced with MSCs 
will regenerate a morphologically superior enthesis with a higher bone mineral 
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density in a rat model of a chronic rotator cuff tear. To determine whether MSCs 
could enhance the structure of the healing enthesis compared to repairs without stem 
cells, the results of this study were compared to those from Chapter Five. It was 
hypothesised that the addition of MSCs would yield a morphologically superior 
interface and increased bone mineral density at the tendon insertion.  
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6.2 Materials and Methods  
 
6.2.1 Study Design 
 
All animal work was conducted in accordance with a Project License protocol 
accepted under the UK Home Office Animals (Scientific Procedures) Act 1986. 
Eighteen female Wistar rats underwent unilateral detachment of the supraspinatus 
tendon, and an additional one animal from the same genus was used to obtain bone 
marrow-derived MSCs. Previously published data was used to calculate the number 
of animals (n = 6) required to generate a power of 0.8 with significance at the 0.05 
level (Sundar et al., 2009a). Three weeks later, tendon repair was carried out in 
animals randomised into three groups: Group 1 received augmentation of the repair 
with cortical allogenic DBM (n = 6); Group 2 received augmentation with non-
meshed, ultra-thick GraftJacket; and Group 3 underwent tendon-bone repair without a 
scaffold (n = 6). All animals received 1 × 106 MSCs in a fibrin sealant Tisseel® kit 
(Baxter, Vienna, Austria) and one animal from each study group received MSCs 
labeled with Quantum Dot nanoparticles (Thermo Fisher Scientific, Massachusetts, 
United States) (QDs) for cell tracking. Fibrin glue without MSCs has previously been 
shown not to enhance healing of the enthesis and therefore it was not used as an 
experimental group in this study in order to minimise the number of animals used, as 
per UK Home Office regulations (Gulotta et al., 2009, Shoemaker et al., 1989, 
Yamazaki et al., 2005).  
 
All procedures were carried out by one surgeon. Animals were freely mobilised and 
specimens were retrieved at six weeks (following euthanasia with carbon dioxide 
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insufflation) postoperatively for histological analysis and pQCT to evaluate bone 
mineral density at the tendon insertion, reversal of degenerative changes within the 
tendon, and histological remodeling of the implanted graft material.  
 
6.2.2 DBM Manufacture 
 
Cortical DBM derived from the tibiae of skeletally mature female Wistar rats were 
manufactured using the same technique described in Chapter Five (section 5.2.2). 
Samples were rehydrated at the time of surgery in normal saline for 30 minutes prior 
to use. 
 
6.2.3 GraftJacket  
 
As in Chapter Five, non-meshed, ultra-thick GraftJacket with an average thickness of 
1.4 mm was used in all cases. Samples were rehydrated at the time of surgery in 
normal saline for 30 minutes prior to use.  
 
6.2.4 Bone Marrow-Derived Mesenchymal Stem Cell Harvest and Culture  
 
One six-month-old female Wistar rat was euthanised by carbon dioxide inhalation and 
bilateral femurs were harvested under sterile conditions. MSCs were harvested by 
lavaging the intramedullary canals with Dulbecco's modified Eagle's medium 
(DMEM) (Invitrogen, Paisley, UK) containing 10% fetal calf serum (FCS) (HyClone, 
Logan, Utah, USA). Cells were washed with sterile PBS three times and centrifuged 
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at 2000 revolutions per minute (rpm) for five minutes. The supernatant was discarded 
and the cell pellet was resuspended in 20 ml DMEM containing 1% 
penicillin/streptomycin solution and 10% FCS, and plated onto T-175 culture flasks. 
Cells were cultured at 37°C in a 5% carbon dioxide incubator. After two days, the 
contents of the flask were removed and washed with media, leaving behind MSCs 
that adhered to the bottom of the flask. Afterwards, media was changed twice a week 
for 14 days. Once confluent, the MSCs were detached with trypsin and serially 
subcultured. Third-passage cells were used for implantation. Previous studies have 
shown that this protocol is a reliable method of obtaining MSCs, and that their 
pluripotency is maintained up to the third passage (Gulotta et al., 2009, Gulotta et al., 
2010, Akhan et al., 2015, Pittenger et al., 1999, Toh et al., 2005). No immunogenic 
reaction was anticipated with stem cell implantation because the rats from where they 
were harvested were the same strain as those receiving them.  
  
6.2.5 Surgical Technique 
 
Tendon detachment and subsequent reattachment were undertaken using the same 
operative protocol described in Chapter Five (section 5.2.4), with the exception that 
MSCs were incorporated into the repair. The fibrin sealant Tisseel® (Baxter, Vienna, 
Austria) contained two parts: a vapor-heated Tisseel® powder dissolved in aprotinin 
solution and a vapor-heated thrombin powder, dissolved in calcium chloride solution. 
One milliliter of the Tisseel® solution contained 100–130 mg of total protein, of 
which 75–115 mg was fibrinogen. One milliliter of thrombin solution contained 45–
55 mg of total protein, of which 500 International Units (IU) 2 was thrombin (Kalia et 
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al., 2006). Preoperatively, MSCs were implanted into the thrombin component in 
vitro at a concentration of 1 × 106 cells/100 µl and mixed with the Tisseel® solution. 
The fibrin glue was injected into a custom-made square-shaped stainless steel mold 
measuring 1 cm by 1cm containing DMEM, which provided nutrition to the cells up 
to the point at which they were implanted (Figure 6.1).  
 
 
 
Figure 6.1: Metallic molds containing fibrin glue and MSCs in vitro. 
 
Prior to securing the graft material (cortical DBM or GraftJacket) during tendon 
reattachment surgery, the sheet of fibrin glue containing MSCs was placed on the 
decorticated humeral head whilst lying in contact with the proximal tendon stump 
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(Figure 6.2). All grafts used to augment healing measured approximately 1.5 cm in 
length and 3-5 mm in width.  
 
 
 
 
Figure 6.2: Supraspinatus tendon-bone interface with cortical DBM + MSCs (A) and 
GraftJacket + MSCs (B).  
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In the group where MSCs were used in isolation, the fibrin glue bridged the gap 
between the retracted supraspinatus musculotendinous unit and its bony insertion. The 
repair construct resembled a laminated structure: superficial layer – cortical 
DBM/GraftJacket, central layer – fibrin glue with MSCs, and deep layer – humeral 
head with tendon footprint (Figure 6.3).    
 
 
 
Figure 6.3: Lateral view of the tendon-bone repair construct comprising superficial 
layer – cortical DBM/GraftJacket, central layer – fibrin glue with MSCs, and deep 
layer – humeral head with tendon footprint.     
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6.2.6 Mesenchymal Stem Cell Tracking  
 
QDs are semiconductor nanoparticles that are phagocytosed or take up by pinocytosis 
into cells and distributed within cytoplasmic vesicles, causing intense fluorescence 
(Muller-Borer et al., 2007). Using them in this study was crucial to establishing 
whether the implanted MSCs remained at the healing enthesis to exert their effect 
locally. Properties that make QDs suitable for cell tracking include their compatibility 
with MSCs without effecting proliferation and differentiation, and their resistance to 
chemical and metabolic degradation (Muller-Borer et al., 2007, Collins et al., 2012, 
Alivisatos, 2004, Chan et al., 2002, Dubertret et al., 2002, Jaiswal et al., 2003).  
 
In this study, three animals (one from each experimental group) received MSCs 
labeled with a Q-Tracker 655 Cell Labeling kit (Thermo Fisher Scientific, 
Massachusetts, United States). QDs were applied to cells at a concentration of 
300,000 particle units/1 × 106 MSCs. This was achieved using the following protocol 
issued from the manufacturer: 1 µL of Qtracker® Reagent A and Component B were 
mixed in a 1.5 mL micro-centrifuge tube and incubated for five minutes at room 
temperature, 0.2 mL of fresh complete growth medium was added to the tube and 
vortexed for 30 seconds, 0.2 mL of the labeling solution was added to a well-plate 
containing MSCs, the sample was incubated at 37 ° C for 45-60 minutes, and the cells 
were washed twice with fresh complete growth medium. On the morning of surgery 
transduced MSCs were suspended in the fibrin sealant, stored in DMEM, and 
implanted at the repair site as described above.  
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6.2.7 Histological Assessment 
 
Histological assessment was undertaken six weeks following tendon reattachment 
using the same method described in Section 5.2.5. 
 
Presence of red fluorescence using fluorescein isothiocyanate (FITC) microscopy was 
used to confirm the position and distribution of the MSCs containing QDs.  
 
6.2.8 pQCT 
 
Changes in bone mineral density at the humeral head were assessed using the same 
method outlined in Section 5.2.6.      
  
6.2.9 Statistical Analysis  
 
Nonparametric statistical methods were used for all analyses because of the non-
normality of the data in the groups being compared. Numerical data were inputted 
into SPSS software package, version 23 (SPSS Inc, an IBM Company, Chicago, 
Illinois). Mann Whitney U tests were used to compare data between groups. Results 
were considered significant at the p < 0.05 level. In order to determine whether there 
was any benefit in using MSCs, the data from this chapter was compared to that of 
Chapter Five.  
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6.3 Results  
 
All animals survived the duration of the study and none had post-operative infection. 
Limping was noted for the first three to five postoperative days but a normal gait 
pattern returned afterwards.  
 
6.3.1 Mesenchymal Stem Cell Tracking 
 
QDs were demonstrated in all specimens where they were implanted, suggesting that 
the MSCs remained at the tendon-bone interface (Figure 6.4). 
 
 
 
Figure 6.4: QDs at the tendon-bone interface denoted by red florescent cells; when 
viewed under a FITC filter.  
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6.3.2 Macroscopic Findings  
 
At the time of euthanasia there was continuity between the repaired tendon and the 
bone in all groups. There were no infections and none of the repairs had failed as 
illustrated by the intact sutures. Remodeling of the graft material occurred to a greater 
extent in DBM group, whereby the scaffold could not be discerned from other tissue-
types in the regenerated tendon-bone interface. In contrast, the GraftJacket group was 
clearly visible at necropsy. MSC-only specimens demonstrated complete closure of 
the enthesis. These were similar findings to Chapter Five, where MSCs were not used.      
 
6.3.3 Quantitative Histology 
 
6.3.3.1 Enthesis Maturation Score 
  
No significant differences were observed in the enthesis maturation scores between 
experimental groups (Figure 6.5) (Table 5.9) (Figure 6.6). DBM had remodeled to a 
greater extent than GraftJacket, although not completely in all specimens. The median 
enthesis maturation score was 3 (95% CI 2.47 to 3.70) in the MSC group, 3 (95% CI 
3 to 3) in the DBM + MSC group, and 2.5 (95% CI 1.88 to 3.46) in the GraftJacket + 
MSC group.  
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Figure 6.5: Photomicrograph of the enthesis at six weeks. Specimens stained with 
H&E. (a) Control: Tendon-bone repair with MSCs, characterised by a graded enthesis 
comprising tendon (T), fibrocartilage (FC), mineralised fibrocartilage, and bone (B). 
(b) DBM + MSCs: DBM neo enthesis comprising a well-organised, graded enthesis. 
(c) GraftJacket + MSCs: GraftJacket neo enthesis with a disorganised structure. 
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 MSCs alone DBM + MSCs GraftJacket + MSCs 
MSCs alone - 1 0.216 
DBM+MSCs 1 - 0.107 
GraftJacket+MSCs 0.216 0.107 - 
 
Table 5.9: Statistical significance (p-values) between the enthesis maturation scores 
following tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + 
MSCs.  
 
 
Figure 6.6: Box and whisker plot illustrating the enthesis maturation scores following 
tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs.  
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6.3.3.2 Modified Movin Score  
  
No significant differences in the modified Movin scores (indicating degeneration) 
were demonstrated between experimental groups (Table 6.0) (Figure 6.7). The median 
modified Movin score was 4.25 (95% CI 2.19 to 5.48) in the MSC group, 6.75 (95% 
CI 3.46 to 9.04) in the DBM + MSC group, and 5.75 (95% CI 4.55 to 7.62) in the 
GraftJacket + MSC group.  
 
 MSCs alone DBM+MSCs GraftJacket+MSCs 
MSCs alone - 0.126 0.053  
DBM+MSCs 0.126 - 0.746 
GraftJacket+MSCs 0.053 0.746 - 
  
 
Table 6.0: Statistical significance (p-values) between the modified Movin scores 
following tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + 
MSCs.   
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Figure 6.7: Box and whisker plot illustrating the modified Movin scores following 
tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs. 
 
6.3.3.3 Fiber Structure   
 
All groups exhibited increased waviness and distance between collagen fibers, 
compared to the organised structure identified in the control specimens in Chapter 
Four (intact tendon-bone interface) (Figure 6.8). The median score was 1 (95% CI 
0.12 to 1.55) in the MSC group, 1.75 (95% CI 1.03 to 2.30) in the DBM + MSC 
group, and 1.25 (95% CI 0.34 to 1.66) in the GraftJacket + MSC group (Table 6.1) 
(Figure 6.9).  
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Figure 6.8: Photomicrograph (under polarised light) showing collagen fiber structure: 
(a) tendon-bone repair using MSCs alone, (b) DBM + MSCs, and (c) GraftJacket + 
MSCs.    
 
 MSCs alone DBM+MSCs GraftJacket+MSCs 
MSCs alone - 0.070 0.613  
DBM+MSCs 0.070 - 0.118 
GraftJacket+MSCs 0.613 0.118 - 
 
Table 6.1: Statistical significance (p-values) between fiber structure following tendon 
reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs.  
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Figure 6.9: Box and whisker plot illustrating the difference in fiber structure 
following tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + 
MSCs.  
 
6.3.3.4 Fiber Arrangement  
  
All groups exhibited a loss of the parallel arrangement observed in the control 
specimens in Chapter Four (intact tendon-bone interface) (Figure 6.8). The median 
score was 1 (95% CI 0.52 to 1.31) in the MSC group, 1 (95% CI 0.81 to 1.69) in the 
DBM + MSC group, and 2 (95% CI 1.70 to 2.13) in the GraftJacket + MSC group 
(Table 6.2) (Figure 6.10). Fiber arrangement was significantly more abnormal in the 
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GraftJacket group than in the DBM group (p = 0.014) and the MSC group (p = 
0.003).  
 
 MSCs alone DBM+MSCs GraftJacket+MSCs 
MSCs alone - 0.179 0.003 
DBM+MSCs 0.179 - 0.014 
GraftJacket+MSCs 0.003 0.014 - 
 
Table 6.2: Statistical significance (p-values) between fiber arrangement following 
tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs.  
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Figure 6.10: Box and whisker plot illustrating the difference in fiber arrangement 
following tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + 
MSCs.  
  
6.3.3.5 Tenocyte Nuclei   
  
Rounding of nuclei (indicating persistent degeneration) was identified in all groups 
following tendon reattachment (Figure 6.11). The median score was 1 (95% CI 0.74 
to 1.60) in the MSC group, 1.50 (95% CI 0.48 to 2.19) in the DBM + MSC group, and 
1 (95% CI 0.79 to 1.88) in the GraftJacket + MSC group (Table 6.3) (Figure 6.12).  
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Figure 6.11: Photomicrograph illustrating rounded nuclei. (a) Controls (tendon-bone 
repair with MSCs alone). (b) DBM + MSC group. (c) GraftJacket + MSC group.  
 
 MSCs alone DBM+MSCs GraftJacket+MSCs 
MSCs alone - 0.523 0.523 
DBM+MSCs 0.523 - 0.859 
GraftJacket+MSCs 0.523 0.859 - 
 
Table 6.3: Statistical significance (p-values) between tenocyte nuclei morphology 
following tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + 
MSCs.  
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Figure 6.12: Box and whisker plot illustrating the difference in tenocyte nuclei 
morphology following tendon reattachment using MSCs alone, DBM + MSCs, and 
GraftJacket + MSCs.  
 
6.3.3.6 Cellularity    
  
Specimens were evaluated for an increase in cellularity, indicating persistent 
degeneration. The median score was 1 (95% CI 0.56 to 1.10) in the MSC group, 1.50 
(95% CI 0.72 to 2.11) in the DBM + MSC group, and 1.25 (95% CI 0.90 to 1.93) in 
the GraftJacket + MSC group (Table 6.4) (Figure 6.13). Cellularity was significantly 
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less (indicating less noticeable degeneration) in the MSC group than in the 
GraftJacket group (p = 0.031).  
 
 MSCs alone DBM+MSCs GraftJacket+MSCs 
MSCs alone - 0.118 0.031 
DBM+MSCs 0.118 - 1 
GraftJacket+MSCs 0.031 1 - 
 
Table 6.4: Statistical significance (p-values) between cellularity following tendon 
reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs.  
 
Figure 6.13: Box and whisker plot illustrating the difference in cellularity following 
tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs. 
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6.3.3.7 Vascularity  
 
Specimens were evaluated for an increase in vascularity, indicating persistent 
degeneration (Longo et al., 2008). The median score was 0 (95% CI -0.13 to 0.30) in 
the MSC group, 0.25 (95% CI -0.26 to 1.42) in the DBM + MSC group, and 0.5 (95% 
CI 0.02 to 0.81) in the GraftJacket + MSC group (Table 6.5) (Figure 6.14).  
 
 MSCs alone DBM+MSCs GraftJacket+MSCs 
MSCs alone - 0.181 0.083 
DBM+MSCs 0.181 - 1 
GraftJacket+MSCs 0.083 1 - 
 
Table 6.5: Statistical significance (p-values) in vascularity following tendon 
reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs.  
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Figure 6.14: Box and whisker plot illustrating the difference in vascularity following 
tendon reattachment using MSCs alone, DBM + MSCs, and GraftJacket + MSCs. 
 
6.3.3.8 Hyalinisation 
 
Hyalinisation was not observed in any of the specimens.  
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6.3.4 Comparison of Quantitative Histology: MSCs vs No MSCs 
 
Results discussed from herein are a direct comparison between the histological 
outcomes in Chapters Five and Six, i.e. MSCs (Chapter Six) versus no MSCs 
(Chapter Five). In this section, the Mann Whitney U test was used to compare the 
results between the two groups.  
 
6.3.4.1 Enthesis Maturation Score 
   
Repairs with MSCs alone and DBM + MSCs resulted in a significantly more mature 
enthesis than repairs augmented with GraftJacket alone (p = 0.044 and 0.007 
respectively). There were no significant differences between other experimental 
groups (Table 6.6) (Figure 6.15).  
  
 Controls (Non-
augmented tendon-
bone repair) 
DBM GraftJacket 
MSCs alone 0.216 1 0.044 
DBM+MSCs 0.107 1 0.007 
GraftJacket+MSCs 1 0.413 0.672 
 
Table 6.6: Statistical significance (p-values) between the enthesis maturation scores 
following tendon reattachment between MSC and non-MSC groups.  
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Figure 6.15: Box and whisker plot illustrating the enthesis maturation scores 
following tendon reattachment between MSC and non-MSC groups.   
 
6.3.4.2 Modified Movin Score  
 
Repairs with MSCs alone resulted in a significantly less degenerative tendon than 
repairs augmented with GraftJacket and non-augmented controls (p = 0.004 and 0.008 
respectively). Furthermore, the addition of MSCs to GraftJacket produced a tendon 
that was significantly less degenerative (p = 0.025). There were no significant 
differences between other experimental groups (Table 6.7) (Figure 6.16).    
 
 214 
 Controls (Non-
augmented tendon-
bone repair) 
DBM GraftJacket 
MSCs alone 0.008 0.126 0.004 
DBM+MSCs 0.423 0.810 0.065 
GraftJacket+MSCs 0.260 0.936 0.025 
   
 
Table 6.7: Statistical significance (p-values) between the modified Movin scores 
following tendon reattachment between MSC and non-MSC groups.      
Figure 6.16: Box and whisker plot illustrating the modified Movin scores following 
tendon reattachment between MSC and non-MSC groups.    
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6.3.4.3 Fiber Structure   
 
The addition of MSCs did not result in any significant improvement in fiber structure 
compared to repairs performed without stem cells (Table 6.8) (Figure 6.17).  
  
 Controls (Non-
augmented tendon-
bone repair) 
DBM GraftJacket 
MSCs alone 0.068 0.190 0.134 
DBM+MSCs 0.799 0.869 0.933 
GraftJacket+MSCs 0.116 0.289 0.218 
 
Table 6.8: Statistical significance (p-values) between the modified Movin scores 
following tendon reattachment between MSC and non-MSC groups.  
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Figure 6.17: Box and whisker plot illustrating the modified Movin scores following 
tendon reattachment between MSC and non-MSC groups.    
 
6.3.4.4 Fiber Arrangement  
  
Fiber arrangement was significantly less abnormal (characterised by a more parallel 
arrangement) in all three MSC groups compared to GraftJacket alone, and the 
addition of MSCs resulted in significantly less abnormal fiber structure compared to 
non-augmented controls (p = 0.044). There were no significant differences between 
other experimental groups (Table 6.9) (Figure 6.18).   
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 Controls (Non-
augmented tendon-
bone repair) 
DBM GraftJacket 
MSCs alone 0.044 0.086 0.003 
DBM+MSCs 0.262 0.473 0.006 
GraftJacket+MSCs 0.195 0.167 0.045 
 
Table 6.9: Statistical significance (p-values) between fiber arrangement following 
tendon reattachment between MSC and non-MSC groups.      
 
Figure 6.18: Box and whisker plot illustrating the difference in fiber arrangement 
following tendon reattachment between MSC and non-MSC groups.       
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6.3.4.5 Tenocyte Nuclei   
 
Significantly less rounded tenocyte nuclei (indicating less degeneration) were 
identified in cases of tendon-bone repair with MSCs alone compared to repairs with 
no augmentation strategy and with GraftJacket (p = 0.047 and 0.015 respectively). 
There were no significant differences between other experimental groups (Table 6.10) 
(Figure 6.19).   
 
 Controls (Non-
augmented tendon-
bone repair) 
DBM GraftJacket 
MSCs alone 0.047 0.149 0.015 
DBM+MSCs 0.402 0.865 0.282 
GraftJacket+MSCs 0.175 0.484 0.080 
 
Table 6.10: Statistical significance (p-values) between tenocyte nuclei morphology 
following tendon reattachment between MSC and non-MSC groups.        
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Figure 6.19: Box and whisker plot illustrating the difference in tenocyte nuclei 
morphology following tendon reattachment between MSC and non-MSC groups.        
  
6.3.4.6 Cellularity    
  
Significantly less cellularity (indicating less degeneration) was identified in cases of 
tendon-bone repair with MSCs alone compared to repairs without stem cells and a 
scaffold, and with GraftJacket (p = 0.016 and 0.003 respectively). Furthermore, the 
addition of MSCs to GraftJacket resulted in significantly less cellularity (p = 0.036). 
There were no significant differences between other experimental groups (Table 6.11) 
(Figure 6.20).  
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 Controls (Non-
augmented tendon-
bone repair) 
DBM GraftJacket 
MSCs alone 0.016 0.120 0.003 
DBM+MSCs 0.677 0.799 0.072 
GraftJacket+MSCs 0.613 0.799 0.036 
  
Table 6.11: Statistical significance (p-values) between cellularity following tendon 
reattachment between MSC and non-MSC groups.    
 
Figure 6.20: Box and whisker plot illustrating the difference in cellularity following 
tendon reattachment between MSC and non-MSC groups.     
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6.3.4.7 Vascularity  
 
Significantly fewer vascular bundles (indicating less degeneration) were identified in 
cases of tendon-bone repair with MSCs alone compared to repairs without stem cells 
and a scaffold, and with GraftJacket (p = 0.013 and 0.016 respectively). Furthermore, 
repairs with GraftJacket + MSCs were significantly less vascular than cases of 
tendon-bone repair without a scaffold (p = 0.041). There were no significant 
differences between other experimental groups (Table 6.12) (Figure 6.21).     
 
 Controls (Non-
augmented tendon-
bone repair) 
DBM GraftJacket 
MSCs alone 0.013 0.181 0.016 
DBM+MSCs 0.138 0.797 0.323 
GraftJacket+MSCs 0.041 0.933 0.115 
 
Table 6.12: Statistical significance (p-values) in vascularity following tendon 
reattachment between MSC and non-MSC groups.  
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Figure 6.21: Box and whisker plot illustrating the difference in vascularity following 
tendon reattachment between MSC and non-MSC groups.  
 
6.3.4.8 Hyalinisation 
 
Hyalinisation was not observed in any of the specimens.  
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6.3.5 pQCT 
  
Control specimens comprised the contralateral shoulder of animals that had 
undergone unilateral tendon detachment three weeks earlier (as discussed in Chapter 
Four). In this group (n = 6), the median total bone mineral density at the supraspinatus 
tendon-bone insertion was 793.25 mg/ccm (95% CI 754.24 to 844.70) (Figure 6.22). 
This significantly decreased six weeks following repair with GraftJacket + MSCs and 
repair with MSCs alone to a median 717.25 mg/ccm (95% CI 582.54 to 782.39) (p = 
0.010) and 719.65 (95% CI 666.80 to 765.27) (p = 0.010) respectively (Table 6.13). 
In repairs with DBM + MSCs, median bone mineral density was 701.20 mg/ccm 
(95% CI 621.27 to 794.73). This was not significantly different to controls (p = 
0.055). No significant increase in bone mineral density was conferred by the addition 
of MSCs to the healing interface (Figure 6.23) (Table 6.14).   
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Figure 6.22: Box and whisker plot showing total bone mineral density at the 
supraspinatus tendon-bone insertion six weeks following repair with MSCs alone, 
cortical DBM and MSCs, and GraftJacket and MSCs. 
 
 Non-operated 
control 
Repair with 
MSCs alone 
DBM with 
MSCs 
GraftJacket with 
MSCs 
Non-operated 
control 
- 0.010 0.055 0.010 
Repair with 
MSCs alone 
0.010  - 0.749 0.873 
DBM with 
MSCs 
0.055 0.749 - 0.749 
GraftJacket 
with MSCs 
0.010  0.873 0.749 - 
 
Table 6.13: Statistical significance (p-values) between total bone mineral density at 
the supraspinatus tendon-bone insertion six weeks following repair with MSCs alone, 
cortical DBM and MSCs, and GraftJacket and MSCs.  
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Figure 6.23: Box and whisker plot showing total bone mineral density at the 
supraspinatus tendon-bone insertion six weeks following repair with and without 
MSCs.  
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 Controls (Non-
augmented tendon-
bone repair)  
DBM GraftJacket 
MSCs alone 0.200 0.337 0.200 
DBM+MSCs 0.631 0.522 0.200 
GraftJacket+MSCs 0.200 0.423 0.337 
 
Table 6.14: Statistical significance (p-values) between total bone mineral density at 
the supraspinatus tendon-bone insertion six weeks following repair with and without 
MSCs.   
 227 
6.4 Discussion  
 
In this chapter, it was hypothesised that compared to MSCs alone, DBM + MSCs 
would regenerate a morphologically superior enthesis characterised by greater 
fibrocartilage formation and improved collagen fiber organisation in a rat model of a 
chronic rotator cuff tear. It was further hypothesised that DBM would result in a 
higher bone mineral density at the insertion site. These hypotheses though, are only 
partially supported by the results.  
 
Using a rat model of chronic rotator cuff degeneration, tendons were reattached to 
their bony insertion with DBM + MSCs, GraftJacket + MSCs, and MSCs alone 
(controls), and analysed after six weeks. MSCs were confined to the healing enthesis 
as illustrated by the presence of QDs on confocal microscopy. All groups 
demonstrated closure of the tendon-bone gap with a fibrocartilaginous enthesis, but 
the degenerative process could not be reversed (as illustrated by a persistently high 
Modified Movin score). Although there were no significant differences in the enthesis 
maturation and Modified Movin scores, repairs augmented with GraftJacket + MSCs 
exhibited a disorganised enthesis, abnormal collagen fiber arrangement, and greater 
cellularity (indicating persistent degeneration) compared to other MSC groups. In 
addition to these histological parameters, bone mineral density at the enthesis was 
examined. This showed that only repairs augmented with DBM + MSCs reached a 
bone mineral density not significantly lower than non-operated controls. This suggests 
that MSCs were able to enhance this aspect of DBM’s function because a similar 
outcome was not observed when DBM was used in isolation (Chapter Five). 
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To determine whether MSCs could enhance the structure of the healing enthesis 
compared to repairs without stem cells, the results of this experiment were compared 
to those from Chapter Five. It was hypothesised that the addition of MSCs would 
yield a morphologically superior interface. This was partially supported by the results, 
in that groups treated with MSCs alone and DBM + MSCs resulted in a more mature 
enthesis (characterised by a significantly higher enthesis maturation score) than those 
repaired with GraftJacket. The addition of MSCs to GraftJacket produced a tendon 
that was significantly less degenerative (characterised by a lower Modified Movin 
score). Furthermore, repairs with MSCs alone produced a tendon that was 
significantly less degenerative than non-augmented controls and repairs enhanced 
with GraftJacket. This highlights a supplementary role of MSCs in enthesis healing 
when used in conjunction with biological scaffolds.  
 
Several in vivo studies have evaluated the use of MSCs in tendon-bone healing 
(Gulotta et al., 2010, Gulotta et al., 2011a, Hernigou et al., 2014, Gulotta et al., 2009). 
In a non-degenerative rotator cuff tear model, Gulotta et al (Gulotta et al., 2009) 
applied MSCs to an acutely detached supraspinatus tendon. At four weeks, the 
biomechanical strengths of the repairs were equal between MSC and control groups, 
and there was no difference in the amount of new cartilage formation or collagen fiber 
organisation. This was attributed to a lack of growth/transcription factors and so 
further studies evaluated the effect of MT1-MMP on MSCs and MSCs transduced 
with Ad-Scx (Gulotta et al., 2010, Gulotta et al., 2011a). The results suggested that 
MSCs used in this context could result in more fibrocartilage, a higher ultimate load 
to failure, and a higher ultimate stress to failure. 
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The current study could not reproduce the results of MSC-induced tendon-bone 
healing observed in other animal models, even in the presence of DBM (Gulotta et al., 
2010, Gulotta et al., 2011a). This is most likely due to the limited tendon-bone surface 
area in a rat model not presenting an environment that is as conducive to healing as 
large animal models and those that utilise a tendon-bone tunnel (Greis et al., 2001, 
Gulotta et al., 2009). DBM contains multiple growth factors such as BMPs and TGFs 
(Sawkins et al., 2013, Veillette and McKee, 2007, Urist, 1965, Urist et al., 1983, 
Reddi, 1998). It is plausible that these were released slowly with time and were 
therefore unable to completely exert their effect on the MSCs during the six weeks 
where enthesis healing was permitted to take place. The next important finding of this 
study was that it was only in the DBM group where bone mineral density did not 
significantly differ from controls, suggesting that there was a predominance of bone 
formation over bone resorption. This is likely to be due to endogenous supplies of 
BMP-2 and TGF-β within DBM acting on MSCs to form new bone in the developing 
enthesis (Sundar et al., 2009b, Urist, 1965).  
 
Limitations of this study are principally due to the short time-period (six weeks) that 
the healing enthesis was allowed to develop over. It is feasible that with a longer 
study protocol, the new bony ingrowth in the DBM group that led to a preservation of 
bone mineral density compared to other experimental groups where bone mineral 
density had decreased, could have developed into fibrocartilage and mineralised 
fibrocartilage. Only one concentration of MSCs was used, as this was extrapolated 
from the existing literature. With greater cell numbers it is possible that a greater 
difference between MSC and non-MSC groups would have been identified. A larger 
number of animals within the groups may have resulted in more significant values and 
 230 
a clearer indication of the benefits or drawbacks of the treatments. The lack of 
biomechanical testing prevents any discussion about functional recovery of the 
enthesis, which is a particularly important consideration in the clinical setting as this 
may affect the success of postoperative rehabilitation.       
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6.5 Conclusion  
 
This study demonstrated that when DBM and MSCs were applied to the healing 
enthesis in a chronic rotator cuff tear model, a fibrocartilaginous-based structure was 
produced, albeit not significantly more mature than other experimental groups. In 
comparison to the results of Chapter Five where stem cells were not used, MSCs were 
found to enhance the effects of GraftJacket and tendon-bone repair without a scaffold. 
Aside from these important histological findings, pQCT analysis showed that it was 
only in the DBM + MSC specimens where bone mineral density was not significantly 
different to non-operated controls.  
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Chapter Seven: General Discussion and Conclusions 
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7.1 Key Findings and Contributions to Current Knowledge 
 
This thesis aimed to investigate the effect of DBM on regeneration of the tendon-bone 
interface, and whether its function could be augmented by MSCs. Particular emphasis 
was given to tendon retraction as this often complicates rotator cuff tears in the 
clinical setting and is associated with a poor outcome (Galatz et al., 2004). The 
following hypothesis was examined: 
 
DBM will improve tendon-bone healing in an enthesis defect model, and its effect may 
be further enhanced by the incorporation of MSCs. 
 
7.2 Mechanical Integrity of Rotator Cuff Repairs  
 
DBM is a collagen-based scaffold containing several growth factors and has been 
postulated to induce tendon-bone regeneration through a cartilaginous precursor 
(Sundar et al., 2009a). Previous studies have examined DBM in models of acute 
tendon rupture, but this is a scenario infrequently encountered in the clinical setting 
where the ruptured rotator cuff tendon retracts and precludes a tension-free repair due 
to the onset of degenerative changes (Sundar et al., 2009a, Meyer et al., 2012a). These 
tendinopathic changes sometimes precede a tear and have additionally been 
recognised in asymptomatic shoulders (Mall et al., 2010). 
 
Scaffolds used in the context of a retracted tendon tear act as an interpositional graft 
and may be the subject of high tensile forces as the musculo-tendinous unit contracts. 
In order to determine the suitability of DBM for this purpose, its mechanical 
 234 
properties were characterised. Porcine and ovine cortical/cancellous scaffolds were 
subjected to tensile forces to evaluate whether cancellous bone could withstand 
without failure, given their higher porosity. Load-deformation analysis for DBM 
indicated that it had an initial non-linear toe region, followed by a linear region, and 
subsequent failure without yielding. The visco-elastic behaviour of demineralised 
bone is similar to tendon tissue and due to the initial straightening of coiled collagen 
fibers followed by stretching. Accordingly, it is plausible that DBM possesses similar 
ductility, toughness, and resistance to fatigue as tendon. Further comparative analysis 
of cortical and cancellous specimens revealed that cancellous scaffolds had such a 
low UTS that it would be unable to resist the forces transmitted through the rotator 
cuff tendon-bone interface without failure. Although this could be enhance by 
increasing the thickness of the graft, it would adversely affect joint movement due to 
the limited space available for other musculo-tendinous units thereby increasing the 
risk of ‘internal impingement.’  
 
7.3 Repair of a Retracted Tendon 
 
When DBM was applied to a large animal model of acute tendon retraction, superior 
results were associated with use of the allograft although it could not be determined 
whether this was due to its mechanical properties or an immunogenic reaction to the 
xenograft due to presence of the α-Gal epitope. Other studies examining healing of a 
retracted tendon using an MSC-collagen gel construct have not been able to produce 
the histological and functional results observed in this study (Awad et al., 1999, 
Juncosa-Melvin et al., 2006). This illustrates the importance of having a strong 
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interpositional graft bridging the tendon-bone interface whilst simultaneously having 
biological factors capable of inducing neo-tendon formation.  
 
7.4 Repair of a Chronic Rotator Cuff Tear 
 
Several animal models of tendon degeneration have been described in the literature 
but none have evaluated the onset of osteopenia at the enthesis or demonstrated fatty 
infiltration (a critical feature observed in the clinical setting and one that is associated 
with poor surgical outcomes) (Goutallier et al., 2003). Accurately reproducing the 
histological conditions that accompany a chronic rotator cuff tear (abnormal collagen 
orientation, abnormal tenocyte morphology, increased cellularity, and increased 
vascularity) is crucial to investigating strategies targeted towards reversing this 
process (Longo et al., 2008). Three weeks after supraspinatus detachment in a Wistar 
rat the musculotendinous unit underwent degeneration and fatty infiltration, and the 
greater tuberosity exhibited a reduction in bone mineral density (Longo et al., 2008). 
These novel findings may have been associated with fundamental inter-species 
differences between the Wistar rats used in this study and the Sprague-Dawley rats 
used in others (Buchmann et al., 2011, Barton et al., 2005, Galan et al., 1993). 
Lipoprotein lipase catalyses the hydrolysis of triglycerides and is highly expressed in 
skeletal tissues. It is regulated differently between Wistar and Sprague-Dawley rats 
and may account for the lack of fat accumulation in otherwise degenerative muscle 
tissue in some studies (Galan et al., 1993).  
 
This model was subsequently used to evaluate the affect of DBM on tendon 
regeneration, and compared to a commercial scaffold that is used widely in clinical 
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practice GraftJacket) and a non-augmented control (direct tendon-bone healing) 
(Wong et al., 2010, Bond et al., 2008). Perhaps the most important finding of this 
study was that the non-augmented control group demonstrated a similar histological 
outcome to those tendons repaired with DBM and dermal collagen, and also resulted 
in a bone mineral density at the tendon insertion comparable to non-operated controls. 
This raises considerable doubt as to the suitability of the rat as a surrogate for chronic 
rotator cuff tendon-bone healing, because in humans spontaneous healing does not to 
occur. The preservation of bone mineral density is advantageous as it may limit 
micromotion of suture anchors within the tendon footprint thereby allowing early 
tendon rehabilitation during the immediate postoperative period without the risk of 
implant failure. This is appealing since applying load to a developing enthesis causes 
bone at the insertion site to mature, an increase in fibrocartilage formation, and an 
improvement in collagen organisation (Thomopoulos et al., 2010).     
 
Stem cells formulate an integral part of many cell-based strategies used to improve 
tendon-bone healing because of their capacity to differentiate and produce 
mineralised fibrocartilage. BMPs are able to enhance their role by promoting 
chondrocytic and osteoblastic differentiation in order to promote a naturally graded 
enthesis with new bone formation providing mechanical integrity (Dorman et al., 
2012, Liu et al., 2010, Gulati et al., 2013, Sun et al., 2015). Contrary to other studies 
though, when applied to the aforementioned degenerative rotator cuff tear model, it 
was not found to have a supplementary effect (Gulotta et al., 2010, Gulotta et al., 
2011a). However, this may have been due to the isolated time point used for analysis 
(six weeks) and its inability to discern between subtle differences in collagen structure 
and cellularity that occurred either earlier or later in the healing process.  
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7.5 Applications  
 
As a result of the work carried out in this thesis there is now increasing evidence 
supporting the use of DBM for tendon-bone healing. Not only is this applicable to the 
rotator cuff, but to other anatomical sites of tendon-bone injury where healing can be 
comprised by degeneration and retraction such as the Achilles tendon and 
extensor/flexor tendons of the hand.  
 
7.6 Limitations  
 
This thesis is centered around two in vivo models of tendon-bone healing: the ovine 
patellar tendon and the rat’s supraspinatus. Initially, the former was used to assess the 
regenerative capacity of DBM, as it is not reliant upon subsidiary structures for 
stability, and therefore can accurately evaluate the effect of biological scaffolds on 
tendon-bone healing. However, it is not possible to create a degenerative model based 
on this, because detachment of the patellar tendon (to induce degeneration) would 
render the animals permanently lame and thus be unethical. For this reason the rat’s 
shoulder presented an appealing alternative. The results though, indicate that the 
detached supraspinatus tendon in a rat undergoes spontaneous healing within six 
weeks. Macroscopically it was not possible to discern non-augmented tendon repairs 
from augmented ones, although with earlier/longer time points, subtle differences 
may have been detected. This raises doubts as to the suitability of the rat as a model 
of rotator cuff function and is the main limitation of this thesis.  
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Considerable histological differences were observed between entheses treated with 
DBM (organised structure) and GraftJacket (disorganised structure), although these 
did not reach statistical significance. It is plausible that the histological scoring system 
used to assess these changes was not sensitive enough as it did not adequately 
discriminate between organised and disorganised areas of mineralised fibrocartilage. 
Furthermore, due to restrictions in the number of animals that could be used for each 
in vivo study, biomechanical testing of the repair construct could not be undertaken 
and therefore limits the interpretation of the histological results.     
 
7.7 General Conclusions  
 
1. The UTS of demineralised cortical bone is greater than that of cancellous bone. 
2. The UTS of ovine demineralised bone is greater than that of porcine bone.  
3. In an acute model of severe tendon retraction, DBM + mmMSCs are able to 
remodel across the entire length of the tendon and result in a fibrocartilaginous 
enthesis.  
4. Allogenic DBM is associated with superior histological and mechanical properties 
than its xenogenic derivative in an acute model of severe tendon retraction.  
5. Three weeks following supraspinatus tendon detachment in a Wistar rat the 
musculotendinous unit undergoes degeneration including fatty infiltration, and the 
bony insertion develops osteopenia.  
6. Application of DBM to a chronic rotator cuff tear results in a fibrocartilaginous 
enthesis not significantly more mature than non-augmented controls or a 
commercially available alternative scaffold (GraftJacket). 
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7. Application of DBM to a chronic rotator cuff tear does not reverse the 
degenerative changes in the supraspinatus musculo-tendinous unit.  
8. Application of DBM to a chronic rotator cuff tear does not increase bone mineral 
density to pre-injury levels.  
9. Application of DBM + MSCs to a chronic rotator cuff tear results in a 
fibrocartilaginous enthesis not significantly more mature than non-augmented 
controls or a commercially available alternative scaffold (GraftJacket). 
10. Application of DBM + MSCs to a chronic rotator cuff tear does not reverse the 
degenerative changes in the supraspinatus musculo-tendinous unit. 
11. Application of DBM + MSCs to a chronic rotator cuff tear preserves bone mineral 
density to pre-injury levels. 
 
7.8 Future Work  
 
7.8.1 In Vitro 
 
DBM has been demonstrated to enhance tendon-bone healing but the precise cellular 
mechanisms governing this process are unknown. Several growth factors have been 
identified within demineralised bone but so far it is only the elution of BMP-7 that has 
been characterised (Pietrzak et al., 2012). Other proteins such as BMP-2 and TGF 
exert a stimulatory effect on the healing enthesis but these have not been studied in 
the same way (Rodeo et al., 2007). In particular, BMPs have been shown to cause 
MSC differentiation and so future studies should evaluate MSC seeding on DBM to 
see if it can be harnessed to enhance stem cell function and therefore improve 
regeneration of a direct enthesis (Dorman et al., 2012, Toh et al., 2005).  
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Xenografts were associated with inferior mechanical and histological properties when 
compared to their allogenic derivatives in a large animal model of tendon retraction 
(Chapter Three). Hyper-acute rejection may have been responsible for this and should 
be investigated by staining the scaffold with human serum containing the anti-Gal 
antibody, and then identifying the α-Gal epitope using a sialic acid-binding lectin 
(Zheng et al., 2005, McDevitt et al., 2003, Mathapati et al., 2011, Kim et al., 2009).    
 
Evaluation of the material properties of human demineralised cortical/cancellous bone 
would provide useful information for any potential future translational work. This 
would include defining its stress/strain, ultimate tensile strength, Young’s modulus, 
ductility, fatigue, toughness, and creep. Comparing these values to those obtained 
from the human supraspinatus tendon would determine the suitability of DBM as a 
potential graft material in the clinical setting.   
 
7.8.2 In Vivo  
  
Future in vivo studies should focus on developing a model of rotator cuff function 
characterised by degeneration, a lack of spontaneous healing, an arch-like structure 
covering the supraspinatus tendon (similar to the coraco-acromial arch in humans), 
the influence of other shoulder muscles such as the deltoid, and movement in both the 
sagittal and coronal planes. The ovine model of chronic rotator cuff degeneration 
(involving detachment and subsequent reattachment of infraspinatus) may be suitable 
because it possesses many of these features, including fatty infiltration, which has not 
been previously observed in a rat model other than in Chapter Four of this thesis 
(Gerber et al., 2004, Buchmann et al., 2011, Melrose et al., 2013). The rat model 
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specifically is commonly used to investigate biological strategies at the healing 
enthesis but its ability to self-regenerate viable and functional tendon tissue even in 
the presence of a tissue-defect does raise some concerns. Wistar rats warrant further 
study as they develop fatty infiltration following tendon detachment unlike their 
Sprague-Dawley counterparts.  
 
Following further in vivo work there may be sufficient evidence to commence a pilot 
study with humans as a precursor to a randomised controlled clinical trial.
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